
<html lang="en"     class="pb-page"  data-request-id="9810e36e-4c99-490c-9193-29377c407069"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-16;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b01588;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood–Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases" /></meta><meta name="dc.Creator" content="Ronan  Gealageas" /></meta><meta name="dc.Creator" content="Alice  Devineau" /></meta><meta name="dc.Creator" content="Pauline P. L.  So" /></meta><meta name="dc.Creator" content="Catrina M. J.  Kim" /></meta><meta name="dc.Creator" content="Jayakumar  Surendradoss" /></meta><meta name="dc.Creator" content="Christian  Buchwalder" /></meta><meta name="dc.Creator" content="Markus  Heller" /></meta><meta name="dc.Creator" content="Verena  Goebeler" /></meta><meta name="dc.Creator" content="Edith M.  Dullaghan" /></meta><meta name="dc.Creator" content="David S.  Grierson" /></meta><meta name="dc.Creator" content="Edward E.  Putnins" /></meta><meta name="dc.Description" content="Studies indicate that MAO-B is induced in peripheral inflammatory diseases. To target peripheral tissues using MAO-B inhibitors that do not permeate the blood–brain barrier (BBB) the MAO-B-selectiv..." /></meta><meta name="Description" content="Studies indicate that MAO-B is induced in peripheral inflammatory diseases. To target peripheral tissues using MAO-B inhibitors that do not permeate the blood–brain barrier (BBB) the MAO-B-selectiv..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 18, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01588" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01588" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01588" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01588" /></link>
        
    
    

<title>Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood–Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01588" /></meta><meta property="og:title" content="Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood–Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0018.jpeg" /></meta><meta property="og:description" content="Studies indicate that MAO-B is induced in peripheral inflammatory diseases. To target peripheral tissues using MAO-B inhibitors that do not permeate the blood–brain barrier (BBB) the MAO-B-selective inhibitor deprenyl was remodeled by replacing the terminal acetylene with a CO2H function, and incorporating a para-OCH2Ar motif (compounds 10a–s). Further, in compound 32 the C-2 side chain corresponded to CH2CN. In vitro, 10c, 10j, 10k, and 32 were identified as potent reversible MAO-B inhibitors, and all four compounds were more stable than deprenyl in plasma, liver microsomal, and hepatocyte stability assays. In vivo, they demonstrated greater plasma bioavailability. Assessment of in vitro BBB permeability showed that compound 10k is a P-glycoprotein (P-gp) substrate and 10j displayed mild interaction. Importantly, compounds 10c, 10j, 10k, and 32 displayed significantly reduced BBB permeability after intravenous, subcutaneous, and oral administration. These polar MAO-B inhibitors are pertinent leads for evaluation of efficacy in noncentral nervous system (CNS) inflammatory disease models." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01588"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01588">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01588&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01588&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01588&amp;href=/doi/10.1021/acs.jmedchem.7b01588" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 7043-7064</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01620" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00084" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood–Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Ronan Gealageas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ronan Gealageas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmaceutical Sciences, The University of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ronan++Gealageas">Ronan Gealageas</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alice Devineau</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alice Devineau</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmaceutical Sciences, The University of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alice++Devineau">Alice Devineau</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pauline P. L. So</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pauline P. L. So</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drug Research and Development, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pauline+P.+L.++So">Pauline P. L. So</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Catrina M. J. Kim</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Catrina M. J. Kim</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drug Research and Development, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Catrina+M.+J.++Kim">Catrina M. J. Kim</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jayakumar Surendradoss</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jayakumar Surendradoss</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drug Research and Development, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jayakumar++Surendradoss">Jayakumar Surendradoss</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christian Buchwalder</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christian Buchwalder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmaceutical Sciences, The University of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Buchwalder">Christian Buchwalder</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5577-8870" title="Orcid link">http://orcid.org/0000-0001-5577-8870</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Markus Heller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Markus Heller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drug Research and Development, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Heller">Markus Heller</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1307-8654" title="Orcid link">http://orcid.org/0000-0002-1307-8654</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Verena Goebeler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Verena Goebeler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Dentistry, The University of British Columbia, 2199 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Verena++Goebeler">Verena Goebeler</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6847-3141" title="Orcid link">http://orcid.org/0000-0002-6847-3141</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Edith M. Dullaghan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edith M. Dullaghan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drug Research and Development, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edith+M.++Dullaghan">Edith M. Dullaghan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David S. Grierson</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David S. Grierson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Pharmaceutical Sciences, The University of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><span class="conrtib-corresp"><strong>*</strong>Phone +1 604 8273353. E-mail: <a href="/cdn-cgi/l/email-protection#d6b2b1a4bfb3a4a5b996bbb7bfbaf8a3b4b5f8b5b7"><span class="__cf_email__" data-cfemail="dfbbb8adb6baadacb09fb2beb6b3f1aabdbcf1bcbe">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+S.++Grierson">David S. Grierson</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4745-4240" title="Orcid link">http://orcid.org/0000-0002-4745-4240</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Edward E. Putnins</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Edward E. Putnins</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Faculty of Dentistry, The University of British Columbia, 2199 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</div></div><span class="conrtib-corresp"><strong>*</strong>Phone +1 604 8221734. E-mail: <a href="/cdn-cgi/l/email-protection#106065647e797e635074757e6479636462693e6572733e7371"><span class="__cf_email__" data-cfemail="ef9f9a9b8186819caf8b8a819b869c9b9d96c19a8d8cc18c8e">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Edward+E.++Putnins">Edward E. Putnins</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8613-324X" title="Orcid link">http://orcid.org/0000-0001-8613-324X</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01588&amp;href=/doi/10.1021%2Facs.jmedchem.7b01588" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 7043–7064</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 18, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 December 2017</li><li><span class="item_label"><b>Published</b> online</span>18 July 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 August 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01588" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01588</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7043%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRonan%2BGealageas%252C%2BAlice%2BDevineau%252C%2BPauline%2BP.%2BL.%2BSo%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D16%26contentID%3Dacs.jmedchem.7b01588%26title%3DDevelopment%2Bof%2BNovel%2BMonoamine%2BOxidase-B%2B%2528MAO-B%2529%2BInhibitors%2Bwith%2BReduced%2BBlood%25E2%2580%2593Brain%2BBarrier%2BPermeability%2Bfor%2Bthe%2BPotential%2BManagement%2Bof%2BNoncentral%2BNervous%2BSystem%2B%2528CNS%2529%2BDiseases%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7064%26publicationDate%3DAugust%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01588"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1815</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01588" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood–Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) Diseases&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Ronan&quot;,&quot;last_name&quot;:&quot;Gealageas&quot;},{&quot;first_name&quot;:&quot;Alice&quot;,&quot;last_name&quot;:&quot;Devineau&quot;},{&quot;first_name&quot;:&quot;Pauline&quot;,&quot;last_name&quot;:&quot;P. L. So&quot;},{&quot;first_name&quot;:&quot;Catrina&quot;,&quot;last_name&quot;:&quot;M. J. Kim&quot;},{&quot;first_name&quot;:&quot;Jayakumar&quot;,&quot;last_name&quot;:&quot;Surendradoss&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Buchwalder&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Heller&quot;},{&quot;first_name&quot;:&quot;Verena&quot;,&quot;last_name&quot;:&quot;Goebeler&quot;},{&quot;first_name&quot;:&quot;Edith&quot;,&quot;last_name&quot;:&quot;M. Dullaghan&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;S. Grierson&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;E. Putnins&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;18&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;7043-7064&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01588&quot;},&quot;abstract&quot;:&quot;Studies indicate that MAO-B is induced in peripheral inflammatory diseases. To target peripheral tissues using MAO-B inhibitors that do not permeate the blood–brain barrier (BBB) the MAO-B-selective inhibitor deprenyl was remodeled by replacing the terminal acetylene with a CO2H function, and incorporating a para-OCH2Ar motif (compounds 10a–s). Further, in compound 32 the C-2 side chain corresponded to CH2CN. In vitro, 10c, 10j, 10k, and 32 were identified as potent reversible MAO-B inhibitors, and all four compounds were more stable than deprenyl in plasma, liver microsomal, and hepatocyte stability assays. In vivo, they demonstrated greater plasma bioavailability. Assessment of in vitro BBB permeability showed that compound 10k is a P-glycoprotein (P-gp) substrate and 10j displayed mild interaction. Importantly, compounds 10c, 10j, 10k, and 32 displayed significantly reduced BBB permeability after intravenous, subcutaneous, and oral administration. These polar MAO-B inhibitors are pertinent leads for evalua&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01588&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01588" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01588&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01588" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01588&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01588" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01588&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01588&amp;href=/doi/10.1021/acs.jmedchem.7b01588" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01588" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01588" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01588%26sid%3Dliteratum%253Aachs%26pmid%3D30016860%26genre%3Darticle%26aulast%3DGealageas%26date%3D2018%26atitle%3DDevelopment%2Bof%2BNovel%2BMonoamine%2BOxidase-B%2B%2528MAO-B%2529%2BInhibitors%2Bwith%2BReduced%2BBlood%25E2%2580%2593Brain%2BBarrier%2BPermeability%2Bfor%2Bthe%2BPotential%2BManagement%2Bof%2BNoncentral%2BNervous%2BSystem%2B%2528CNS%2529%2BDiseases%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D16%26spage%3D7043%26epage%3D7064%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/jmcmar.2018.61.issue-16/20180823/jmcmar.2018.61.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Studies indicate that MAO-B is induced in peripheral inflammatory diseases. To target peripheral tissues using MAO-B inhibitors that do not permeate the blood–brain barrier (BBB) the MAO-B-selective inhibitor deprenyl was remodeled by replacing the terminal acetylene with a CO<sub>2</sub>H function, and incorporating a <i>para</i>-OCH<sub>2</sub>Ar motif (compounds <b>10a</b>–<b>s</b>). Further, in compound <b>32</b> the C-2 side chain corresponded to CH<sub>2</sub>CN. In vitro, <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> were identified as potent reversible MAO-B inhibitors, and all four compounds were more stable than deprenyl in plasma, liver microsomal, and hepatocyte stability assays. In vivo, they demonstrated greater plasma bioavailability. Assessment of in vitro BBB permeability showed that compound <b>10k</b> is a P-glycoprotein (P-gp) substrate and <b>10j</b> displayed mild interaction. Importantly, compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> displayed significantly reduced BBB permeability after intravenous, subcutaneous, and oral administration. These polar MAO-B inhibitors are pertinent leads for evaluation of efficacy in noncentral nervous system (CNS) inflammatory disease models.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05500" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05500" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Monoamine oxidases (MAOs, EC 1.4.3.4) are mitochondrial outer membrane enzymes that catalyze the oxidative deamination of various endogenous (neurotransmitters) and dietary amines to form an aldehyde, ammonia (or a substituted amine), and H<sub>2</sub>O<sub>2</sub> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a).<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Hydrogen peroxide is an oxidative stress molecule, implicated in normal cellular and pathophysiological roles, which undergoes reduction to highly reactive hydroxyradicals via the iron-dependent Fenton reaction.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> The two MAO isoenzymes, MAO-A and MAO-B, contain a covalently bound flavin adenine dinucleotide (FAD) cofactor. However, they have different tissue distribution and substrate specificities. MAO-A preferentially catalyzes the oxidation of 5-HT (serotonin), whereas MAO-B oxidizes benzylamine and 2-phenylethylamine. Dopamine, noradrenaline, adrenaline, tryptamine, and tyramine are oxidized by both isoenzymes.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Clorgyline and deprenyl (selegiline)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> are selective MAO-A and MAO-B inhibitors, respectively, whereas phenelzine (phenethylhydrazine) inhibits both MAO isoforms.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> These and related drugs of this class<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> were initially developed as antidepressants. More recently, their therapeutic value has been extended to the clinical management of neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s disease (AD).<a onclick="showRef(event, 'ref4 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref7">(4,7)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) MAO activity and selective MAO-A/B inhibitors; (b) incorporation of a CO<sub>2</sub>H function into drug structures suppresses BBB penetration; (c) irreversible MAO inhibition by rasagiline.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Protein and mRNA analysis and positron emission tomography (PET) imaging have shown that MAO-A and -B are widely expressed in peripheral tissues such as placenta, duodenum, lung, liver, kidney, thyroid, spleen, and heart. However, expression of each enzyme does vary across these tissues.<a onclick="showRef(event, 'ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10 ref11">(8−11)</a> Human platelets and lymphocytes only express MAO-B, whereas endothelial cells of lymphatic vessels only express MAO-A.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Use of MAO-A, MAO-B, and MAO-A/B inhibitors has traditionally been prescribed for CNS-associated disorders.<a onclick="showRef(event, 'ref4 ref7'); return false;" href="javascript:void(0);" class="ref ref4 ref7">(4,7)</a> However, a review of patents filed from 2002 to 2017 outlined how this class of drugs may have the therapeutic potential to manage a variety of non-CNS disorders such as inflammation, obesity/diabetes, hair growth, cancer, cardiovascular damage, ocular diseases, and muscle dystrophies.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Their potential to manage inflammation associated with chronic diseases has a growing body of support.</div><div class="NLM_p">Treatment of patients suffering from Crohn’s disease or rheumatoid arthritis with MAO-A/B inhibitors (phenelzine, tranylcypromine) was associated with disease remission.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> In addition, MAO-B knockout mice showed less apoptosis and fibrosis in cardiac pressure overload experiments, and gene expression profiling in tissues from patients with atrial fibrillation identified MAO-B as one of five significantly induced oxidative stress proteins.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> Treatment of mice in a diabetic cardiomyopathy model with the MAO-B inhibitor pargyline<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> reduced mast cell degranulation, cardiac fibrosis, and normalized diastolic function.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Pertinent to the present study, Ekuni et al.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> identified MAO-B as one of the 10 most significantly up-regulated genes in epithelial tissues harvested from rats with lipopolysaccharide-induced chronic inflammatory periodontal disease. Interestingly, inhibition of MAO-A/B activity with phenelzine effectively reduced disease progression. Collectively, these data support that MAO activity is induced in peripheral chronic inflammatory diseases and that MAO inhibition is associated with reduction in disease severity.</div><div class="NLM_p">MAO-A (moclobemide), MAO-B (deprenyl), and MAO-A/B inhibitor (phenelzine) have all been shown to reduce pro-inflammatory or induce anti-inflammatory cytokine expression in a number of cell lines.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18−21)</a> These data further support their development as potential anti-inflammatory agents. However, by focusing on selective MAO-B inhibitors the ability of MAO-A to degrade dietary tyramine in the gut is preserved. Therefore, the risk of patients experiencing the “cheese effect”, which induces hypertensive crisis in patients treated with MAO-A inhibitors, would be reduced.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Selective targeting of peripheral tissues with MAO-B inhibitors can be achieved by designing polar MAO-B inhibitor-based drugs that do not permeate the BBB. An additional advantage to this strategy is the potential to further reduce a relatively rare CNS side effect. MAO inhibitors have been associated with serotonin increase in the brain (serotonin syndrome), resulting in mental status changes, autonomic hyperactivity, and neuromuscular abnormalities.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Typically, the MAO-B-selective inhibitor deprenyl (selegiline)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> has quite a low incidence of serotonin syndrome, but reduced CNS permeability of novel polar MAO-B inhibitors would further reduce the risk of serotonin syndrome.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">To remodel the MAO-B-selective drug deprenyl, such that it no longer crosses the BBB, inspiration was taken from the structures of the second/third-generation antihistamines cetirizine<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> and fexofenadine<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>b). By incorporating a CO<sub>2</sub>H function into the structure of these drugs the peripheral histamine receptors are targeted without the undesired secondary effects of drowsiness and loss of concentration associated with use of their first-generation congeners chlorphenamine and terfenadine, which readily penetrate the BBB.</div><div class="NLM_p">Deprenyl, like the related drug rasagiline (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>c), is an irreversible MAO-B inhibitor, since the <i>N</i>-propargyl unit in its structure reacts with the FAD cofactor to form a covalent azadiene-type adduct.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> Importantly, the presence of the acetylene motif indicates that significant space exists in the enzyme active site between the FAD cofactor and the tertiary amine function undergoing redox dealkylation. Consequently, no significant steric clash should occur between FAD and a deprenyl analog in which the acetylene unit is replaced by a CO<sub>2</sub>H function, as in the <span class="smallcaps smallerCapital">l</span>-methamphetamine derivative <b>A</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Further, the possibility for H-bonding/salt bridge interactions to occur between the CO<sub>2</sub>H group in <b>A</b> and the 5-nitrogen of FAD or to one of the multiple tyrosine residues lining the catalytic site/pocket would, in principle, reinforce binding in the MAO-B active site. Also, as compound <b>A</b> lacks reactive functionality it would be a reversible MAO-B inhibitor. Interestingly, in silico calculations<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> predicted that despite the presence of the terminal CO<sub>2</sub>H group compound <b>A</b> would still manage to cross the BBB. However, compound <b>10a</b> (R<sup>1</sup> = R<sup>2</sup> = H, R<sup>3</sup> = Me) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), incorporating an additional <i>O</i>-benzyl motif on the para position of the phenyl ring, was predicted to not be BBB permeable.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of deprenyl, the polar deprenyl-inspired compounds <b>A</b> and <b>B</b>, and the <b>B</b>-type compound <b>10a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Herein, results are presented on the synthesis and evaluation of compound <b>10a</b> and 24 additional <span class="smallcaps smallerCapital">l</span>-methamphetamine analogues of general structure <b>B</b>. The results obtained demonstrate that these deprenyl-inspired compounds <b>B</b> maintain selective affinity for MAO-B. Further, the ability of the most active inhibitors to cross the BBB is very significantly attenuated.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55758" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55758" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> In Silico Prediction of CO<sub>2</sub>H-Functionalized Methamphetamines Related to Deprenyl to Cross the BBB</h3><div class="NLM_p">In silico prediction of whether compounds in which the acetylene subunit in deprenyl was exchanged for a polar carboxylic acid motif would cross the BBB were made using the Simulations Plus ADMET predictor software (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Two values were determined from the BBB algorithm: a “high” or “low” score predicting that the molecule will or will not enter the CNS and a numerical LogBBB value indicative of the ratio of compound in blood relative to brain. Although negative values for LogBBB indicate that the concentration of the molecule in the blood is superior to that in the brain, the high/low calculated values are more predictive. The calculations suggested that replacing the acetylene by CO<sub>2</sub>H would not be sufficient to block BBB passage (entry 1). Exchanging the amphetamine methyl group by CO<sub>2</sub>H, so as to have two acid functions in the molecule (entry 2), or introducing a polar phenolic OH at the para position (entry 3), also does not tip the scale. However, introducing a benzyl group onto the phenolic OH, as in <b>10a</b>, provided molecules predicted to not cross the BBB (Entry 4).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Silico Prediction of BBB Passage for CO<sub>2</sub>H-Functionalized Methamphetamines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0015.gif" alt="" id="fx1" /></img><div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry</h3><div class="NLM_p">The synthetic route developed to access compounds <b>10a</b>–<b>s</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), bearing different functionality in the −OCH<sub>2</sub>Aryl ring from <span class="smallcaps smallerCapital">l</span>-tyrosine ester carbamate <b>1</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> involved, in the first steps, introduction of an <i>O</i>-benzyl group to give <b>2</b> (BnBr, acetone, K<sub>2</sub>CO<sub>3</sub>; 85%<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a>), LAH reduction of the ester function (known to occur without racemization<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>), conversion of the derived alcohol <b>3</b> to the corresponding tosylate <b>4</b> (TsCl, Bu<sub>4</sub>NHSO<sub>4</sub> in benzene–H<sub>2</sub>O; 67%), and zinc metal reduction of the corresponding iodide generated in situ through iodine exchange of the tosylate group (94%).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> This four-step procedure provided ready access to multigram quantities of the (<i>R</i>)-<span class="smallcaps smallerCapital">l</span>-amphetamine derivative <b>5</b>.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0012.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) BnBr, K<sub>2</sub>CO<sub>3</sub>, acetone, RT 16 h then reflux 3 h, 85%; (ii) LAH, THF, RT, 95%; (iii) TsCl, <i>n</i>-Bu<sub>4</sub>NHSO<sub>4</sub>, 10% aq NaOH–C<sub>6</sub>H<sub>6</sub>, RT, 30 min, 67%; (iv) Zn dust, NaI, THF–H<sub>2</sub>O, reflux, 2.5 h, 94%; (v) LAH, THF, reflux, 4 h, 54%; (vi) <i>tert</i>-butyl bromoacetate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, RT, 15 h, 79%; (vii) Pd/C(cat), H<sub>2</sub>, MeOH, 99%; (viii) ArCH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, RT, 15 h, 36–99%; (ix) (for <b>9n</b>) 3-OMeBnOH, DIAD, PPh<sub>3</sub>, THF, RT, 3 min, 62%; (x) conc. HCl, THF, 0 °C, 3 h, 35–87%; (xi) Propargyl bromide, Cs<sub>2</sub>CO<sub>3</sub>, THF, RT 15h, 42%.</p></p></figure><div class="NLM_p">Reduction of the carbamate function in <b>5</b> using LAH in refluxing THF followed by alkylation of the derived secondary amino group in <i>O</i>-benzyl methamphetamine <b>6</b> with <i>tert</i>-butyl bromoacetate in DMF, using K<sub>2</sub>CO<sub>3</sub> as base, produced the pivotal intermediate <b>7</b>. At this juncture, acid hydrolysis of the <i>tert</i>-butyl ester group in <b>7</b> gave <i>O</i>-benzyl amphetamine carboxylic acid derivative <b>10a</b>, whereas hydrogenolysis of the <i>O</i>-benzyl group in <b>7</b> provided phenol <b>8</b>, which served as the precursor to intermediates <b>9b</b>–<b>s</b>. With the exception of the conversion of <b>8</b> to <b>9n</b> under Mitsunobu conditions, compounds <b>9b</b>–<b>m</b> and <b>9o</b>–<b>s</b> were obtained by <i>O</i>-alkylation of the phenolic hydroxyl group in <b>8</b> through reaction with requisite benzyl halide. Subsequent acid treatment of compounds <b>9</b> liberated the acid function in the target compounds <b>10b</b>–<b>s</b>. Further, in order to have the <i>O</i>-benzyl-substituted deprenyl analog <b>11</b> as a control/reference compound (see <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), it was prepared by reacting intermediate <b>6</b> with propargyl bromide using Cs<sub>2</sub>CO<sub>3</sub> as base (42%).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro MAO-A/B Inhibition Results<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a> and Their Comparison to Deprenyl, Clorgyline, Safinamide, and Reference Compound <b>11</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0016.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0017.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">All values represent the means of data ± SEM from two independent experiments, each performed in duplicate.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Compounds did not reach 50% inhibition at the highest compound concentration tested (50 μM), i.e., Prism was unable to calculate an IC<sub>50</sub> value within the curvature (>50 μM (UTC) = unable to calculate).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">IC<sub>50</sub> values were determined by extrapolating the curvature of log (inhibitor) vs normalized response with a variable slope in Prism 5.02 (GraphPad Software) resulting in higher than 50 μM IC<sub>50</sub> values.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">Two independent experiments were performed, but GraphPad Prism was unable to determine an IC<sub>50</sub> value for MAO-A for both experiments; therefore, no SEM is shown.</p></div><div class="footnote" id="t2fn5"><sup><sup>e</sup></sup><p class="last">IC<sub>50</sub> values represent data from one independent experiment, performed in duplicate.</p></div></div><div></div></div><div class="NLM_p">To access compounds <b>21</b> and <b>22</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), in which the C-2 methyl group in <b>10a</b> and <b>10c</b> is replaced by a more polar ester function, Boc-<span class="smallcaps smallerCapital">l</span>-tyrosine methyl ester <b>11</b><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> was converted to the corresponding <i>O</i>-benzyl and <i>O</i>-3-chlorobenzyl derivatives <b>13</b> and <b>14</b>, respectively. <i>N</i>-Methylation of the carbamate nitrogen in these intermediates (MeI, NaH, THF)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> gave <b>15</b> and <b>16</b>. Note that in these reactions ester demethylation occurred, presumably during reaction quench and workup. Of further note was the observation that the presence of rotomers about the amide bond was observed in the <sup>1</sup>H NMR spectra for these two intermediates. Reaction of <b>15</b> and <b>16</b> with SOCl<sub>2</sub>–MeOH resulted in both <i>N</i>-Boc deprotection and reintroduction of the methyl ester function. Subsequent reaction of <i>N</i>-methyl esters <b>17</b> and <b>18</b> with <i>tert</i>-butyl bromoacetate followed by acid treatment provided the desired <i>O</i>-benzylated ester–acids <b>21</b> and <b>22</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) BnBr or 3-ClBnBr, K<sub>2</sub>CO<sub>3</sub>, acetone, RT 16 h than reflux 3 h, 95% for <b>13</b>, 100% for <b>14</b>; (ii) MeI, NaH, THF, RT, 15 h, 35% for <b>15</b>, 76% for <b>16</b>; (iii) SO<sub>2</sub>Cl, MeOH, RT, 15 h, 62% for both <b>17</b> and <b>18</b>; (iv) <i>tert</i>-butyl bromoacetate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, RT, 15 h, 49% for <b>19</b>, 54% for <b>20</b>; (v) conc. HCl, THF, 0 °C, 3 h, 86% for <b>21</b>, 75% for <b>22</b>.</p></p></figure><div class="NLM_p">To further obtain polar deprenyl-inspired compounds <b>25</b>, <b>26</b>, <b>29</b>, and <b>32</b>, (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>) wherein the C-2 methyl group is functionalized by an OH, an OBn, and a CN function, both the carbamate and the ester groups in the tyrosine derivative <b>2</b> were reduced using LAH in refluxing THF to give alcohol <b>23</b>. <i>N</i>-Alkylation of <b>23</b> with <i>tert-</i>butyl bromoacetate in the presence of Cs<sub>2</sub>CO<sub>3</sub> and NaI(cat) under microwave heating conditions led to direct formation of carboxylic acid <b>25</b>. Alternatively, <i>N</i>-alkylation of <b>23</b> (<i>tert</i>-butyl bromoacetate, Et<sub>3</sub>N, DMF, RT) followed by <i>O</i>-benzylation of the derived alcohol <b>24</b> (BnBr, NaH, THF, 15 h) and acid treatment gave compound <b>26</b>. To prepare compounds <b>29</b> and <b>32</b>, alcohol <b>24</b> was reacted with TsCl and the derived chloro intermediate <b>27</b> was reacted with KCN to give <b>28</b>. Subsequent reaction of <b>28</b> with acid effected ester hydrolysis to give <b>29</b>, whereas hydrogenolysis of the <i>O</i>-benzyl group in <b>28</b> gave phenol <b>30</b>. Reaction of <b>30</b> with 3,4-dichlorobenzyl bromide followed by treatment of intermediate <b>31</b> with acid gave the target compound <b>32</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) LAH, THF, reflux, 3 h, 88%; (ii) <i>tert</i>-butyl bromoacetate, Et<sub>3</sub>N, DMF, RT, 15 h, 80%; (iii) BnBr, NaH, THF, 15 h, then conc HCl, 2 h, 46%; (iv) <i>tert</i>-butyl bromoacetate, Cs<sub>2</sub>CO<sub>3</sub>, NaI (cat), DMF, 30 min, 90 °C, μW, 66%; (v) TsCl, Et<sub>3</sub>N, DMAP, DCM, RT, 15 h, 88%; (vi) KCN, 18-C-6, NaI (cat), DMF, 100 °C, 90 min, 80%; (vii) Pd/C, H<sub>2</sub> (1 atm), 90%; (viii) 3,4-diClBnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, RT, 15 h, 88%; (ix) conc. HCl, THF, 0 °C, 3 h, 77% for <b>29</b>, 66% for <b>32</b>.</p></p></figure><div class="NLM_p last">With the exception of intermediates <b>9n</b> and <b>18</b>, where byproducts were detected in the <sup>1</sup>H NMR spectra, the proton spectra for all compounds showed the presence of a unique product, whose peak positions and multiplicities were consistent with the proposed structures. Note that purification of final product <b>10n</b> and intermediate <b>20</b> by column chromatography enabled removal of the impurity observed in their precursors <b>9n</b> and <b>18</b>. For all final compounds tested, purity was established by HPLC (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). The HPLC experiments were conducted on samples that were stored at −20 °C for an extended period of time (>1.5 years) in water or water–DMSO prior to evaluation. With the exception of compounds <b>10m</b> (93.6%), <b>10p</b> (91.8%), <b>22</b> (93.4%), and <b>25</b> (91.6%), the other 21 compounds were established to be >95% pure.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> In Vitro MAO Inhibition Assay Results</h3><div class="NLM_p">The 25 polar deprenyl-inspired compounds B (<b>10a</b>–<b>s</b>, <b>21</b>, <b>22</b>, <b>25</b>, <b>26</b>, <b>29</b>, and <b>32</b>) described in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a> were tested against human recombinant MAO-A and MAO-B in a cell-free biochemical assay to determine to what extent replacement of the terminal acetylene motif in deprenyl by a carboxylic acid function and introduction of a −OCH<sub>2</sub>Ar motif onto the para position of the phenyl ring influenced activity/potency and MAO-B selectivity.</div><div class="NLM_p">In the presence of the serially diluted compounds, each monoamine oxidase reacted with tyramine (MAO-A/B substrate) or benzylamine (MAO-B specific substrate) to produce H<sub>2</sub>O<sub>2</sub>. The H<sub>2</sub>O<sub>2</sub> was further oxidized by horseradish peroxidase (HRP), generating fluorescent resorufin in amounts proportional to MAO-A and MAO-B activities. Clorgyline, a selective MAO-A inhibitor (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>a), and the MAO-B-selective inhibitors deprenyl and safinamide (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) were included as positive controls. The inhibition data for all 25 compounds (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) showed that with the exception of compound <b>10s</b> bearing a 3-pyridyl substituent as the “benzyl” motif and <b>10o</b> bearing a −CO<sub>2</sub>Me group at the 4 position of the aromatic ring, all compounds displayed significant ability to inhibit MAO-B (IC<sub>50</sub> = 0.203–26.607 μM).</div><div class="NLM_p">Further, at concentrations up to 50 μM the majority of these compounds displayed no activity against MAO-A (>50 μM (UTC)). Thus, even for the least active of these polar inhibitors the selectivity toward MAO-B relative to MAO-A was high. Within the series of compounds <b>10a</b>–<b>s</b>, the three mono/dihalo-substituted analogues <b>10c</b> (IC<sub>50</sub> 0.264 μM), <b>10j</b> (IC<sub>50</sub> 0.203 μM), and <b>10k</b> (IC<sub>50</sub> 0.218 μM) were the most potent (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), being approximately 4 times more active than the parent unsubstituted compound <b>10a</b> (IC<sub>50</sub> 0.894). Introduction of a polar cyano (<b>10e</b>, <b>10f</b>, <b>10g</b>), nitro (<b>10m</b>), or ester function (<b>10o</b>) onto the benzyl motif resulted in a loss in activity, as did exchanging the phenyl by a pyridine (<b>10q</b>, <b>10r</b>, <b>10s</b>) or replacing the benzyl group by a bicyclic naphthalene ring (<b>10p</b>) (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0003.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of MAO-A and MAO-B enzyme activity by lead compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Expanding further the scope of the SAR, replacement of the methamphetamine C-2 methyl group by a more polar CO<sub>2</sub>Me function, as in <b>21</b> (IC<sub>50</sub> 7.928 μM) and <b>22</b> (IC<sub>50</sub> 1.26 μM), also resulted in a decrease in potency (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In contrast, compound <b>32</b> (IC<sub>50</sub> 0.206 μM) in which the C-2 methyl group was replaced by CH<sub>2</sub>CN and the CH<sub>2</sub><b>Ar</b> motif corresponded to the 3,4-dichlorophenyl ring was found along with compound <b>10j</b> (IC<sub>50</sub> 0.203 μM) to be the most potent of the polar compound <b>B</b> analogue identified (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p">Interestingly, the inhibitory activities of the four most active compounds, <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b>, were approximately 100 times less than the parent irreversible MAO-B inhibitor deprenyl and its O-Bn-substituted analogue <b>11</b>. However, a more informative measure of potency was obtained by comparing their activities to that for the reversible benzylamine-based MAO-B-selective inhibitor safinamide. Under the assay conditions used in the present study it was determined that compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> and safinamide have comparable submicromolar activities, safinamide being more potent by a factor of 10 (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_p last">Thus, provided the four hit compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> do not enter the BBB to any significant extent, they could be used to selectively target peripheral MAO-B. They were consequently evaluated in assays to measure P-gp interaction, in vitro metabolic stability, and in vivo pharmacokinetic properties after intravenous, oral, and subcutaneous administration.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Assessment of P-gp Interaction with MAO-B Inhibitors</h3><div class="NLM_p">Prediction and comparison of BBB permeability and P-gp-associated efflux in the MDCK-WT and MDCK-MDR1 II cell culture model has been widely used in CNS drug discovery. MDCK-MDR1 II cells are derived from transfecting the human MDR1 gene encoding P-glycoprotein into MDCK cells.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> P-gp is highly expressed in the capillaries of the blood–brain barrier and acts as a major efflux transporter that affects drug permeability into the brain.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> The ability of the selected hit compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> to cross the BBB in bilateral directions could thus be predicted based on efflux ratios in MDCK-WT and MDCK-MDR1 transwell assays (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0004.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Permeability assays and calculated efflux ratios for compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> using wild-type MDCK-WT and MDCK-MDR1 II cell lines. Efflux ratio ≥ 2 identifies the compound as a P-gp substrate. Cultures were treated with (white) or without (black) verapamil (an established P-gp inhibitor). Values were indicated as mean ± standard deviation (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Using the efflux ratio of 2 as a cut off, compounds with efflux ratios greater than 2 were categorized as P-gp substrates. In MDCK-WT cells the calculated efflux ratios remained under 2 for the four hit molecules and deprenyl, whereas cetirizine (positive control) showed decreased values from 3.00 to 1.39 in the presence of verapamil (P-gp inhibitor), indicating positive drug efflux by P-gp. The four MAO-B inhibitors were also evaluated in MDCK-MDR1 II cells, which is a common cell line used to study in vitro brain uptake and to classify human P-gp substrates. Deprenyl, which is not a P-gp substrate, demonstrated unchanged efflux ratios in MDR1 cells and MDCK-WT cells. In MDCK-MDR1 II cells, cetirizine had efflux ratios of 4.12 and 1.41 without and with verapamil, respectively. The data for both MDCK cell lines confirmed that cetirizine is a P-gp substrate. Compound <b>10c</b> efflux ratio was not affected by the presence of verapamil. Compound <b>10j</b> demonstrated mild interactions with P-gp as indicated by the decrease in efflux ratio from 2.12 to 1.15 in MDR1 cells. Compound <b>10k</b> was found to be a P-gp substrate, resulting in an efflux ratio of 3.07 without verapamil and 1.22 with verapamil. Compound <b>32</b> exhibited no change in efflux ratios after verapamil treatment. On the basis of the results, compound <b>10k</b> was classified as the active P-gp substrate and compound <b>10j</b> displayed very mild efflux transport by P-gp among the four lead compounds, whereas compounds <b>10c</b> and <b>32</b> were not classified as P-gp substrates.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> In Vitro Metabolic Stability</h3><div class="NLM_p">In an effort to determine the susceptibility of compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> to metabolic clearance,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> they were assessed in vitro for metabolic stability in plasma (mouse/human), liver microsomes (mouse/human), and cryopreserved hepatocytes (mouse). As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B, all four novel compounds were stable in both mouse and human plasma with ≥75% of the parent remaining intact after 4 h incubation at 37 °C. In comparison, deprenyl was more rapidly metabolized, with ∼61% and 55% remaining at the end of the 4 h incubation period in mouse and human plasma, respectively (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro metabolic stability of the novel compounds in plasma (mouse/human), liver microsomes (mouse/human), and hepatocytes (mouse). Positive control compounds were enalapril (mouse plasma), procaine (human plasma), and propranolol (mouse liver microsomes, human liver microsomes, and mouse hepatocytes). Data are shown as mean ± standard deviation (SD). Each experiment was done in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In mouse liver microsomes the four active hits displayed moderate-to-high stability, with compound <b>32</b> being the least stable (∼39% remaining) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). Furthermore, the observed metabolic turnover in mouse liver microsomes was almost entirely β-nicotinamide adenine dinucleotide phosphate (NADPH; cofactor) dependent, as discerned from the “minus NADPH” condition data. The mean % parent remaining after 60 min incubation without NADPH was, respectively, 87.3%, 93.4%, 89.5%, and 96.9% for compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32.</b> In contrast to mouse liver microsomes, all four hit compounds were more stable in human liver microsomes with ≥90% parent remaining at the end of the 60 min incubation period (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). These data suggest species-dependent differences in their metabolic stability. Once again, deprenyl was less stable than the four hit compounds in both mouse (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C) and human liver microsomes (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D). Upon incubation with cryopreserved mouse hepatocytes, compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> were almost completely stable with ≥90% parent remaining intact after 60 min incubation, whereas compound <b>32</b> showed moderate stability in hepatocytes, with ∼64% remaining at 60 min (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>E). In all of these metabolic stability studies, the observed stability profiles of the positive control compounds enalapril, procaine, and propranolol were consistent with our historical data. Overall, the novel MAO-B inhibitors <b>10c</b>, <b>10j</b>, and <b>10k</b> were determined to be stable in plasma (mouse/human), liver microsomes (mouse/human), and hepatocytes (mouse), whereas compound <b>32</b> was stable in mouse/human plasma and human liver microsomes and less stable in mouse liver microsomes and mouse hepatocytes.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vivo Acute Tolerability Study</h3><div class="NLM_p last">Tolerability tests in mice were carried out to assess whether compounds <b>10c</b>, <b>10j</b>, <b>10k,</b> and <b>32</b> could be safely administered in vivo at the defined therapeutic concentrations and duration. For our assessment animals were clinically observed for any signs of acute toxicity following compound administration. No abnormal clinical findings were noted for the four hit compounds following administration. All animals tolerated the single dose of each compound injected (57.5 μmol/kg) at the specified route of administration and survived until the termination of the study, at which they were euthanized. In contrast, several animals exhibited lethargy and piloerection after injection with the same dose of deprenyl, which was noted as early as 1 h postinjection, but the effects diminished over time.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Pharmacokinetic Study Results from Intravenous Administration</h3><div class="NLM_p">To examine the pharmacokinetic properties, the four selected MAO-B inhibitors were administered to mice intravenously (iv) at a single (57.5 μmol/kg) dose. Plasma and brain samples were collected, and the concentrations measured were plotted against each time point in a pharmacokinetic curve using GraphPad Prism (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and  <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Pharmacokinetic parameters were generated by noncompartmental analysis (NCA) of the data using the Phoenix WinNonLin program. Some of the parameters such as half-life (HL Lambda_z), peak plasma concentration (Cmax), time to reach <i>C</i><sub>max</sub> (Tmax), area under the curve from time zero to the last quantifiable concentration (AUClast) to assess the extent of bioavailability, and the brain to plasma ratio <i>K</i>p (AUClast<sub>brain</sub>/AUClast<sub>plasma</sub>) as a measure of brain penetration are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0006.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma pharmacokinetic curves of deprenyl and compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> following a single 57.5 μmol/kg intravenous dose in C57BL/6 mice. Twenty-one animals were injected at 0 min, with 3 animals sacrificed at each time point, for a total of 7 time points (0 min, 5 min, 15 min, 30 min, 1 h, 4 h, 24 h). For the plotting of pharmacokinetic curves, values that were below the limit of quantification were plotted as one-half of the limit of quantification, while values that were above the limit of quantification or nondetected were omitted from the plots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0007.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Brain pharmacokinetic curves of deprenyl and compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> following a single intravenously 57.5 μmol/kg dose in C57BL/6 mice. Twenty-one animals were injected at 0 min, with 3 animals sacrificed at each time point, for a total of 7 time points (0 min, 5 min, 15 min, 30 min, 1 h, 4 h, 24 h). For the plotting of pharmacokinetic curves, values that were below the limit of quantification were plotted as one-half of the limit of quantification, while values that were above the limit of quantification or nondetected were omitted from the plots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Plasma and Brain Pharmacokinetic Parameters of Deprenyl and Compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> Following a Single 57.5 μmol/kg Dose via Intravenous Administration in C57BL/6 Mice<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">plasma PK parameters</th><th class="colsep0 rowsep0" align="center">deprenyl</th><th class="colsep0 rowsep0" align="center">compound <b>10c</b></th><th class="colsep0 rowsep0" align="center">compound <b>10j</b></th><th class="colsep0 rowsep0" align="center">compound <b>10k</b></th><th class="colsep0 rowsep0" align="center">compound <b>32</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dosing (mg/kg)</td><td class="colsep0 rowsep0" align="left">10.8</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">24.5</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">23.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HL_Lambda_z (h)</td><td class="colsep0 rowsep0" align="left">0.56</td><td class="colsep0 rowsep0" align="left">4.51</td><td class="colsep0 rowsep0" align="left">3.93</td><td class="colsep0 rowsep0" align="left">3.97</td><td class="colsep0 rowsep0" align="left">0.74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tmax (h)</td><td class="colsep0 rowsep0" align="left">0.0833</td><td class="colsep0 rowsep0" align="left">0.0833</td><td class="colsep0 rowsep0" align="left">0.0833</td><td class="colsep0 rowsep0" align="left">0.0833</td><td class="colsep0 rowsep0" align="left">0.0833</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cmax (ng/mL)</td><td class="colsep0 rowsep0" align="left">568.91</td><td class="colsep0 rowsep0" align="left">16567.55</td><td class="colsep0 rowsep0" align="left">16746.35</td><td class="colsep0 rowsep0" align="left">16191.38</td><td class="colsep0 rowsep0" align="left">52103.22</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUCIast (h·ng/mL)</td><td class="colsep0 rowsep0" align="left">242.02</td><td class="colsep0 rowsep0" align="left">111878.46</td><td class="colsep0 rowsep0" align="left">94843.99</td><td class="colsep0 rowsep0" align="left">81989.03</td><td class="colsep0 rowsep0" align="left">39130.26</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">brain PK parameters</th><th class="colsep0 rowsep0" align="center">deprenyl</th><th class="colsep0 rowsep0" align="center">compound <b>10c</b></th><th class="colsep0 rowsep0" align="center">compound <b>10j</b></th><th class="colsep0 rowsep0" align="center">compound <b>10k</b></th><th class="colsep0 rowsep0" align="center">compound <b>32</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dosing (mg/kg)</td><td class="colsep0 rowsep0" align="left">10.8</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">24.5</td><td class="colsep0 rowsep0" align="left">22</td><td class="colsep0 rowsep0" align="left">23.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HL_Lambda_z (h)</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">0.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tmax (h)</td><td class="colsep0 rowsep0" align="left">0.0833</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.0833</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cmax (ng/mL)</td><td class="colsep0 rowsep0" align="left">4219.19</td><td class="colsep0 rowsep0" align="left">648.47</td><td class="colsep0 rowsep0" align="left">653.02</td><td class="colsep0 rowsep0" align="left">452.93</td><td class="colsep0 rowsep0" align="left">305.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUCIast (h·ng/mL)</td><td class="colsep0 rowsep0" align="left">1387.03</td><td class="colsep0 rowsep0" align="left">2278.72</td><td class="colsep0 rowsep0" align="left">10672.3</td><td class="colsep0 rowsep0" align="left">7452.74</td><td class="colsep0 rowsep0" align="left">182.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>p</sub> (AUCIast brain/plasma)</td><td class="colsep0 rowsep0" align="left">5.73</td><td class="colsep0 rowsep0" align="left">0.02</td><td class="colsep0 rowsep0" align="left">0.11</td><td class="colsep0 rowsep0" align="left">0.09</td><td class="colsep0 rowsep0" align="left">0.004</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup><sup>a</sup></sup><p class="last">Twenty-one animals were injected at 0 min, with 3 animals sacrificed at each time point, for a total of 7 timepoints (0 min, 5 min, 15 min, 30 min, 1 h, 4 h, 24 h). Values that were above or below the limit of quantification or were undetected were omitted from the pharmacokinetic calculations.</p></div></div></div><div class="NLM_p last">Following iv administration, the plasma Cmax for deprenyl (568.91 ng/mL) was much lower than that of the other compounds (<b>10c</b>, 16 567.55 ng/mL; <b>10j</b>, 16 746.35 ng/mL; <b>10k</b>, 16 191.38 ng/mL and <b>32</b>, 52 103.22 ng/mL). Deprenyl attained a Cmax of 4219.19 ng/mL in the brain by 5 min (Tmax), whereas the other compounds took longer to reach Cmax and/or had a significantly lower Cmax (<b>10c</b>, 648.47 ng/mL; <b>10j</b>, 653.02 ng/mL; <b>10k</b>, 452.93 ng/mL; and <b>32</b>, 305.33 ng/mL). These data suggested that deprenyl readily passes into the brain while the other polar compounds remain mostly in the plasma compartment. This is further supported by the brain to plasma distribution ratio (Kp) based on AUClast values which is much higher for deprenyl (5.73) than for compounds <b>10c</b> (0.02), <b>10j</b> (0.11), <b>10k</b> (0.09), and <b>32</b> (0.004). Note that the pharmacokinetic results are preliminary in nature, as one or more of the compounds may undergo enterohepatic recirculation and/or a two-phase elimination (e.g., compound <b>10j</b>). Additional time points between 4 and 24 h and/or beyond 24 h may provide a more descriptive analysis in future studies. Nevertheless, the overall results showed that the polar MAO-B inhibitors <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> have reduced transport across the blood–brain barrier as predicted.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Pharmacokinetic Study Results from Subcutaneous and Oral Administration</h3><div class="NLM_p">Pharmacokinetic studies of subcutaneous and oral administration were carried out for compounds <b>10j</b> and <b>32</b>. The pharmacokinetic curves for these studies are illustrated in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a> and <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, and the calculated pharmacokinetic parameters are presented in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0008.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plasma pharmacokinetic curves of compound <b>10j</b> and compound <b>32</b> following a single 57.5 μmol/kg dose via subcutaneous (SC) and oral (PO) administration. Fifteen animals were injected at 0 min, with 3 animals sacrificed at each time point, for a total of 5 time points (1, 2, 4, 6, and 24 h). For the plotting of pharmacokinetic curves, values that were below the limit of quantification were plotted as one-half of the limit of quantification while values that were above the limit of quantification or nondetected were omitted from the plots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0009.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Brain pharmacokinetic curves of compound <b>10j</b> and compound <b>32</b> following a single 57.5 μmol/kg dose via subcutaneous and oral administration. Fifteen animals were injected at 0 min, with 3 animals sacrificed at each time point, for a total of 5 time points (1, 2, 4, 6, and 24 h). For the plotting of pharmacokinetic curves, values that were below the limit of quantification were plotted as one-half of the limit of quantification while values that were above the limit of quantification or nondetected were omitted from the plots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Plasma and Brain Pharmacokinetic Parameters of Compound <b>10j</b> and Compound <b>32</b> Following a Single 57.5 μmol/kg Dose via Subcutaneous (SC) or Oral (PO) Administration<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">plasma PK parameters</th><th class="colsep0 rowsep0" align="center">compound <b>10j</b></th><th class="colsep0 rowsep0" align="center">compound <b>10j</b></th><th class="colsep0 rowsep0" align="center">compound <b>32</b></th><th class="colsep0 rowsep0" align="center">compound <b>32</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dosing (mg/kg)</td><td class="colsep0 rowsep0" align="left">24.5</td><td class="colsep0 rowsep0" align="left">24.5</td><td class="colsep0 rowsep0" align="left">23.4</td><td class="colsep0 rowsep0" align="left">23.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">administration</td><td class="colsep0 rowsep0" align="left">SC</td><td class="colsep0 rowsep0" align="left">PO</td><td class="colsep0 rowsep0" align="left">SC</td><td class="colsep0 rowsep0" align="left">PO</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HL_Lambcla_z (h)</td><td class="colsep0 rowsep0" align="left">4.81</td><td class="colsep0 rowsep0" align="left">3.59</td><td class="colsep0 rowsep0" align="left">3.62</td><td class="colsep0 rowsep0" align="left">2.93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tmax (h)</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cmax (ng/mL)</td><td class="colsep0 rowsep0" align="left">7105.06</td><td class="colsep0 rowsep0" align="left">8529.33</td><td class="colsep0 rowsep0" align="left">13 346.31</td><td class="colsep0 rowsep0" align="left">16 832.87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUCIast (h·ng/mL)</td><td class="colsep0 rowsep0" align="left">66 910.31</td><td class="colsep0 rowsep0" align="left">10 3854.75</td><td class="colsep0 rowsep0" align="left">35 118.27</td><td class="colsep0 rowsep0" align="left">72 959.25</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">brain PK parameters</th><th class="colsep0 rowsep0" align="center">compound <b>10j</b></th><th class="colsep0 rowsep0" align="center">compound <b>10j</b></th><th class="colsep0 rowsep0" align="center">compound <b>32</b></th><th class="colsep0 rowsep0" align="center">compound <b>32</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dosing (mg/kg)</td><td class="colsep0 rowsep0" align="left">24.5</td><td class="colsep0 rowsep0" align="left">24.5</td><td class="colsep0 rowsep0" align="left">23.4</td><td class="colsep0 rowsep0" align="left">23.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">administration</td><td class="colsep0 rowsep0" align="left">SC</td><td class="colsep0 rowsep0" align="left">PO</td><td class="colsep0 rowsep0" align="left">SC</td><td class="colsep0 rowsep0" align="left">PO</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HL_Lambcla_z (h)</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">1.07</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Tmax (h)</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cmax (ng/mL)</td><td class="colsep0 rowsep0" align="left">806.41</td><td class="colsep0 rowsep0" align="left">811.55</td><td class="colsep0 rowsep0" align="left">91.26</td><td class="colsep0 rowsep0" align="left">91.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUCIast (h·ng/mL)</td><td class="colsep0 rowsep0" align="left">12 913.36</td><td class="colsep0 rowsep0" align="left">12 566.46</td><td class="colsep0 rowsep0" align="left">176.32</td><td class="colsep0 rowsep0" align="left">116.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Kp (AUCIast brain/plasma)</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">0.002</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup><sup>a</sup></sup><p class="last">Fifteen animals were injected at 0 min, with 3 animals sacrificed at each time point, for a total of 5 timepoints (1, 2, 4, 6, and 24 h). Values that were above or below the limit of quantification or were undetected were omitted from the pharmacokinetic calculations.</p></div></div></div><div class="NLM_p">After subcutaneous dosing the plasma concentrations of compound <b>10j</b> increased to a Cmax of 7105.06 ng/mL at 2 h, while compound <b>32</b> increased to a Cmax of 13 346.31 ng/mL at 1 h (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). After oral administration the plasma concentration of compound <b>10j</b> increased to a Cmax of 8529.33 ng/mL at 1 h, while compound <b>32</b> increased to a Cmax of 16 823.87 ng/mL at 1 h. Plasma concentrations then declined overtime with a half-life of 4.81 and 3.59 h for compound <b>10j</b> and 3.62 and 2.93 h for compound <b>32</b>, respectively, for sc and po. It appears that the Cmax and half-life were relatively comparable for both routes of administration. In terms of bioavailability, the AUClast of compound <b>10j</b> from sc and po dosing was 66 910.31 and 103 854.75 h·ng/mL, respectively. Similarly, the AUClast of compound <b>32</b> from sc and oral dosing was 35 118.27 and 72 959.25 h·ng/mL, respectively. These results indicate that both compounds are bioavailable in plasma following either sc or po administration.</div><div class="NLM_p last">In the brain, compound <b>10j</b> took much longer (i.e., 6 h) to reach the Cmax of 806.41 and 811.55 ng/mL following sc and po dosing, respectively. On the other hand, compound <b>32</b> reached Cmax after 1 h, but the brain concentrations were low at 91.26 ng/mL for sc dosing and 91.94 ng/mL for po dosing. The half-life was noncalculable for compound <b>10j</b> as it remained in the brain past the 24 h time point. Likewise, it was also difficult to calculate the half-life for compound <b>32</b> as the brain concentrations were at the lower limits of quantification in the later time points. The AUClast is 12913.36 and 12566.46 h·ng/mL for compound <b>10j</b> and 176.32  and 116.43 h·ng/mL for compound <b>32</b> under sc and po dosing. The brain to plasma distribution ratio (Kp) based on AUClast values is 0.19 and 0.12 for compound <b>10j</b> for the sc and po route and 0.005 and 0.002 for compound <b>32</b> for the sc and po route, respectively. Therefore, these data support that both compounds do not enter the brain readily for all routes of administration tested. This was expected based on the design of our compounds to not cross the blood–brain barrier. Future studies with additional time points will provide more detailed pharmacokinetic profiles of the compounds.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04317" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04317" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The in vitro data (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) showed that the polar type <b>B</b> methamphetamine derivatives <b>10a</b>–<b>s</b> obtained by replacing the acetylene unit in deprenyl by a CO<sub>2</sub>H function and introducing a <i>p</i>-O-CH<sub>2</sub>Ar motif onto the phenyl ring were selective MAO-B inhibitors. The most potent compounds were the halo-substituted analogues <b>10c</b>, <b>10j</b>, and <b>10k</b> (R and/or R′ = Cl, Br) (IC<sub>50</sub> values 0.203–0.264 μM) (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).</div><figure id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0010.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structural comparison of compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> with safinamide and compounds <b>21</b>, <b>22</b>, <b>25</b>, <b>26</b>, <b>29</b>, and <b>32</b> with the coumarin amide <b>33</b>. V-shaped wedges represent the constriction residues (Tyr 326 and Ile 199) in the MAO-B binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These molecules bear a structural resemblance to the reversible and selective MAO-B inhibitor safinamide,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> which also contains a −OCH<sub>2</sub>Ar motif in its structure. Structure–activity studies on safinamide have shown that both potency and MAO-B selectivity are enhanced by incorporating halogen atoms on the <i>O</i>-benzyl phenyl ring.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Relative to <b>10a</b> compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> show the same trend, suggesting that they bind in a similar way to safinamide in the MAO-B site (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). Indeed, X-ray diffraction data for safinamide and modeling studies carried out on compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>, Figure 11a and 11b (in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), and <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>) indicate that they all bind in the MAO-B substrate site such that the ether linker straddles the restriction site defined by residues Tyr 326 and Ile 199 and the Ar motif extends toward the exterior cavity, which is globally more hydrophobic than the corresponding pocket in MAO-A.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In the interior cavity (catalytic site) the polar neutral amide function in safinamide curves away from the FAD cofactor, with the tertiary amine and amide NH forming H bonds to the side chain C═O in Gln 206. The carboxylic acid functions in compounds <b>10c</b>, <b>10k</b>, and <b>10j</b> are also predicted to not interact with the FAD cofactor (O═C···FAD (N5) distance of 5.19–6.56 Å). Instead, in its deprotonated state, the acid function H bonds to the phenolic hydroxyl group in proximal tyrosine residues (Tyr 435 or 188). Further, being more extended phenethylamine-type compounds, the tertiary nitrogen forms H-bonding or cation−π interactions with proximal tyrosines, rather than H  bonding to Gln 206. These differences in binding mode with residues in the catalytic site may, in part, account for the 10-fold difference in measured IC<sub>50</sub> values for compounds <b>10c</b>, <b>10k</b>, and <b>10j</b> (see <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) relative to safinamide (IC<sub>50</sub> = 0.024 μM).</div><figure id="fig11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0011.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Binding modes of safinamide (top panels, carbons shown in pink) in human MAO-B (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v5z">2v5z</a>) and predicted binding modes of <b>10j</b> (mid panels, carbons shown in cyan) and <b>32</b> (lower panels, carbons shown in cyan). For the docking, the coordinates of the safinamide–hMAO-B cocomplex were used (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Hydrogen bonds and cation−π interactions are indicated by green and magenta dashed lines, respectively. For the cation−π interactions, the center of the aromatic ring is shown as a small sphere. Protein residues are labeled with the 3-letter code followed by the residue number.  N5 of FAD is indicated by an italicized label. Orientation of the structures has been rotated by roughly 180° between the left and the right panels in order to illustrate the predicted interactions to the protein for the docked poses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although larger in structure (greater volume), a wide range of coumarin-based compounds, such as coumarin amide <b>33</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), are also potent and selective MAO-B inhibitors.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> From structural (X-ray diffraction) studies it has been determined that coumarin <b>33</b> binds in the MAO-B substrate site in a similar manner to safinamide.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> This showed that the additional atoms composing the lactone ring are tolerated in this site. Indeed, structures of inhibitor-MAO-B complexes determined for a wide variety of MAO-B inhibitors demonstrate that there is considerable room for structural variation in the subelements that occupy the inner substrate cavity.<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> It was with this knowledge in mind that the polar compounds <b>21</b>, <b>22</b>, <b>25</b>, <b>26</b>, <b>29</b>, and <b>32</b> (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) were designed and tested. Interestingly, compound <b>22</b>, where the CO<sub>2</sub>Me represents a ring-opened version of the lactone motif, and compound <b>25</b>, in which the ester function has been reduced to the corresponding alcohol, were active in the 1 μM range. However, within this framework it was the cyano compound <b>29</b> (IC<sub>50</sub> MAO-B 0.532 μM) and <b>32</b> (IC<sub>50</sub> MAO-B 0.206 μM) that displayed the greatest affinity for the MAO-B binding site (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>, bottom). Interestingly, in the predicted model, the CN group is not observed to form strong interactions with the catalytic site residues.</div><div class="NLM_p">In terms of their selectivity for MAO-B over MAO-A, the four polar compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> were highly MAO-B selective. Any impact on MAO-A activity can be associated with significant dietary concerns. Approximately 70% of MAO activity in the intestine is due to MAO-A,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and inhibition of its activity can increase the risk of hypertensive crisis due to tyramine uptake and its potentiation of cardiovascular activity by releasing noradrenaline (cheese effect).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> This negative side effect is associated with MAO-A inhibitors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Recently, long-term use of selective irreversible MAO-B inhibitors (ie. deprenyl) has been suggested to also inhibit MAO-A activity.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> We present evidence that compounds <b>10j</b> and <b>32</b> were well absorbed orally (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>); however, they are unlikely to be at risk of the cheese effect because they were reversible inhibitors and more MAO-B selective over MAO-A when compared to deprenyl.</div><div class="NLM_p">MAO-B inhibitors like deprenyl when delivered transdermally (6 mg/24 h) are effective antidepressants,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> but they are preferentially used for the management of neurodegenerative diseases such as Alzheimer’s and Parkinson’s.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In this context, they must pass the BBB to produce their therapeutic effect. Our objective has been to develop polar MAO-B inhibitors that have significantly reduced BBB permeability. In the mouse iv pharmacokinetic study (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) the maximum concentration (Cmax) of deprenyl in the brain (4219.19 ng/mL) far exceeded what was recovered from the brain of animals treated with equimolar doses of compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> (452.93–653.02 ng/mL) and compound <b>32</b> (305.33 ng/mL). These data support that transport of the novel compounds into the brain has been significantly reduced. The maximal concentrations of drugs recovered from the brains (Cmax) of animals treated with compounds <b>10c</b> (648.47 ng/mL) and <b>10j</b> (653.02 ng/mL) were higher than what was found for <b>10k</b> (452.93 ng/mL). This 30% lower Cmax for compound <b>10k</b> in the brain when compared to compounds <b>10c</b> and <b>10j</b> may reflect that compound <b>10k</b> like cetirizine<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> is an active P-gp substrate (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In contrast, compound <b>10j</b>, a weak P-gp interactor, was not associated with a lower Cmax in the brain over compound <b>10c</b>. Compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> also exhibited significantly higher maximum plasma concentrations (Cmax) (16 191.38–16 746.35 ng/mL) when compared to deprenyl (5689.91 ng/mL) and increased in vivo plasma half-life (3.93–4.51 h) (HL-Lambda-z) when compared to deprenyl (0.56 h) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). These 3 hit compounds when compared to deprenyl were more stable in the mouse and human plasma stability in vitro assays and the mouse and human liver microsome and mouse hepatocyte assays (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). This increase in relative metabolic stability of compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> is reflected in higher plasma concentrations (Cmax) and longer plasma half-lives (HL-Lambda-z) in the intravenous pharmacokinetic study. Overall, compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> all demonstrated a much lower brain to plasma ratio (Kp) (range 0.02–0.11), and all were significantly lower than deprenyl (5.73). Compound <b>10j</b> showed similar AUClast brain/plasma ratios after subcutaneous (0.19) and oral (0.12). These data support that compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> all had reduced penetration into the brain over deprenyl. Compound <b>10k</b> had the lowest maximum brain concentration; however, it had the poorest selectivity for MAO-B over MAO-A and therefore would not be the strongest lead. In contrast, compound <b>10c</b> with a better selectivity for MAO-B over MAO-A and the lowest AUClast brain/plasma ratio of these 3 leads makes it a strong lead.</div><div class="NLM_p">After intravenous administration the in vivo plasma half-life for compound <b>32</b> (0.74 h) (HL-Lambda-z) was significantly shorter than the half-lives for compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> hits (range 3.93–4.51 h) but was longer than deprenyl (0.56 h) (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). This shorter in vivo half-life for compound <b>32</b> may reflect an increased rate of drug metabolism in the mouse liver. Evidence for this was found in the mouse liver microsomal and hepatocyte stability assays (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). In these metabolic assays compound <b>32</b> was more stable than deprenyl but less stable when compared to compounds <b>10c</b>, <b>10j</b>, and <b>10k</b>. The human plasma and liver microsome assays did not reflect these findings, suggesting species-specific differences. Of the 4 hits tested, compound <b>32</b> had the lowest Cmax (305.33 ng/mL) in the brain after intravenous administration (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) and an AUClast brain/plasma ratio of 0.004, 0.005, and 0.002 after intravenous, subcutaneous, and oral administration, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). This was 2 orders of magnitude less that the other 3 hits and was significantly lower than what was determined for deprenyl (5.73) after intravenous administration. The lower brain concentration of compound <b>32</b> cannot be explained by a P-gp efflux mechanism (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Compound <b>32</b> exhibited the lowest brain concentration (Cmax, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) that was measured for all administration routes; however, its reduced stability in the mouse liver assays (not human liver assays) suggests its bioavailabilty may be reduced in mouse studies. Regardless, compound <b>32</b> serves as the second lead for further optimization studies. In future long-term disease modeling studies the plasma, tissue, and brain samples will be assayed for MAO-A and -B residual enzyme activity, MAO-B selectivity over MAO-A, as well as reduced transport across the BBB.</div><div class="NLM_p last">Upregulation of MAO-B protein and gene expression has been identified in samples taken from patients with diseases of the heart and rat periodontium.<a onclick="showRef(event, 'ref14 ref15 ref17'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref17">(14,15,17)</a> Collectively, the role of MAO-B in the pathogenesis of these inflammatory diseases and the mechanisms by which MAO inhibition may reduce these diseases is not fully understood. However, the MAO-B-selective inhibtors deprenyl reduced proinflammatory cytokine expression in in vitro airway epithelial cell cultures<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and pargyline<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> reduced mast cell degranulation and fibrosis in a diabetic cardiomyopathy animal model.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In conclusion, the development of novel polar selective MAO-B inhibitors with reduced BBB penetration has positioned our laboratories to test their potential efficacy for the management of non-CNS inflammatory diseases in future studies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Experimental General</h3><div class="NLM_p last">All chemicals were purchased from Sigma-Aldrich (Oakville, Canada), Alpha-Aesar (Tewksbury, United States), or Oakwood Chemicals (Estill, United States), and they were used without purification unless mentioned. All solvents were dried and kept under N<sub>2</sub>. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 400 and 100 MHz, respectively, on a Bruker AC 400 Ultrashield 10 spectrophotometer. Chemical shifts are expressed in ppm (δ scale). When peak multiplicities are reported, the following abbreviations are used: s (singlet), d (doublet), m (multiplet), t (triplet), dd (doublet of doublet), td (triplet of doublet), tt (triplet of triplet), ddd (doublet of doublet of doublet). Coupling constants are reported in Hertz (Hz). High-resolution mass spectra for compound <b>25</b> were collected on a Waters Xevo G2-S QTof, run in resolution mode. A 1 μM solution of compound <b>25</b> (in 30% ACN, 0.5% FA) was infused at 3 μL/min. Spectra were accumulated for 30 s for the mass measurement. High-resolution mass spectra for all other compounds were recorded on a AB Sciex UHPLC/MS/MS System and a Thermo Scientific Q Exactive Orbitrap High Resolution Mass Spectrometer, respectively. Flash column chromatography was performed using silica gel (Silicycle, Siliaflash F60, 40–63 μm, 230–400 mesh) or on a Biotage Isolera purification system (PartnerTech Å tvidaberg AB) using prepacked silica gel columns (Biotage, part no. FSKO-1107-0010, FSKO-1107-0025, or FSKO-1107-0050). A Biotage Initiator 2.5 apparatus was used for experiments using microwave heating. The purity of all final compounds was determined by HPLC using a Waters Alliance e2696 separations module coupled to a Waters 2489 UV/vis detector (λ = 225 nm). The column was a reversed phase C18 Waters Atlantis T3, 100 Å, 5 μm particle size (4.6 × 150 mm), supported by a C18 guard cartridge and was operated in an oven at 40 °C. The column was eluted with the following gradient: A = 0.1% trifluoroacetic acid (TFA) in water; B = methanol; flow rate = 1 mL/min; 0–10 min 10–100% B; 10–13 min 100% B. With the exception of compounds <b>10m</b> (93.6%), <b>10p</b> (91.8%), <b>22</b> (93.4%), and <b>25</b> (91.6%), the other 21 compounds were established to be >95% pure. For the biological assays: Recombinant human MAO A and B proteins,  MAO-B inhibitors deprenyl and safinamide, cetirizine, verapamil, Lucifer yellow, enalapril, and propranolol were obtained from Sigma-Aldrich (St. Louis, MO). MDCK-WT cells were obtained from the American Type Culture Collection (Manassas, VA). MDCK-MDR1 II cells were obtained from The Netherlands Cancer Institute (Amsterdam, The Netherlands). Mouse and human plasma were obtained from GeneTex (Irvine, CA) and BioreclamationIVT (Baltimore, MD), respectively. Liver microsomes (mouse and human) were obtained from BD Gentest (Woburn, MA) or BioreclamationIVT (Baltimore, MD). Cryopreserved mouse hepatocytes were obtained from BioreclamationIVT (Baltimore, MD).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <span class="smallcaps smallerCapital">l</span>-(<i>N</i>-Methoxycarbonyl)(<i>O</i>-benzyl)tyrosine methyl ester (<b>2</b>)</h4><div class="NLM_p last">Adapting the procedure by Desjardine  et al.,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> a mixture of <span class="smallcaps smallerCapital">l</span>-<i>N</i>-(methoxycarbonyl)-tyrosine methyl ester <b>1</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> (8.0 g, 32 mmol), benzyl bromide (4.5 mL, 38 mmol), and K<sub>2</sub>CO<sub>3</sub> (5.2 g, 38 mmol) in acetone (125 mL) was stirred for 16 h at room temperature and then refluxed for 3 h. Solids were filtered off, and the filtrate was concentrated to dryness in vacuo. The crude product mixture was silica column chromatographed (hexane/EtOAc from 9:1 to 5:5), affording <b>2</b> as a translucent wax, which turned into a white solid upon standing (9.3 g, 85% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.44–7.37 (m, 4H), 7.35–7.30 (m, 1H), 7.03 (br d, <i>J</i> = 8.0 Hz, 2H), 6.90 (br d, <i>J</i> = 8.0 Hz, 2H), 5.13 (br d, <i>J</i> = 7.8 Hz, 1H), 5.04 (s, 2H), 4.61 (dt, <i>J</i> = 7.8, 5.8 Hz, 1H), 3.72 (s, 3H), 3.67 (s, 3H), 3.09–3.00 (m, 2H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> <span class="smallcaps smallerCapital">l</span>-(<i>N</i>-Methoxycarbonyl)(<i>O</i>-benzyl))tyrosinol (<b>3</b>)</h4><div class="NLM_p last">Following the procedure by Ousmer et al.,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> compound <b>2</b> (3.44 g, 10 mmol) in THF (25 mL) was added dropwise over 2 h to a cold (0 °C) suspension of LiAlH<sub>4</sub> (0.740 g, 20 mmol) in THF (40 mL) maintained under nitrogen. The reaction was stirred overnight at RT, then cooled to 0 °C, and quenched by slow dropwise addition of 4 N HCl (Caution: production of hydrogen gas). The mixture was subsequently diluted by addition of H<sub>2</sub>O (100 mL) and extracted with EtOAc. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Trace amounts of inorganic salts were removed by filtration through a plug of silica gel (EtOAc/hexane 1:1), affording <b>3</b> as a white solid (3.0 g, 95% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.44–7.31 (m, 5H), 7.12 (d, <i>J</i> = 8.8 Hz, 2H), 6.92 (d, <i>J</i> = 8.8 Hz, 2H), 5.04 (s, 2H), 4.99 (br s, 1H), 3.88 (br s, 1H), 3.68–3.65 (m, 1H), 3.64 (s, 3H), 3.58–3.54 (m, 1H), 2.80 (m, 2H), 2.41 (br s, 1H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ: 157.5, 157.2, 137.0, 130.2 (2 × CH), 129.8, 128.5 (2 × CH), 127.9, 127.4 (2 × CH), 114.9 (2 × CH), 70.0, 64.0, 54.1, 52.2, 36.4.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <span class="smallcaps smallerCapital">l</span>-(<i>N</i>-Methoxycarbonyl)(<i>O</i>-benzyl))tyrosinol tosylate (<b>4</b>)</h4><div class="NLM_p last">Following the procedure by Kohno et al.,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> a solution of <i>n</i>-Bu<sub>4</sub>N.HSO<sub>4</sub> (0.470 g, 1.38 mmol) in water (10 mL) was added dropwise over 15 min to a rapidly stirred and cooled (0 °C) biphasic mixture of compound <b>3</b> (2.24 g, 7.11 mmol) and p-TsCl (1.49 g, 7.8 mmol, 1.1 equiv) in 10% aqueous NaOH (15 mL) and benzene (20 mL). The two-phase mixture was subsequently stirred at RT for 30 min. The layers were then separated, the aqueous layer was washed with benzene, and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to dryness in vacuo. The crude product mixture was crystallized from EtOAc–hexane to provide <b>4</b> as colorless crystals (2.23 g, 67% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.79–7.76 (m, 2H), 7.44–7.31 (m, 7H), 7.00–6.98 (m, 2H), 6.85–6.83 (m, 2H), 5.03 (s, 2H), 4.82 (br d, <i>J</i> = 7.7 Hz, 1H), 4.03–3.95 (m, 2H), 3.92 (dd, <i>J</i> = 9.5, 2.9 Hz, 1H), 3.61 (s, 3H), 2.84–2.71 (m, 2H), 2.46 (s, 3H).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>R</i>)-Methyl (1-(4-Benzyloxyphenyl)propan-2-yl)carbamate (<b>5</b>)</h4><div class="NLM_p last">Following the procedure by Kohno et al.,<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> a mixture of compound <b>4</b> (2.00 g, 4.26 mmol), zinc dust (2.78 g, 42.61 mmol), and NaI (3.19 g, 21.3 mmol) in THF (20 mL)-H<sub>2</sub>O (1 mL) was refluxed for 2.5 h. Salts and the remaining zinc were then filtered off, and the filtrate was concentrated in vacuo. The residue was taken up in EtOAc/water, the layers were separated, and the aqueous layer was extracted twice with EtOAc. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to give a bright orange solid. Silica flash column chromatography (EtOAc–hexane; 3:7) provided <b>5</b> as a colorless wax, which turned into a white solid upon standing (1.2 g, 94% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.45–7.43 (m, 2H), 7.41–7.37 (m, 2H), 7.35–7.31 (m, 1H), 7.12–7.09 (m, 2H), 6.94–6.91 (m, 2H), 5.05 (s, 2H), 4.63 (br s, 1H), 3.94 (br s, 1H), 3.65 (s, 3H), 2.80 (dd, <i>J</i> = 13.6, 5.2 Hz, 1H), 2.66 (dd, <i>J</i> = 13.6, 7.1 Hz, 1H), 1.13 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ: 157.6, 156.4, 137.2, 130.5 (2 × CH), 130.4, 128.6 (2 × CH), 128.0, 127.5 (2 × CH), 114.8 (2 × CH), 70.1, 52.0, 48.2, 42.1, 20.3.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>R</i>)-1-(4-(Benzyloxy)phenyl)-<i>N</i>-methylpropan-2-amine (<b>6</b>)</h4><div class="NLM_p last">A solution of <b>5</b> (1.15 g, 3.84 mmol) in dry THF (5 mL) was added slowly to a solution of LiAlH<sub>4</sub> (583 mg, 15.37 mmol) in dry THF (10 mL) at 0 °C. The resulting mixture was stirred at reflux for 4 h and then quenched at 0 °C by sequential addition of H<sub>2</sub>O (600 μL), 10% NaOH<sub>aq</sub> (600 μL), and H<sub>2</sub>O (1.2 mL),  the solids were removed by filtration, and the filtrate was concentrated. The crude mixture was silica flash column chromatographed (DCM/MeOH 98:2 to 90:10), affording <b>6</b> as a colorless oil (529 mg, 54% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.45–7.42 (m, 2H), 7.41–7.37 (m, 2H), 7.35–7.30 (m, 1H), 7.12–7.09 (m, 2H), 6.94–6.90 (m, 2H), 5.05 (s, 2H), 2.81 (m, 1H), 2.67 (dd, <i>J</i> = 13.4, 7.0 Hz, 1H), 2.58 (dd, <i>J</i> = 13.4, 6.3 Hz, 1H), 2.40 (s, 3H), 1.78 (br s, 1H), 1.06 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-((<i>R</i>)-(1-(4-(Benzyloxy)phenyl)propan-2-yl)(methyl))glycine <i>tert</i>-Butyl Ester (<b>7</b>)</h4><div class="NLM_p last"><i>tert</i>-Butyl bromoacetate (304 μL, 2.06 mmol) was added dropwise to a vigorously stirred solution of compound <b>6</b> (525 mg, 2.06 mmol) in DMF (3 mL). Cs<sub>2</sub>CO<sub>3</sub> (1.34 g, 4.11 mmol) was added after 5 min, and the resulting suspension was stirred overnight at room temperature. The crude mixture was diluted with water and extracted with DCM. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude mixture was silica column chromatographed (hexane/EtOAc 8:2 to 5:5), affording <b>7</b> as a viscous pale yellow oil (603 mg, 79% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.45–7.42 (m, 2H), 7.40–7.36 (m, 2H), 7.34–7.30 (m, 1H), 7.11–7.07 (m, 2H), 6.91–6.88 (m, 2H), 5.04 (s, 2H), 3.22 (br s, 2H), 2.97–2.88 (m, 2H), 2.41 (s, 3H), 2.36–2.29 (m, 1H), 1.48 (s, 9H), 0.93 (d, <i>J</i> = 6.7 Hz, 3H).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-((<i>R</i>)-(1-(4-Phenol)propan-2-yl)(methyl))glycine <i>tert</i>-Butyl Ester (<b>8</b>)</h4><div class="NLM_p last">Palladium on charcoal (10%, 60 mg) was added to a solution of compound <b>7</b> (600 mg, 1.62 mmol) in nitrogen-flushed MeOH (20 mL), and the reaction was stirred overnight at room temperature under hydrogen at 1 atm. The mixture was filtered through a 2-layer pad of Celite and alumina to remove the catalyst, and the filtrate was concentrated in vacuo, affording <b>8</b> as a light yellow oil (453 mg, 99% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.00 (d, <i>J</i> = 8.1 Hz, 2H), 6.74 (d, <i>J</i> = 8.1 Hz, 2H), 3.23 (s, 2H), 2.95–2.90 (m, 2H), 2.41 (s, 3H), 2.30 (dd, <i>J</i> = 13.3, 11.2 Hz, 1H), 1.47 (s, 9H), 0.92 (d, <i>J</i> = 6.1 Hz, 3H).</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-((<i>R</i>)-(1-(4-(Benzyloxy)phenyl)propan-2-yl)(methyl))glycine Hydrochloride (<b>10a</b>)</h4><div class="NLM_p last">Concentrated HCl (1.5 mL) was added dropwise to a cooled (0 °C) solution of <i>tert</i>-butyl ester <b>8</b> (200 mg, 0.54 mmol) in THF (1.5 mL), and the mixture was stirred for 3 h. The solvent was then removed in vacuo, and the derived solid material was washed (triturated) with DCM and then C-18 reverse phase column chromatographed (H<sub>2</sub>O/MeOH, 95:5 to 50:50). In this way compound <b>10a</b> was separated from small quantities (15 mg, 11%) of the contaminant resulting from <i>O</i>-debenzylation. It was isolated as a colorless solid (105 mg, 55% yield). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.43–7.41 (m, 2H), 7.38–7.34 (m, 2H), 7.32–7.28 (m, 1H), 7.21–7.18 (m, 2H), 6.99–6.96 (m, 2H), 5.07 (s, 2H), 3.70–3.59 (m, 2 + 1H), 3.13 (dd, <i>J</i> = 13.2, 4.2 Hz, 1H), 2.88 (s, 3H), 2.73 (dd, <i>J</i> = 13.2, 10.5 Hz, 1H), 1.21 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i>4) δ: 170.0, 159.5, 138.6, 131.5 (2 × CH), 129.5 (2 × CH), 129.4, 128.9, 128.6 (2 × CH), 116.3 (2 × CH), 71.0, 64.3, 56.4, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>24</sub>NO<sub>3</sub><sup>+</sup>: 314.17507, found: 314.17493.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (General Procedure) Preparation of <i>N</i>-((<i>R</i>)-(1-(4-(benzyloxy)phenyl)propan-2-yl)(methyl))glycine <i>tert</i>-Butyl Esters (<b>9b–s</b>) (step 1) and Their Conversion to <i>N</i>-((<i>R</i>)-(1-(Benzyloxy)phenyl)propan-2-yl)(methyl))glycine Hydrochlorides (<b>10b–s</b>) (step 2)</h4><div class="NLM_p"><b>Step 1</b>: Compound <b>8</b> (1 equiv), the requisite halide (1.1 equiv), and K<sub>2</sub>CO<sub>3</sub> (3 equiv) were added to DMF (2.0 mL for 0.36 mmol of compound <b>8</b>), and the resulting mixture was stirred overnight at room temperature. Solids in suspension were filtered off, and the solvent was evaporated in vacuo. The crude product mixture was column chromatographed (silica gel; hexane/EtOAc mixtures) to give compounds <b>9b–s</b>.</div><div class="NLM_p last"><b>Step 2</b>: Concentrated HCl (1.5 mL) was added dropwise to a cooled (0 °C) solution of the intermediate <i>tert</i>-butyl esters <b>9b</b>–<b>s</b> in THF (1.5 mL), and the mixture was stirred for 3 h. Removal of the solvent in vacuo and C-18 reverse phase column chromatography (H<sub>2</sub>O/MeOH mixtures) of the residue provided the desired product <b>10 b–s</b>.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-((<i>R</i>)-(1-(4-(2-Chlorobenzyloxy)phenyl)propan-2-yl)(methyl))glycine Hydrochloride <b>10b</b> via <b>9b</b></h4><div class="NLM_p">Following the two-step general procedure <i>N</i>-((<i>R</i>)-(1-(4-(2-chlorobenzyloxy)phenyl)propan-2-yl)(methyl)) glycine <i>tert</i>-butyl ester <b>9b</b> was prepared by reaction of <b>8</b> (100 mg, 0.36 mmol) with 2-chlorobenzyl bromide (51 μL, 0.39 mmol). It was isolated after silica chromatography (hexane/EtOAc 8:2 to 5:5) as a viscous pale yellow oil (83 mg, 57% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.57–7.54 (m, 1H), 7.40–7.37 (m, 1H), 7.30–7.22 (m, 2H), 7.12–7.08 (m, 2H), 6.92–6.88 (m, 2H), 5.14 (s, 2H), 3.22 (br s, 2H), 2.97–2.89 (m, 2H), 2.41 (s, 3H), 2.36–2.30 (m, 1H), 1.48 (s, 9H), 0.93 (d, <i>J</i> = 6.7 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9b</b> afforded <b>10b</b>, isolated as a white solid (69 mg, 87% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 95:5 to 50:50). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.56–7.52 (m, 1H), 7.44–7.40 (m, 1H), 7.33–7.28 (m, 2H), 7.23–7.20 (m, 2H), 6.98–6.96 (m, 2H), 5.13 (s, 2H), 3.70–3.61 (m, 2 + 1H), 3.15 (dd, <i>J</i> = 13.1, 4.0 Hz, 1H), 2.88 (s, 3H), 2.72 (dd, <i>J</i> = 13.1, 10.6 Hz, 1H), 1.21 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 159.2, 136.0, 134.0, 131.6 (2 × CH), 130.4 (3 × CH), 129.8, 128.2, 116.3 (2 × CH), 68.3, 64.3, 56.4, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>23</sub>ClNO<sub>3</sub><sup>+</sup>: 348.13610, found: 348.13620.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-((<i>R</i>)-(1-(4-(3-Chlorobenzyloxy)phenyl)propan-2-yl)(methyl))glycine Hydrochloride <b>10c</b> via <b>9c</b></h4><div class="NLM_p">Following the two-step general procedure <i>N</i>-((<i>R</i>)-(1-(4-(3-chlorobenzyloxy)phenyl)propan-2-yl)(methyl)) glycine <i>tert</i>-butyl ester <b>9c</b> was prepared by reaction of <b>8</b> (400 mg, 1.43 mmol) with 3-chlorobenzyl bromide (226 μL, 1.72 mmol, 1.2 equiv). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 7:3) as a viscous pale yellow oil (210 mg, 36% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.42 (br s, 1H), 7.31–7.27 (m, 3H), 7.11–7.08 (m, 2H), 6.89–6.85 (m, 2H), 5.00 (s, 2H), 3.21 (s, 2H), 2.96–2.90 (m, 2H), 2.41 (s, 3H), 2.36–2.32 (m, 1H), 1.47 (s, 9H), 0.92 (d, <i>J</i> = 6.8 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9c</b> afforded <b>10c</b>, isolated as a white solid (145 mg, 73% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 95:5 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.43 (br s 1H), 7.35–7.33 (m, 2H), 7.31–7.27 (m, 1H), 7.20 (d, <i>J</i> = 8.7 Hz, 2H), 6.96 (d, <i>J</i> = 8.7 Hz, 2H), 5.04 (s, 2H), 3.70–3.55 (m, 2 + 1H), 3.14 (dd, <i>J</i> = 13.1, 4.0 Hz, 1H), 2.88 (s, 3H), 2.71 (dd, <i>J</i> = 13.1, 10.6 Hz, 1H), 1.20 (d, <i>J</i> = 6.6 Hz, 3H).). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 159.2, 141.1, 135.4 (2 × CH), 131.5, 131.1, 129.7, 128.8, 128.3, 126.7, 116.3 (2 × CH), 70.0, 64.3, 56.5, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>23</sub>ClNO<sub>3</sub><sup>+</sup>: 348.13610, found: 348.13617.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (<i>R</i>)-<i>N</i>-(1-(4-((4-Chlorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride <b>10d</b> via <b>9d</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-(1-(4-((4-chlorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9d</b> was prepared by reaction of <b>8</b> (70 mg, 0.25 mmol) with 4-chlorobenzyl bromide (57 mg, 0.28 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 5:5) as a colorless wax (43 mg, 42% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.30–7.27 (m, 4H), 7.04 (d, <i>J</i> = 8.4 Hz, 2H), 6.82 (d, <i>J</i> = 8.4 Hz, 2H), 4.95 (s, 2H), 3.17 (s, 2H), 2.92–2.85 (m, 2H), 2.37 (s, 3H), 2.28 (dd, <i>J</i> = 14.0, 10.8 Hz, 1H), 1.43 (s, 9H), 0.88 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9d</b> (40 mg, 0.10 mmol) afforded <b>10d</b>, isolated as a colorless solid (25 mg, 66% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.40 (d, <i>J</i> =  8.4 Hz, 2H), 7.35 (d, <i>J</i> =  8.4 Hz, 2H), 7.20 (d, <i>J</i> = 8.4 Hz, 2H), 6.96 (d, <i>J</i> = 8.4 Hz, 2H), 5.03 (s, 2H), 3.70–3.59 (m, 2 + 1H), 3.14 (dd, <i>J</i> = 13.1, 3.8 Hz, 1H), 2.88 (s, 3H), 2.72 (dd, <i>J</i> = 13.1, 10.6 Hz, 1H), 1.20 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.8, 159.3, 137.5, 134.6, 131.5 (2 × CH), 130.1 (2 × CH), 129.62, 129.59 (2 × CH), 116.4 (2 × CH), 70.1, 64.3, 56.5, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>23</sub>ClNO<sub>3</sub><sup>+</sup>: 348.13610, found: 348.13519.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (<i>R</i>)-<i>N</i>-(1-(4-((2-Cyanobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride <b>10e</b> via <b>9e</b></h4><div class="NLM_p">Following the two-step general procedure <i>R</i>)-<i>N</i>-(1-(4-((2-cyanobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9e</b> was prepared by reaction of <b>8</b> (100 mg, 0.36 mmol) with 2-cyanobenzyl bromide (77 mg, 0.39 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 5:5) as a colorless solid (121 mg, 90% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.67 (dd, <i>J</i> = 8.4, 0.7 Hz, 2H), 7.60 (td, <i>J</i> = 7.6, 1.4 Hz, 1H), 7.40 (td, <i>J</i> = 7.6, 1.1 Hz, 1H), 7.10 (d, <i>J</i> = 8.6 Hz, 2H), 6.90 (d, <i>J</i> = 8.6 Hz, 2H), 5.21 (s, 2H), 3.21 (m, 2H), 2.95–2.87 (m, 2H), 2.40 (s, 3H), 2.32 (dd, <i>J</i> = 14.0, 10.8 Hz, 1H), 1.46 (s, 9H), 0.91 (d, <i>J</i> = 6.6 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9e</b> afforded <b>10e</b>, isolated as a colorless solid (88 mg, 77% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.77 (br d, <i>J</i> = 7.6, 1H), 7.70–7.66 (m, 2H), 7.54–7.47 (m, 1H), 7.25–7.21 (m, 2H), 7.02–6.99 (m, 2H), 5.21 (s, 2H), 3.71–3.60 (m, 2 + 1H), 3.16 (dd, <i>J</i> = 13.2, 4.0 Hz, 1H), 2.89 (s, 3H), 2.73 (dd, <i>J</i> = 13.2, 10.5 Hz, 1H), 1.21 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 159.0, 141.8, 134.3, 134.2, 131.6 (2 × CH), 130.3, 130.2, 130.0, 118.1, 116.4 (2 × CH), 112.9, 69.1, 64.3, 56.5, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 339.17032, found: 339.17056.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>R</i>)-<i>N</i>-(1-(4-((3-Cyanobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride <b>10f</b> via <b>9f</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-(1-(4-((3-cyanobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9f</b> was prepared by reaction of <b>8</b> (100 mg, 0.36 mmol) with 3-cyanobenzyl bromide (77 mg, 0.39 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 5:5) as a colorless solid (126 mg, 89% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.71 (br s, 1H), 7.64 (br d, <i>J</i> = 8.0 Hz, 1H), 7.57 (br d, <i>J</i> = 7.6 Hz, 1H), 7.45 (br t, <i>J</i> = 7.6 Hz, 1H), 7.10–7.07 (m, 2H), 6.87–6.83 (m, 2H), 5.03 (s, 2H), 3.20 (d, <i>J</i> = 1.4 Hz, 2H), 2.94–2.86 (m, 2H), 2.39 (s, 3H), 2.32 (dd, <i>J</i> = 14.1, 10.7 Hz, 1H), 1.46 (s, 9H), 0.91 (d, <i>J</i> = 6.5 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9f</b> afforded <b>10f</b>, isolated as a colorless solid (90 mg, 75% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.78 (br s 1H), 7.74 (br d, <i>J</i> = 7.7 Hz, 1H), 7.66 (dt, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.55 (t, <i>J</i> = 7.7 Hz, 1H), 7.24–7.20 (m, 2H), 7.00–6.96 (m, 2H), 5.11 (s, 2H), 3.70–3.58 (m, 2 + 1H), 3.15 (dd, <i>J</i> = 13.2, 4.2 Hz, 1H), 2.89 (s, 3H), 2.73 (dd, <i>J</i> = 13.2, 10.6 Hz, 1H), 1.21 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 159.0, 140.6, 133.0, 132.6, 131.8, 131.6 (2 × CH), 130.7, 129.9, 119.6, 116.3 (2 × CH), 113.5, 69.6, 64.3, 56.5, 38.8, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 339.17032, found: 339.17050.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (<i>R</i>)-<i>N</i>-(1-(4-((4-Cyanobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride <b>10g</b> via <b>9g</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-(1-(4-((4-cyanobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9g</b> was prepared by reaction of <b>8</b> (100 mg, 0.36 mmol) with 4-cyanobenzyl bromide (77 mg, 0.39 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 6:4) as a colorless wax (127 mg, 90% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.67 (d, <i>J</i> = 8.4 Hz, 2H), 7.54 (d, <i>J</i> = 8.0 Hz, 2H), 7.10 (d, <i>J</i> = 8.4 Hz, 2H), 6.86 (d, <i>J</i> = 8.4 Hz, 2H), 5.09 (s, 2H), 3.22 (s, 2H), 2.97–2.93 (m, 2H), 2.42 (s, 3H), 2.37–2.31 (m, 1H), 1.47 (s, 9H), 0.93 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9g</b> (110 mg, 0.28 mmol) afforded <b>10g</b>, isolated as an off-white solid (51 mg, 49% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.72 (d, <i>J</i> =  8.2 Hz, 2H), 7.60 (d, <i>J</i> =  8.2 Hz, 2H), 7.22 (d, <i>J</i> = 8.6 Hz, 2H), 6.97 (d, <i>J</i> = 8.6 Hz, 2H), 5.15 (s, 2H), 3.70–3.59 (m, 2 + 1H), 3.15 (dd, <i>J</i> = 13.1, 4.2 Hz, 1H), 2.89 (s, 3H), 2.73 (dd, <i>J</i> = 13.1, 10.6 Hz, 1H), 1.21 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 159.0, 144.5, 133.4, 131.76 129.9, 128.9, 119.7, 116.3, 112.5, 69.9, 64.3, 56.5, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 339.17032, found: 339.17065.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>R</i>)-<i>N</i>-(1-(4-((3-Fluorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride <b>10h</b> via <b>9h</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-(1-(4-((3-fluorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9h</b> was prepared by reaction of <b>8</b> (100 mg, 0.36 mmol) with 3-fluorobenzyl bromide (48 μL, 0.39 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 5:5) as a colorless wax (118 mg, 85% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.35–7.30 (m, 1H), 7.19–7.13 (m, 2H), 7.11–7.07 (m, 2H), 6.99 (td, <i>J</i> = 8.5, 2.2 Hz, 1H), 6.89–6.86 (m, 2H), 5.01 (s, 2H), 3.21 (s, 2H), 2.97–2.89 (m, 2H), 2.41 (s, 3H), 2.33 (dd, <i>J</i> = 14.1, 10.8 Hz, 1H), 1.47 (s, 9H), 0.93 (d, <i>J</i> = 6.5 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9h</b> afforded <b>10h</b>, isolated as a colorless solid (86 mg, 77% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.35 (td, <i>J</i> = 8.0, 6.0 Hz, 1H), 7.22–7.18 (m, 3H), 7.16–7.13 (m, 1H), 7.01 (td, <i>J</i> = 8.5, 2.5 Hz, 1H), 6.97–6.93 (m, 2H), 5.03 (s, 2H), 3.70–3.59 (m, 2 + 1H), 3.15 (dd, <i>J</i> = 13.2, 3.9 Hz, 1H), 2.88 (s, 3H), 2.70 (dd, <i>J</i> = 13.2, 10.6 Hz, 1H), 1.19 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 164.2 (d, <i>J</i> = 244.2 Hz), 159.1, 141.5 (d, <i>J</i> = 7.3 Hz), 131.5 (2 × CH), 131.3 (d, <i>J</i> = 8.1 Hz), 129.7, 124.0 (d, <i>J</i> = 2.8 Hz), 116.3 (2 × CH), 115.4 (d, <i>J</i> = 21.3 Hz), 114.9 (d, <i>J</i> = 22.3 Hz), 70.0 (d, <i>J</i> = 2.1 Hz), 64.2, 56.4, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>23</sub>FNO<sub>3</sub><sup>+</sup>: 332.16565, found: 332.16595.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>R</i>)-<i>N</i>-(1-(4-((3,5-Difluorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride <b>10i</b> via <b>9i</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-(1-(4-((3,5-difluorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9i</b> was prepared by reaction of <b>8</b> (100 mg, 0.36 mmol) with 3,5-difluorobenzyl bromide (51 μL, 0.39 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 5:5) as a colorless wax (144 mg, 99% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.11–7.07 (m, 2H), 6.96–6.92 (m, 2H), 6.87–6.83 (m, 2H), 6.72 (tt, <i>J</i> = 8.9, 2.3 Hz, 1H), 4.99 (s, 2H), 3.21 (d, <i>J</i> = 1.3 Hz, 2H), 2.96–2.87 (m, 2H), 2.40 (s, 3H), 2.32 (dd, <i>J</i> = 14.1, 10.8 Hz, 1H), 1.47 (s, 9H), 0.92 (d, <i>J</i> = 6.5 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9i</b> afforded <b>10i</b>, isolated as a colorless solid (108 mg, 79% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.24–7.20 (m, 2H), 7.07–7.01 (m, 2H), 6.99–6.96 (m, 2H), 6.87 (tt, <i>J</i> = 9.2, 2.3 Hz, 1H), 5.09 (s, 2H), 3.70–3.59 (m, 2 + 1H), 3.15 (dd, <i>J</i> = 13.2, 4.2 Hz, 1H), 2.88 (s, 3H), 2.73 (dd, <i>J</i> = 13.2, 10.5 Hz, 1H), 1.21 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 164.6 (dd, <i>J</i> = 247.2, 12.4 Hz, 2 × C<sub>q</sub>), 159.0, 143.5 (t, <i>J</i> = 9.1 Hz), 131.6 (2 × CH), 129.9, 116.3 (2 × CH), 110.8 (dd, <i>J</i> = 19.1, 6.9 Hz, 2 × CH), 103.7 (t, <i>J</i> = 25.9 Hz), 69.5 (t, <i>J</i> = 2.2 Hz), 64.3, 56.4, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>22</sub>F<sub>2</sub>NO<sub>3</sub><sup>+</sup>: 350.15623, found: 350.15649.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (<i>R</i>)-<i>N</i>-(1-(4-((4-Bromo-3-chlorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride <b>10j</b> via <b>9j</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-(1-(4-((4-bromo-3-chlorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9j</b> was prepared by reaction of <b>8</b> (200 mg, 0.72 mmol) with 4-bromo-3-chlorobenzyl bromide (224 mg, 0.79 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 5:5) as a colorless wax (246 mg, 71% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.53 (d, <i>J</i> = 1.6 Hz, 1H), 7.17 (dd, <i>J</i> = 8.2, 1.6 Hz, 1H), 7.10–7.07 (m, 2H), 6.86–6.83 (m, 2H), 4.96 (s, 2H), 3.21 (s, 2H), 2.96–2.88 (m, 2H), 2.40 (s, 3H), 2.33 (dd, <i>J</i> = 14.1, 10.8 Hz, 1H), 1.47 (s, 9H), 0.92 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9j</b> (120 mg, 0.25 mmol) afforded <b>10j</b>, isolated as a colorless solid (87 mg, 76% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.65 (d, <i>J</i> = 8.3 Hz, 1H), 7.58 (d, <i>J</i> = 1.7 Hz, 1H), 7.26 (dd, <i>J</i> = 8.3, 1.7 Hz, 1H), 7.21 (d, <i>J</i> = 8.6 Hz, 2H), 6.96 (d, <i>J</i> = 8.6 Hz, 2H), 5.02 (s, 2H), 3.69–3.58 (m, 2 + 1H), 3.14 (dd, <i>J</i> = 13.2, 4.1 Hz, 1H), 2.88 (s, 3H), 2.72 (dd, <i>J</i> = 13.2, 10.6 Hz, 1H), 1.20 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 159.0, 140.3, 135.4, 135.0, 131.5 (2 × CH), 130.1, 129.8, 128.2, 122.2, 116.4 (2 × CH), 69.4, 64.3, 56.5, 38.6, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>20</sub>BrClNO<sub>3</sub><sup>–</sup>: 426.02946, found: 426.03046 (main isotope).</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (<i>R</i>)-<i>N</i>-(1-(4-((3,4-Dichlorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride <b>10k</b> via <b>9k</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-(1-(4-((3,4-dichlorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9k</b> was prepared by reaction of <b>8</b> (80 mg, 0.29 mmol) with 3,4-dichlorobenzyl bromide (46 μL, 0.32 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 5:5) as a colorless wax (66 mg, 53% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.53 (br s, 1H), 7.52–7.40 (m, 1H), 7.26–7.24 (m, 1H), 7.09 (br d, <i>J</i> = 8.4 Hz, 2H), 6.85 (br d, <i>J</i> = 8.4 Hz, 2H), 4.98 (s, 2H), 3.22 (s, 2H), 2.97–2.89 (m, 2H), 2.41 (s, 3H), 2.33 (dd, <i>J</i> = 14.0, 10.8 Hz, 1H), 1.47 (s, 9H), 0.93 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9k</b> afforded <b>10k</b>, isolated as a colorless solid (43 mg, 68% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.58 (d, <i>J</i> = 1.1 Hz, 1H), 7.50 (d, <i>J</i> = 8.2 Hz, 1H), 7.34 (dd, <i>J</i> = 8.2, 1.1 Hz, 1H), 7.21 (d, <i>J</i> = 8.4 Hz, 2H), 6.96 (d, <i>J</i> = 8.4 Hz, 2H), 5.04 (s, 2H), 3.70–3.59 (m, 2 + 1H), 3.14 (dd, <i>J</i> = 13.2, 4.1 Hz, 1H), 2.88 (s, 3H), 2.72 (dd, <i>J</i> = 13.2, 10.5 Hz, 1H), 1.21 (d, <i>J</i> = 6.6 Hz, 3H).). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 168.8, 159.0, 139.6, 133.4, 132.5, 131.6, 131.5 (2 × CH), 130.3, 129.8, 128.1, 116.4 (2 × CH), 69.4, 64.3, 56.5, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>20</sub>Cl<sub>2</sub>NO<sub>3</sub><sup>–</sup>: 380.08257, found: 380.08289 (main isotope).</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (<i>R</i>)-<i>N</i>-(1-(4-((2,5-Dichlorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine hydrochloride <b>10l</b> via <b>9l</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-(1-(4-((2,5-dichlorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9l</b> was prepared by reaction of <b>8</b> (100 mg, 0.36 mmol) with 2,5-dichlorobenzyl bromide (94 mg, 0.39 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 6:4) as a colorless wax (92 mg, 59% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.59 (d, <i>J</i> = 2.4 Hz, 1H), 7.32 (d, <i>J</i> = 8.8 Hz, 2H), 7.23 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 7.11 (d, <i>J</i> = 8.4 Hz, 2H), 6.90 (d, <i>J</i> = 8.4 Hz, 2H), 5.09 (s, 2H), 3.24 (s, 2H), 2.97–2.95 (m, 2H), 2.44 (s, 3H), 2.36 (dd, <i>J</i> = 14.0, 10.8 Hz, 1H), 1.48 (s, 9H), 0.94 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9l</b> (80 mg, 0.18 mmol) afforded <b>10l</b>, isolated as an off-white solid (61 mg, 77% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 5:5). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.53 (d, <i>J</i> = 1.7 Hz, 1H), 7.39 (d, <i>J</i> = 8.4 Hz, 1H), 7.30 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.23 (d, <i>J</i> = 7.7 Hz, 2H), 6.97 (d, <i>J</i> = 7.7 Hz, 2H), 5.08 (s, 2H), 3.71–3.58 (m, 2 + 1H), 3.16 (br d, <i>J</i> = 12.1 Hz, 1H), 2.88 (s, 3H), 2.73 (br t, <i>J</i> = 11.6 Hz, 1H), 1.21 (d, <i>J</i> = 5.9 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 158.9, 138.1, 134.1, 132.1, 131.8, 131.6 (2 × CH), 130.2, 130.1, 129.8, 116.3 (2 × CH), 67.7, 64.2, 56.5, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>20</sub>Cl<sub>2</sub>NO<sub>3</sub><sup>–</sup>: 380.08257, found: 380.08325.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-((<i>R</i>)-(1-(4-(3-Nitrobenzyloxy)phenyl)propan-2-yl)(methyl))glycine Hydrochloride <b>10m</b> via <b>9m</b></h4><div class="NLM_p">Following the two-step general procedure <i>N</i>-((<i>R</i>)- (1-(4-(3-nitrobenzyloxy)phenyl)propan-2-yl)(methyl)) glycine <i>tert</i>-butyl ester <b>9m</b> was prepared by reaction of <b>8</b> (95 mg, 0.34 mmol) with 3-nitrobenzyl bromide (81 mg, 0.37 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 7:3) as a colorless wax (55 mg, 80% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.30 (br t, <i>J</i> = 2.0 Hz, 1H), 8.16 (dd, <i>J</i> = 8.2, 1.4 Hz, 1H), 7.76 (ddd, <i>J</i> = 8.2, 1.5, 1.0 Hz, 1H), 7.55 (t, <i>J</i> = 8.0 Hz, 1H), 7.12–7.08 (m, 2H), 6.90–6.86 (m, 2H), 5.10 (s, 2H), 3.21 (br s, 2H), 2.96–2.87 (m, 2H), 2.39 (s, 3H), 2.32 (dd, <i>J</i> = 13.8, 10.7 Hz, 1H), 1.46 (s, 9H), 0.92 (d, <i>J</i> = 6.7 Hz, 3H).</div><div class="NLM_p last">Subsequent acid treatment of <b>9m</b> afforded <b>10m</b>, isolated as a pale yellow solid (34 mg, 65% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 8.30 (br s, 1H), 8.16 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 7.83 (d, <i>J</i> = 7.6 Hz, 1H), 7.61 (t, <i>J</i> = 8.0 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 2H), 7.00 (d, <i>J</i> = 8.4 Hz, 2H), 5.18 (s, 2H), 3.66 (br s, 2 + 1H), 3.15 (dd, <i>J</i> = 13.0, 3.7 Hz, 1H), 2.89 (s, 3H), 2.73 (dd, <i>J</i> = 13.0, 10.6 Hz, 1H), 1.21 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 158.9, 149.7, 141.1, 134.4, 131.6 (2 × CH), 130.8, 130.0, 123.7, 122.9, 116.4 (2 × CH), 69.6, 64.3, 56.4, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>21</sub>N<sub>2</sub>O<sub>5</sub><sup>–</sup>: 357.14560, found: 357.14594.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> (<i>R</i>)-<i>N</i>-(1-(4-((3-Methoxybenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride <b>10n</b> via <b>9n</b></h4><div class="NLM_p">Compound <b>8</b> (100 mg, 0.36 mmol), 3-methoxybenzyl alcohol (99 mg, 0.72 mmol), and PPh<sub>3</sub> (376 mg, 1.43 mmol) were dissolved in THF (2 mL) under stirring. DIAD (141 μL, 0.72 mmol) was added dropwise, and the mixture was stirred for 30 min. Solvents were then evaporated in vacuo, and the crude residue was chromatographed through two successive automated flash silica gel columns (hexane/EtOAc 9:1 to 6:4, then 95:5 to 9:1) in an attempt to separate it from the side product, diisopropyl hydrazine-1,2-dicarboxylate (DIHD). The mixture containing (<i>R</i>)-<i>N</i>-(1-(4-((3-methoxybenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9n</b> was obtained as a colorless wax (87 mg, 62% yield, estimated from the crude <sup>1</sup>H NMR spectrum). The mixture was engaged in the next step without further purification.</div><div class="NLM_p last">Acid treatment of <b>9n</b> according to the general procedure afforded <b>10n</b>, isolated as a colorless solid (57 mg, 68% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 6:4 to 3:7). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.27 (t, <i>J</i> = 7.8 Hz, 1H), 7.13 (d, <i>J</i> = 8.2 Hz, 2H), 6.98–6.95 (m, 2H), 6.88 (d, <i>J</i> = 8.2 Hz, 2H), 6.84 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 4.98 (s, 2H), 3.80 (s, 3H), 3.71 (br s, 1H), 3.59–3.48 (m, 2H), 3.24 (br d, <i>J</i> = 13.3 Hz, 1H), 2.83 (s, 3H), 2.52 (t, <i>J</i> = 11.8 Hz, 1H), 1.17 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ: 168.0, 160.0, 158.1, 138.6, 130.5, 129.8, 128.4, 119.8, 115.4, 113.7, 113.0, 70.1, 62.5, 55.8, 55.4, 38.3, 37.5, 13.2. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>26</sub>NO<sub>4</sub><sup>+</sup>: 344.18563, found: 344.18469.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> (<i>R</i>)-<i>N</i>-(1-(4-((4-(Methoxycarbonyl)benzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride <b>10o</b> via <b>9o</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-(1-(4-((4-(methoxycarbonyl)benzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine <i>tert</i>-butyl ester <b>9o</b> was prepared by reaction of <b>8</b> (75 mg, 0.27 mmol) with methyl 4-(bromomethyl)benzoate (68 mg, 0.30 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 5:5) as a colorless wax (80 mg, 70% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.04 (d, <i>J</i> = 8.4 Hz, 2H), 7.49 (d, <i>J</i> = 8.0 Hz, 2H), 7.08 (d, <i>J</i> = 8.4 Hz, 2H), 6.87 (d, <i>J</i> = 8.4 Hz, 2H), 5.09 (s, 2H), 3.09 (s, 3H), 3.21 (br s, 2H), 2.96–2.88 (m, 2H), 2.40 (s, 3H), 2.32 (dd, <i>J</i> = 14.2, 10.6 Hz, 1H),1.47 (s, 9H), 0.92 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p last">Acid treatment of <b>9o</b> according to the general procedure afforded <b>10o</b>, isolated as a colorless solid (37 mg, 48% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 8.00 (d, <i>J</i> =  8.1 Hz, 2H), 7.53 (d, <i>J</i> =  8.1 Hz, 2H), 7.20 (d, <i>J</i> = 8.4 Hz, 2H), 6.97 (d, <i>J</i> = 8.4 Hz, 2H), 5.13 (s, 2H), 3.89 (s, 3H), 3.71–3.59 (m, 2 + 1H), 3.14 (dd, <i>J</i> = 13.1, 4.0 Hz, 1H), 2.88 (s, 3H), 2.72 (dd, <i>J</i> = 13.1, 10.6 Hz, 1H), 1.21 (d, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 170.0, 168.4, 159.4, 144.4, 134.5, 131.7, 130.9, 130.8, 129.9, 128.4, 116.5, 70.4, 64.5, 56.7, 52.8, 38.8, 37.7, 13.3. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>24</sub>NO<sub>5</sub><sup>–</sup>: 370.16600, found: 370.16739.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> (<i>R</i>)-<i>N</i>-Methyl-<i>N</i>-(1-(4-(naphthalen-2-ylmethoxy)phenyl)propan-2-yl)glycine Hydrochloride <b>10p</b> via <b>9p</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-methyl-<i>N</i>-(1-(4-(naphthalen-2-ylmethoxy)phenyl)propan-2-yl)glycine <i>tert</i>-butyl ester <b>9p</b> was prepared by reaction of <b>8</b> (70 mg, 0.25 mmol) with 2-(bromomethyl)naphthalene (61 mg, 0.28 mmol). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 5:5) as a colorless wax (51 mg, 49% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.89–7.84 (m, 4H), 7.50–7.48 (m, 3H), 7.12–7.09 (m, 2H), 6.96–6.94 (m, 2H), 5.21 (s, 2H), 3.23 (s, 2H), 2.98–2.94 (m, 2H), 2.43 (s, 3H), 2.37–2.31 (m, 1H), 1.48 (s, 9H), 0.95 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p last">Acid treatment of <b>9p</b> afforded <b>10p</b>, isolated as a beige solid (30 mg, 62% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.87–7.81 (m, 4H), 7.52 (br d, <i>J</i> =  8.3 Hz, 1H), 7.47–7.45 (m, 2H), 7.18 (d, <i>J</i> = 8.2 Hz, 2H), 7.00 (d, <i>J</i> = 8.2 Hz, 2H), 5.19 (s, 2H), 3.62 (br s, 2 + 1H), 3.11 (dd, <i>J</i> = 13.1, 3.3 Hz, 1H), 2.85 (s, 3H), 2.69 (dd, <i>J</i> = 13.1, 10.6 Hz, 1H), 1.17 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.8, 159.5, 136.1, 134.7, 134.49, 131.5 (2 × CH), 129.4, 129.2, 128.9, 128.7, 127.31, 127.27, 127.1, 126.4, 116.4 (2 × CH), 71.1, 64.3, 56.5, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>26</sub>NO<sub>3</sub><sup>+</sup>: 364.19072, found: 364.18982.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>R</i>)-<i>N</i>-Methyl-<i>N</i>-(1-(4-(pyridin-2-ylmethoxy)phenyl)propan-2-yl)glycine Hydrochloride <b>10q</b> via <b>9q</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-methyl-<i>N</i>-(1-(4-(pyridin-2-ylmethoxy)phenyl)propan-2-yl) <i>tert</i>-butyl ester <b>9q</b> was prepared by reaction of <b>8</b> (100 mg, 0.36 mmol) with 2-(bromomethyl)-pyridine hydrobromide (100 mg, 0.39 mmol) and K<sub>2</sub>CO<sub>3</sub> (247 mg, 1.79 mmol, 5 equiv). It was isolated after silica chromatography (hexane/EtOAc 9:1 to 5:5) as a colorless wax (77 mg, 58% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.57 (br d, <i>J</i> = 1.6 Hz, 1H), 7.68 (td, <i>J</i> = 7.7, 1.5 Hz, 1H), 7.50 (d, <i>J</i> = 7.7 Hz, 1H), 7.19 (dd, <i>J</i> = 7.2, 5.1 Hz, 1H), 7.08–7.05 (m, 2H), 6.89–6.87 (m, 2H), 5.16 (s, 2H), 3.20 (br s, 2H), 2.94–2.87 (m, 2H), 2.39 (s, 3H), 2.31 (dd, <i>J</i> = 14.1, 10.8 Hz, 1H), 1.45 (s, 9H), 0.91 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p last">Acid treatment of <b>9q</b> afforded <b>10q</b>, isolated as a light brown solid (55 mg, 68% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 8.54 (d, <i>J</i> = 4.9 Hz, 1H), 7.86 (td, <i>J</i> = 7.8, 1.4 Hz, 1H), 7.59 (d, <i>J</i> = 7.8 Hz, 1H), 7.37 (dd, <i>J</i> = 7.8, 4.9 Hz, 1H), 7.22 (d, <i>J</i> = 8.4 Hz, 1H), 7.00 (d, <i>J</i> = 8.4 Hz, 1H), 5.16 (s, 2H), 3.69–3.60 (m, 2 + 1H), 3.15 (dd, <i>J</i> = 13.1, 3.9 Hz, 1H), 2.89 (s, 3H), 2.73 (dd, <i>J</i> = 13.1, 10.6 Hz, 1H), 1.21 (d, <i>J</i> = 6.6 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 159.1, 158.2, 149.8, 139.0, 131.6 (2 × CH), 129.9, 124.4, 123.3, 116.3 (2 × CH), 71.2, 64.3, 56.5, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub><sup>–</sup>: 313.15577, found: 313.15601.</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> (<i>R</i>)-<i>N</i>-Methyl-<i>N</i>-(1-(4-(pyridin-4-ylmethoxy)phenyl)propan-2-yl)glycine Hydrochloride <b>10r</b> via <b>9r</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-methyl-<i>N</i>-(1-(4-(pyridin-4-ylmethoxy)phenyl)propan-2-yl)glycine <i>tert</i>-butyl ester <b>9r</b> was prepared by reaction of <b>8</b> (100 mg, 0.36 mmol) with 4-(bromomethyl)-pyridine hydrobromide (100 mg, 0.39 mmol) and K<sub>2</sub>CO<sub>3</sub> (247 mg, 1.79 mmol, 5 equiv). It was isolated after silica chromatography (DCM/MeOH 99:1 to 95:5) as a colorless wax (72 mg, 54% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.60 (br s, 2H), 7.34 (br d, <i>J</i> =  2.0 Hz, 2H), 7.07 (d, <i>J</i> = 8.8 Hz, 2H), 6.83 (d, <i>J</i> = 8.8 Hz, 2H), 5.03 (s, 2H), 3.19 (s, 2H), 2.94–2.88 (m, 2H), 2.38 (s, 3H), 2.31 (dd, <i>J</i> = 14.0, 10.4 Hz, 1H), 1.44 (s, 9H), 0.90 (d, <i>J</i> = 6.4 Hz, 3H).</div><div class="NLM_p last">Acid treatment of <b>9r</b> (43 mg, 0.12 mmol) afforded <b>10r</b>, isolated as an off-white wax (16 mg, 35% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 8.52 (d, <i>J</i> =  4.9 Hz, 2H), 7.51 (d, <i>J</i> =  4.9 Hz, 2H), 7.23 (d, <i>J</i> = 8.2 Hz, 2H), 7.00 (d, <i>J</i> = 8.2 Hz, 2H), 5.18 (s, 2H), 3.69–3.57 (m, 2 + 1H), 3.14 (dd, <i>J</i> = 13.0, 3.5 Hz, 1H), 2.88 (s, 3H), 2.74 (dd, <i>J</i> = 13.0, 10.7 Hz, 1H), 1.21 (d, <i>J</i> = 6.5 Hz, 3H).). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 159.0, 150.2 (2 × CH), 149.5, 131.6 (2 × CH), 130.1, 123.3 (2 × CH), 116.3 (2 × CH), 70.0, 64.3, 56.6, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 315.17032, found: 315.17029.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> (<i>R</i>)-<i>N</i>-Methyl-<i>N</i>-(1-(4-(pyridin-3-ylmethoxy)phenyl)propan-2-yl)glycine Hydrochloride <b>10s</b> via <b>9s</b></h4><div class="NLM_p">Following the two-step general procedure (<i>R</i>)-<i>N</i>-methyl-<i>N</i>-(1-(4-(pyridin-3-ylmethoxy)phenyl)propan-2-yl) <i>tert</i>-butyl ester <b>9s</b> was prepared by reaction of <b>8</b> (100 mg, 0.36 mmol) with 3-(bromomethyl)-pyridine hydrobromide (100 mg, 0.39 mmol) and K<sub>2</sub>CO<sub>3</sub> (247 mg, 1.79 mmol, 5 equiv). It was isolated after silica chromatography (DCM/MeOH 9:1 to 5:5) as a colorless wax (53 mg, 40% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 8.66 (br s, 1H), 8.56 (br s, 1H), 7.75 (br d, <i>J</i> = 7.8 Hz, 1H), 7.30 (dd, <i>J</i> = 7.7, 4.9 Hz, 1H), 7.10–7.08 (m, 2H), 6.88–6.86 (m, 2H), 5.03 (s, 2H), 3.20 (s, 2H), 2.96–2.87 (m, 2H), 2.39 (s, 3H), 2.32 (dd, <i>J</i> = 14.1, 10.8 Hz, 1H), 1.45 (s, 9H), 0.91 (d <i>J</i> = 6.5 Hz, 3H).</div><div class="NLM_p last">Acid treatment of <b>9s</b> afforded <b>10s</b>, isolated as an off-white wax (39 mg, 70% yield) after C-18 reverse phase chromatography (H<sub>2</sub>O/MeOH, 9:1 to 3:7). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 8.84 (br s, 1H), 8.51 (br s,1H), 7.94 (d, <i>J</i> = 7.8 Hz, 1H), 7.47 (dd, <i>J</i> = 7.0, 4.8 Hz, 1H), 7.23 (br d, <i>J</i> = 8.4 Hz, 2H), 7.01 (br d, <i>J</i> = 8.4 Hz, 2H), 5.15 (s, 2H), 3.70–3.60 (m, 3H), 3.15 (dd, <i>J</i> = 13.2, 3.6 Hz, 1H), 2.89 (s, 3H), 2.74 (dd, <i>J</i> = 12.8, 10.6 Hz, 1H), 1.21 (d, <i>J</i> = 6.5 Hz, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 159.1, 149.5, 149.3, 137.6, 135.3, 131.6 (2 × CH), 129.9, 125.4, 116.4 (2 × CH), 68.4, 64.3, 56.5, 38.7, 37.5, 13.1. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>18</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub><sup>–</sup>: 313.15577, found: 313.15610.</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> (<i>R</i>)-<i>N</i>-(1-(4-(Benzyloxy)phenyl)propan-2-yl)-<i>N</i>-methylprop-2-yn-1-amine (<b>11</b>)</h4><div class="NLM_p">Propargyl bromide (58 μL, 0.52 mmol) was added dropwise to a suspension of compound <b>6</b> (120 mg, 0.47 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (306 mg, 0.94 mmol) in THF (3 mL). The resulting mixture was stirred overnight at room temperature. The crude mixture was diluted with water and extracted with DCM. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was flash silica gel column chromatographed (hexane/EtOAc 90/10 to 70/30), affording compound <b>11</b> as a dark yellow oil (58 mg, 42% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.44–7.30 (m, 5H), 7.10 (br d, <i>J</i> = 8.6 Hz, 2H), 6.90 (br d, <i>J</i> = 8.6 Hz, 2H), 5.04 (s, 2H), 3.48 (br s, 2H), 3.04–2.95 (m, 2H), 2.46 (s, 3H), 2.37 (dd, <i>J</i> = 12.6, 9.5 Hz, 1H), 2.28 (br t, <i>J</i> = 2.2 Hz, 1H), 0.99 (d, <i>J</i> = 6.6 Hz, 3H).</div><div class="NLM_p last">A small portion of compound <b>11</b> (25 mg, 0.09 mmol) was converted to the corresponding hydrochloride salt by treatment with HCl in MeOH for 15 min at 0 °C. The residue obtained after removal of solvent in vacuo was partitioned between DCM and water, and the aqueous phase was concentrated to dryness, affording <b>11-HCl</b> (11 mg, 39% yield) as a slightly beige solid. <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.44–7.42 (m, 2H), 7.38–7.34 (m, 2H), 7.31–7.28 (m, 1H), 7.11 (br d, <i>J</i> = 8.6 Hz, 2H), 6.93 (br d, <i>J</i> = 8.6 Hz, 2H), 5.00 (s, 2H), 3.60 (br s, 2H), 3.18–3.10 (m, 1H), 2.84 (br s, 1H), 3.02 (dd, <i>J</i> = 13.0, 3.6 Hz, 1H), 2.51 (s, 3H), 2.41 (dd, <i>J</i> = 12.9, 10.4 Hz, 1H), 1.00 (d, <i>J</i> = 6.5 Hz, 3H). HRMS: <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>24</sub>NO<sup>+</sup>: 294.18524, found: 294.18491.</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(Boc)-<i>O</i>-Benzyltyrosine Methyl Ester (<b>13</b>)</h4><div class="NLM_p last">Following the procedure for <i>O</i>-benzylation of <b>2</b>, <i>N</i>-(Boc)tyrosine methyl ester <b>12</b> (1.0 g, 3.39 mmol) was converted to compound <b>13</b>, isolated as a colorless solid (1.3 g, 95% yield) after silica flash column chromatography (hexane/EtOAc 9:1 to 5:5). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.46–7.39 (m, 4H), 7.37–7.35 (m, 1H), 7.08–7.05 (m, 2H), 6.94–6.92 (m, 2H), 5.06 (s, 2H), 5.00 (br d, <i>J</i> = 8.2 Hz, 1H), 4.58–4.56 (m, 1H), 3.73 (s, 3H), 3.07–3.03 (m, 2H), 1.45 (s, 9H).</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-(Boc)-<i>O</i>-(3-Chlorobenzyl))tyrosine Methyl Ester (<b>14</b>)</h4><div class="NLM_p last">Following the <i>O</i>-benzylation procedure used to prepare <b>2</b>, <i>N</i>-(Boc)tyrosine methyl ester <b>12</b> (1.0 g, 3.39 mmol) was converted to compound <b>14</b>, isolated as a colorless solid (1.5 g, 100% yield), after silica flash column chromatography (hexane/EtOAc 9:1 to 5:5). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.43 (br s, 1H), 7.31–7.30 (m, 3H), 7.05–7.03 (m, 2H), 6.89–6.87 (m, 2H), 5.01 (s, 2H), 4.98–4.96 (m, 1H), 4.57–4.52 (m, 1H), 3.71 (s, 3H), 3.07–2.98 (m, 2H), 1.42 (s, 9H).</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-(Boc)-<i>N</i>-(Methyl)(<i>O</i>-benzyl)tyrosine (<b>15</b>)</h4><div class="NLM_p last">To a solution of <b>13</b> (1.30 g, 3.37 mmol) and MeI (1.05 mL, 16.86 mmol) in dry THF (15 mL), cooled to 0 °C, was added NaH (60% suspension in oil, 674 mg, 16.86 mmol) in portions. The resulting mixture was stirred overnight at room temperature and then cooled to 0 °C and quenched with ice water. After removal of the THF in vacuo, the residue was taken up in water and washed twice with hexane. The water layer was then acidified to pH 4 with citric acid and extracted with DCM. The combined organic layers were washed with brine and water, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude mixture was silica flash column chromatographed (hexane/EtOAc 6:4), affording <b>15</b> as a pale yellow oil (453 mg, 35% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) (<i>N</i>-Boc-rotamers) δ: 7.46–7.39 (m, 4H), 7.37–7.35 (m, 1H), 7.17–7.11 (m, 2H), 6.95–6.93 (m, 2H), 5.07 (s, 2H), 4.83–4.81 (dd, <i>J</i> = 10.8, 5.0 Hz, 1H), 4.61–4.57 (dd, <i>J</i> = 10.8, 4.2 Hz, 1H), 3.33–3.24 (m, 2H), 3.11- 2.97 (dd, <i>J</i> = 14.3, 11.1, 1H, rotamers), 2.78/2.72 (2s, 3H rotamers), 1.43/1.37 (2s, 9H, rotamers).</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(Boc) <i>N-</i>(Methyl)-<i>O-</i>(3-chlorobenzyl)tyrosine (<b>16</b>)</h4><div class="NLM_p last">Following the procedure used to prepare <b>15</b>, compound <b>16</b> was obtained from <b>14</b> (1.0 g, 2.38 mmol) as a colorless oil (760 mg, 76% yield), after silica flash column chromatography (hexane/EtOAc 9:1 to 6:4). <sup>1</sup>H NMR (CDCl<sub>3</sub>) (mixture of NBoc-rotamers) δ: 7.43 (s, 1H), 7.30–7.26 (m, 3H), 7.15–7.09 (m, 2H), 6.90–6.88 (m, 2H), 5.01 (s, 2H), 4.82–4.76 (m, 1H), 4.58–4.54 (m, 1H), 3.30–3.22 (m, 2H), 3.09–2.95 (m, 2H), 2.75/2.69 (2s, 3H, rotamers), 1.40/1.34 (2s, 9H, rotamers).</div></div><div id="sec4_2_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-(Methyl)(<i>O</i>-benzyl)tyrosine Methyl Ester (<b>17</b>)</h4><div class="NLM_p last">Compound <b>15</b> (450 mg, 1.17 mmol) was dissolved in MeOH (6.0 mL) and cooled to 0 °C before thionyl chloride (169 μL, 2.34 mmol) was added dropwise. The resulting solution was stirred overnight at room temperature. The solvent was then evaporated, and the residue was taken up in DCM, washed with 5% aqueous NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Compound <b>17</b> was obtained as a pale yellow oil (245 mg, 62% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.44–7.36 (m, 4H), 7.34–7.30 (m, 1H), 7.10–7.07 (m, 2H), 6.92–6.88 (m, 2H), 5.04 (s, 2H), 3.67 (s, 3H), 3.41 (t, <i>J</i> = 6.7 Hz, 1H), 2.94–2.86 (m, 2H), 2.36 (s, 3H), 1.66 (br s, 1H).</div></div><div id="sec4_2_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N-</i>(Methyl)-<i>O-</i>(3-chlorobenzyl)tyrosine Methyl Ester (<b>18</b>)</h4><div class="NLM_p last">Following the procedure used to prepare <b>17</b>, compound <b>18</b> was obtained from <b>16</b> (750 mg, 1.79 mmol) as a pale yellow oil (368 mg, 62% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.43 (br s, 1H), 7.30 (br s, 3H), 7.10–7.08 (m, 2H), 6.89–6.87 (m, 2H), 5.01 (s, 2H), 3.67 (s, 3H)], 3.43–3.39 (m, 1H), 2.90–2.89 (m, 2H), 2.36 (br s, 3H).</div></div><div id="sec4_2_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(<i>tert</i>-Butyl Acetate)-<i>N</i>-(methyl)(<i>O</i>-benzyloxy)tyrosine Methyl Ester (<b>19</b>)</h4><div class="NLM_p last">Compound <b>17</b> (230 mg, 0.77 mmol) was dissolved in DMF (1.5 mL), and <i>tert</i>-butyl bromoacetate (114 μL, 0.77 mmol) was added dropwise. After 5 min of stirring, Cs<sub>2</sub>CO<sub>3</sub> (501 mg, 1.54 mmol) was added and the resulting mixture was stirred overnight at room temperature. It was then diluted with a large amount of water and extracted with DCM. The organic layers were combined and dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude product was silica flash column chromatographed (hexane/EtOAc 9:1 to 7:3), affording <b>19</b> as a yellowish wax (157 mg, 49% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.44–7.35 (m, 4H), 7.34–7.29 (m, 1H), 7.15–7.11 (m, 2H), 6.90–6.87 (m, 2H), 5.02 (s, 2H), 3.59 (dd, <i>J</i> = 9.4, 5.9 Hz, 1H), 3.59 (s, 3H), 3.42 (d, <i>J</i> = 17.0 Hz, 1H), 3.26 (d, <i>J</i> = 17.0 Hz, 1H), 2.99 (dd, <i>J</i> = 13.4, 9.4 Hz, 1H), 2.93 (dd, <i>J</i> = 13.4, 5.9 Hz, 1H), 2.48 (s, 3H), 1.47 (s, 9H).</div></div><div id="sec4_2_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(<i>tert</i>-Butyl Acetate)-<i>N-</i>(methyl)-<i>O-</i>(3-chlorobenzyl)tyrosine Methyl Ester (<b>20</b>)</h4><div class="NLM_p last">Following the procedure used to prepare <b>19</b>, compound <b>20</b> was obtained from <b>18</b> (350 mg, 1.05 mmol) as a yellowish wax (252 mg, 54% yield) after silica flash column chromatography (hexane/EtOAc 9:1 to 7:3). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.42 (br s, 1H), 7.29–7.27 (m, 3H), 7.14–7.12 (m, 2H), 6.97–6.84 (m, 2H), 4.99 (s, 2H), 3.60–3.56 (m, 3H+1H), 3.42 (d, <i>J</i> = 17.2 Hz, 1H), 3.25 (d, <i>J</i> = 16.8 Hz, 1H), 3.02–2.90 (m, 2H), 2.47 (s, 3H), 1.46 (s, 9H).</div></div><div id="sec4_2_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-Carboxymethyl)-<i>N</i>-(methyl-<i>O</i>-benzyl)tyrosine Methyl Ester Hydrochloride (<b>21</b>)</h4><div class="NLM_p last">Concentrated HCl (1.5 mL) was added dropwise to a cooled (0 °C) solution of <i>tert</i>-butyl ester <b>19</b> (100 mg, 0.24 mmol) in THF (1.5 mL), and the mixture was stirred for 3 h. Removal of the solvent in vacuo and C-18 reverse phase column chromatography (H<sub>2</sub>O/MeOH 9:1 to 3:7) of the residue provided product <b>21</b> as a white powder (82 mg, 86% yield). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.42–7.39 (m, 2H), 7.37–7.32 (m, 2H), 7.31–7.26 (m, 1H), 7.16–7.12 (m, 2H), 6.96–6.89 (m, 2H), 5.03 (s, 2H), 3.89 (dd, <i>J</i> = 8.4, 6.8 Hz, 1H), 3.59 (s, 3H), 3.58 (d, <i>J</i> = 16.9 Hz, 1H), 3.48 (d, <i>J</i> = 16.9 Hz, 1H), 3.09–2.99 (m, 2H), 2.62 (s, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 172.8, 172.1, 159.2, 138.7, 131.3 (2 × CH), 130.0, 129.5 (2 × CH), 128.8, 128.6 (2 × CH), 116.1 (2 × CH), 70.9, 69.2, 56.7, 52.3, 40.2, 35.4. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>24</sub>NO<sub>5</sub><sup>+</sup>: 358.16490, found: 358.16473.</div></div><div id="sec4_2_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-Carboxymethyl-<i>N</i>-methyl-<i>O</i>-(3-chlorobenzyl)tyrosine Methyl Ester Hydrochloride (<b>22</b>)</h4><div class="NLM_p last">Following the procedure for <b>21</b>, <i>tert</i>-butyl ester <b>20</b> (100 mg, 0.22 mmol) in THF (1.5 mL) was treated with conc. HCl. Silica C-18 reverse phase column chromatography (H<sub>2</sub>O/MeOH 9:1 to 3:7) of the crude mixture provided product <b>22</b> as a yellow solid (72 mg, 75% yield). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.43 (br s, 1H), 7.34–7.27 (m, 3H), 7.16–7.13 (m, 2H), 6.92–6.89 (m, 2H), 5.03 (s, 2H), 3.90 (t, <i>J</i> = 7.6 Hz, 1H), 3.59 (d, <i>J</i> = 16.9 Hz, 1H), 3.59 (s, 3H), 3.49 (d, <i>J</i> = 16.9 Hz, 1H), 3.05–3.03 (m, 2H), 2.62 (s, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 172.8, 172.1, 158.9, 141.2, 135.3, 131.4 (2 × CH), 131.0, 130.2, 128.8, 128.3, 126.7, 116.1 (2 × CH), 70.0, 69.1, 56.7, 52.3, 40.2, 35.4. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>24</sub>NO<sub>5</sub><sup>+</sup>: 392.12593, found: 392.12552.</div></div><div id="sec4_2_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>(S</i>)-<i>N</i>-(1-(4-(Benzyloxy)phenyl)-3-hydroxypropan-2-yl)-<i>N</i>-methylamine (<b>23</b>)</h4><div class="NLM_p last">Compound <b>2</b> (5.0 g, 14.6 mmol) was dissolved in dry THF (75 mL), and LiAlH<sub>4</sub> (2.2 g, 58.2 mmol) was added in portions. The resulting suspension was stirred for 3 h at reflux and then quenched by successive dropwise addition of water (2.2 mL), 10% aqueous NaOH (2.2 mL), and water (2.2 mL). The solids were collected by filtration and washed with DCM and THF. The combined filtrate and washings were concentrated in vacuo, and the residue was silica flash column chromatographed (hexane/EtOAC 1:1 to EtOAc, then DCM/MeOH 7:3), affording compound <b>23</b> as a colorless solid (3.48 g, 88% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.44–7.31 (m, 5H), 7.10 (d, <i>J</i> = 8.4 Hz, 2H), 6.92 (d, <i>J</i> = 8.4 Hz, 2H), 5.05 (s, 2H), 3.64 (dd, <i>J</i> = 10.8, 3.6 Hz, 1H), 3.34 (dd, <i>J</i> = 10.8, 4.8 Hz, 1H), 2.78–2.64 (m, 2H+1H), 2.41 (s, 3H), 2.06 (br s, 2H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ: 158.1, 137.5, 130.7, 130.6 (2 × CH), 129.0 (2 × CH), 128.4, 127.9 (2 × CH), 115.4 (2 × CH), 70.1, 62.1, 61.4, 35.8, 33.0.</div></div><div id="sec4_2_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>tert</i>-Butyl (<i>S</i>)-<i>N</i>-(1-(4-(Benzyloxy)phenyl)-3-hydroxypropan-2-yl)-<i>N</i>-methylglycinate (<b>24</b>)</h4><div class="NLM_p last">To a solution of <b>23</b> (1.14 g, 4.20 mmol) in DMF (20 mL) was added Et<sub>3</sub>N (615 μL, 4.41 mmol) and <i>tert</i>-butyl bromoacetate (665 μL, 4.41 mmol). The mixture was stirred at room temperature overnight and then concentrated in vacuo. The residue was taken up in DCM and washed with an aqueous solution of citric acid. The aqueous layer was extracted three times with DCM. Then the combined organic layers were successively washed with satd. NaHCO<sub>3</sub>, brine, and water. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude mixture was silica flash chromatographed (hexane/EtOAc 7:3 to 5:5), affording <b>24</b> as a colorless oil (1.30 g, 80% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.44–7.30 (m, 5H), 7.06 (d, <i>J</i> = 8.4 Hz, 2H), 6.90 (d, <i>J</i> = 8.4 Hz, 2H), 5.04 (s, 2H), 3.44 (dd, <i>J</i> = 10.4, 4.4 Hz, 1H), 3.32 (br t, <i>J</i> = 10.4 Hz, 1H), 3.28 (d, <i>J</i> = 16.4 Hz, 1H), 3.13 (d, <i>J</i> = 16.4 Hz, 1H), 3.01–2.94 (m, 1H), 2.78 (dd, <i>J</i> = 13.6, 5.6 Hz, 1H), 2.43 (s, 3H), 2.35 (dd, <i>J</i> = 13.6, 8.8 Hz, 1H), 1.47 (s, 9H).</div></div><div id="sec4_2_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> (<i>S</i>)-<i>N</i>-(1-(4-(Benzyloxy)phenyl)-3-hydroxypropan-2-yl)-<i>N</i>-methylglycinine (<b>25</b>)</h4><div class="NLM_p last">A mixture of compound <b>23</b> (140 mg, 0.52 mmol), <i>tert</i>-butyl bromoacetate (76 μL, 0.52 mmol), Cs<sub>2</sub>CO<sub>3</sub> (336 mg, 1.03 mmol), and a catalytic amount of NaI in DMF (2.0 mL) was heated at 90 °C under microwave irradiation for 30 min. The mixture was then diluted with water and extracted with DCM, and the DCM extract was washed with brine and concentrated in vacuo. The residue was taken up in minimum DCM, and the insoluble material was removed by suction filtration. Concentration of the filtrate afforded <b>25</b> as a white powder (120 mg, 66% yield). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.43–7.27 (m, 5H), 7.09 (d, <i>J</i> = 8.6 Hz, 2H), 6.91 (d, <i>J</i> = 8.6 Hz, 2H), 5.05 (s, 2H), 3.47 (dd, <i>J</i> = 11.4, 10.0 Hz, 1H), 3.39 (dd, <i>J</i> = 11.4, 3.8 Hz, 1H), 3.27 (d, <i>J</i> = 15.5 Hz, 1H), 3.12 (d, <i>J</i> = 15.5 Hz, 1H), 2.95 (br s, 1H), 2.84 (dd, <i>J</i> = 13.4, 3.8 Hz, 1H), 2.39 (s, 3H), 2.28 (dd, <i>J</i> = 13.4, 10.7 Hz, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i>6) δ: 175.3, 156.5, 137.2, 132.4, 129.9, 128.4 (2 × CH), 127.8, 127.7 (2 × CH), 114.6 (2 × CH), 69.1, 66.7, 59.7, 58.4, 37.1, 30.4. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>23</sub>NO<sub>4</sub> [M + H]<sup>+</sup> = 330.1705, found: 330.1703.</div></div><div id="sec4_2_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> (<i>S</i>)-<i>N</i>-(1-(Benzyloxy)-3-(4-(benzyloxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride (<b>26</b>)</h4><div class="NLM_p last">Sodium hydride (60% suspension in oil, 42 mg, 1.04 mmol) was added to a cold (0 °C) solution of <b>24</b> (200 mg, 0.52 mmol) in THF (3.0 mL). After stirring for 10 min, benzyl bromide (93 μL, 0.78 mmol) was added dropwise and the resulting mixture was stirred overnight at RT. After cooling to 0 °C the reaction was stopped by dropwise addition of conc. HCl (2.0 mL). The resulting mixture was stirred for an additional 2 h and concentrated in vacuo. The residue was column chromatographed twice (C18 reverse phase (first column H<sub>2</sub>O/MeOH 90:10 to 5:95 and second column 50:50 to 20:80)), affording <b>26</b> as a white solid (108 mg, 46% yield). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.43–7.42 (m, 2H), 7.38–7.27 (m, 8H), 7.15 (d, <i>J</i> = 8.6 Hz, 2H), 6.94 (d, <i>J</i> = 8.6 Hz, 2H), 5.06 (s, 2H), 4.55 (d, <i>J</i> = 11.7 Hz, 1H), 4.45 (d, <i>J</i> = 11.7 Hz, 1H), 3.83–3.68 (m, 3H), 3.64 (dd, <i>J</i> = 11.7, 2.9 Hz, 1H), 3.55 (dd, <i>J</i> = 11.7, 7.1 Hz, 1H), 3.07 (dd, <i>J</i> = 13.3, 4.6 Hz, 1H), 2.93 (s, 3H), 2.90 (dd, <i>J</i> = 13.3, 10.9 Hz, 1H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 169.9, 159.5, 138.6, 138.4, 131.4 (2 × CH), 129.59 (2 × CH), 129.51 (2 × CH), 129.3 (2 × CH), 129.1, 128.9, 128.8, 128.5 (2 × CH), 116.4 (2 × CH), 74.4, 71.0, 67.3, 66.4, 57.9, 39.8, 31.9. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>26</sub>H<sub>30</sub>NO<sub>4</sub><sup>+</sup>:420.21693, found: 420.21628.</div></div><div id="sec4_2_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>tert</i>-Butyl (<i>S</i>)-<i>N</i>-(1-(4-(Benzyloxy)phenyl)-3-chloropropan-2-yl)-<i>N</i>-methylglycinate (<b>27</b>)</h4><div class="NLM_p last">To a solution of <b>24</b> (1.23 g, 3.20 mmol) in dry DCM (20 mL) was added Et<sub>3</sub>N (900 μL, 6.40 mmol) at 0 °C followed by TsCl (1.22 g, 6.40 mmol) and DMAP (117 mg, 0.96 mmol). The mixture was stirred at room temperature overnight. The mixture was then diluted with DCM and washed with a 10% citric solution. The aqueous phase was extracted with DCM (3×), and the combined organic layers were washed with satd. NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash silica gel column chromatography of the residue (hexane to hexane/EtOAc 85:15) afforded <b>27</b> as a pale yellow oil (1.14 g, 88% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.45–7.31 (m, 5H), 7.18 (d, <i>J</i> = 8.4 Hz, 2H), 6.93 (d, <i>J</i> = 8.4 Hz, 2H), 5.05 (s, 2H), 4.16–4.10 (m, 1H), 3.31 (s, 2H), 3.20 (dd, <i>J</i> = 14.4, 4.8 Hz, 1H), 2.90–2.85 (m, 3H), 2.49 (s, 3H), 1.47 (s, 9H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ: 170.3, 157.8, 137.2, 130.6 (2 × CH), 130.3, 128.7 (2 × CH), 128.0, 127.6 (2 × CH), 114.8 (2 × CH), 81.2, 70.1, 62.5, 61.5, 59.5, 42.5, 41.5, 28.3 (3 × CH<sub>3</sub>).</div></div><div id="sec4_2_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>tert</i>-Butyl (<i>S</i>)-<i>N</i>-(1-(4-(Benzyloxy)phenyl)-3-cyanopropan-2-yl)-<i>N</i>-methylglycinate (<b>28</b>)</h4><div class="NLM_p last">To a solution of <b>27</b> (235 mg, 0.58 mmol) in dry DMF (2.5 mL) was added KCN (379 mg, 5.82 mmol), 18-crown-6 (31 mg, 0.12 mmol), and a catalytic amount of NaI. The mixture was stirred at 100 °C for 90 min in a microwave reactor, diluted with DCM,  washed with satd. NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Flash silica gel column chromatography of the solid residue (hexane to hexane/EtOAc 8:2) afforded <b>28</b> as a pale yellow oil (183 mg, 80% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.45–7.31 (m, 5H), 7.14 (d, <i>J</i> = 8.0 Hz, 2H), 6.93 (d, <i>J</i> = 8.0 Hz, 2H), 5.05 (s, 2H), 3.39 (d, <i>J</i> = 16.8 Hz, 1H), 3.33 (d, <i>J</i> = 16.8 Hz, 1H), 3.26–3.20 (m, 1H), 3.02 (dd, <i>J</i> = 13.6, 4.8 Hz, 1H), 2.67 (dd, <i>J</i> = 13.6, 9.6 Hz, 1H), 2.53 (s, 3H), 2.46 (dd, <i>J</i> = 17.2, 4.8 Hz, 1H), 2.37 (dd, <i>J</i> = 17.2, 6.4 Hz, 1H), 1.48 (s, 9H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ: 170.5, 157.7, 137.1, 130.4, 130.1 (2 × CH), 128.7 (2 × CH), 128.0, 127.5 (2 × CH), 118.8, 115.2 (2 × CH), 81.3, 70.1, 61.7, 56.6, 38.0, 36.4, 28.2 (3 × CH<sub>3</sub>), 19.0.</div></div><div id="sec4_2_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> (<i>S</i>)-<i>N</i>-(1-(4-(Benzyloxy)phenyl)-3-cyanopropan-2-yl)-<i>N</i>-methylglycine Hydrochloride (<b>29</b>)</h4><div class="NLM_p last">Following the procedure for <b>21</b>, <i>tert</i>-butyl ester <b>28</b> (74 mg, 0.19 mmol) in THF (1.5 mL) was treated with conc. HCl. Reverse phase C-18 column chromatography (H<sub>2</sub>O/MeOH 9:1 to 3:7) of the crude mixture provided product <b>29</b> as a colorless solid (54 mg, 77% yield). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.41–7.27 (m, 5H), 7.20 (d, <i>J</i> = 8.3 Hz, 2H), 6.95 (d, <i>J</i> = 8.3 Hz, 2H), 5.03 (s, 2H), 3.60–3.50 (m, 3H), 3.10 (dd, <i>J</i> = 13.3, 5.0 Hz, 1H), 2.79 (dd, <i>J</i> = 13.3, 9.8 Hz, 1H), 2.75–2.62 (m, 2H), 2.69 (s, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 172.4, 159.4, 138.6, 131.4 (2 × CH), 130.0, 129.5 (2 × CH), 128.9, 128.6 (2 × CH), 119.0, 116.4 (2 × CH), 71.0, 63.4, 57.0, 38.6, 36.1, 18.6. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>23</sub>N<sub>2</sub>O<sub>3</sub><sup>+</sup>: 339.17032, found: 339.17044.</div></div><div id="sec4_2_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>tert</i>-Butyl (<i>S</i>)-<i>N</i>-(1-Cyano-3-(4-hydroxyphenyl)propan-2-yl)-<i>N</i>-methylglycinate (<b>30</b>)</h4><div class="NLM_p last">Palladium on charcoal (10%, 25 mg) was added to a solution of compound <b>28</b> (213 mg, 0.54 mmol) in nitrogen-flushed MeOH (5.0 mL), and the reaction was stirred overnight at room temperature under hydrogen at 1 atm. The mixture was then filtered through a Celite pad, followed by an alumina pad, to remove the catalyst, and the filtrate was concentrated in vacuo, affording <b>30</b> as a colorless oil, which solidified on standing (148 mg, 90% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.06 (d, <i>J</i> = 8.0 Hz, 2H), 6.77 (d, <i>J</i> = 8.0 Hz, 2H), 5.43 (br s, OH), 3.38 (d, <i>J</i> = 16.8 Hz, 1H), 3.33 (d, <i>J</i> = 16.8 Hz, 1H), 3.22–3.17 (m, 1H), 2.99 (dd, <i>J</i> = 13.6, 4.8 Hz, 1H), 2.64 (dd, <i>J</i> = 13.6, 9.6 Hz, 1H), 2.52 (s, 3H), 2.46 (dd, <i>J</i> = 17.0, 4.8 Hz, 1H), 2.36 (dd, <i>J</i> = 17.0, 6.2 Hz, 1H), 1.47 (s, 9H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) <b>δ</b>: 170.7, 154.8, 130.3 (2 × CH), 129.9, 118.8, 115.8 (2 × CH), 81.7, 61.9, 56.6, 38.1, 36.4, 28.3 (3 × CH<sub>3</sub>), 19.0.</div></div><div id="sec4_2_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>tert</i>-Butyl-(<i>S</i>)-<i>N</i>-(1-cyano-3-(4-((3,4-dichlorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycinate (<b>31</b>)</h4><div class="NLM_p last">To a solution of <b>30</b> (131 mg, 0.43 mmol) in dry DMF (2 mL) were successively added K<sub>2</sub>CO<sub>3</sub> (179 mg, 1.29 mmol) and 3,4-dichlorobenzyl bromide (83 μL, 0.56 mmol). The reaction was stirred at room temperature under nitrogen overnight. The mixture was then filtered through a pad of Celite using DCM as solvent and concentrated in vacuo. Flash silica gel column chromatography (hexane/EtOAc 90:10 to 75:25) of the concentrate afforded <b>31</b> as a colorless oil (175 mg, 88% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ: 7.53 (s, 1H), 7.45 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 7.14 (d, <i>J</i> = 8.4 Hz, 2H), 6.88 (d, <i>J</i> = 8.4 Hz, 2H), 4.99 (s, 2H), 3.38 (d, <i>J</i> = 17.0 Hz, 1H), 3.32 (d, <i>J</i> = 17.0 Hz, 1H), 3.26–3.19 (m, 1H), 3.02 (dd, <i>J</i> = 13.6, 5.2 Hz, 1H), 2.68 (dd, <i>J</i> = 13.6, 9.2 Hz, 1H), 2.52 (s, 3H), 2.46 (dd, <i>J</i> = 17.2, 4.8 Hz, 1H), 2.37(dd, <i>J</i> = 17.2, 6.0 Hz, 1H), 1.47 (s, 9H). <sup>13</sup>C NMR (CDCl<sub>3</sub>) δ: 170.5, 157.3, 137.4, 132.9, 132.1, 131.0, 130.7, 130.3 (2 × CH), 129.4, 126.6, 118.8, 115.2 (2 × CH), 81.5, 68.7, 61.8, 56.6, 38.0, 36.5, 28.3 (3 × CH<sub>3</sub>), 19.1.</div></div><div id="sec4_2_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> (<i>S</i>)-<i>N</i>-(1-Cyano-3-(4-((3,4-dichlorobenzyl)oxy)phenyl)propan-2-yl)-<i>N</i>-methylglycine Hydrochloride (<b>32</b>)</h4><div class="NLM_p last">Following the procedure for <b>21</b>, <i>tert</i>-butyl ester <b>31</b> (162 mg, 0.44 mmol) in THF (1.5 mL) was treated with conc. HCl. Reverse phase C-18 column chromatography (H<sub>2</sub>O/MeOH 9:1 to 3:7) of the crude mixture provided product <b>32</b> as a colorless solid (120 mg, 66% yield). <sup>1</sup>H NMR (MeOH-<i>d</i><sub>4</sub>) δ: 7.58 (s, 1H), 7.49 (d, <i>J</i> = 8.2 Hz, 1H), 7.33 (d, <i>J</i> = 8.2 Hz, 1H), 7.22 (d, <i>J</i> = 8.2 Hz, 2H), 6.95 (d, <i>J</i> = 8.2 Hz, 2H), 5.03 (s, 2H), 3.57–3.48 (m, 3H), 3.10 (dd, <i>J</i> = 13.3, 3.8 Hz, 1H), 2.79 (dd, <i>J</i> = 13.3, 9.9 Hz, 1H), 2.74–2.62 (m, 2H), 2.66 (s, 3H). <sup>13</sup>C NMR (MeOH-<i>d</i><sub>4</sub>) δ: 173.0, 159.9, 139.6, 133.4, 132.5, 131.6, 131.5 (2 × CH), 130.7, 130.3, 128.1, 119.1, 116.3 (2 × CH), 69.4, 63.4, 57.1, 38.6, 36.2, 18.7. HRMS: <i>m</i>/<i>z</i> calculated for C<sub>20</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>2</sub>O<sub>3</sub><sup>–</sup>: 405.07782, found: 405.07837.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Docking Studies</h3><div class="NLM_p last">Docking of compounds was performed using applications of the software suite offered by OpenEye, Inc. The compounds were obtained as isomeric SMILES strings. Protonation states were adjusted to pH 7.4 using FIXPKA from QUACPAC,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> followed by conformer generation of up to 800 conformers using OMEGA2<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> and standard parameters. In addition, stereochemistry of amine nitrogens was enumerated, yielding a total of 8 molecules for docking. Docking was performed using HYBRID<a onclick="showRef(event, 'ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref52 ref53">(51−53)</a> and the coordinates of the cocrystal structure of human MAO-B complexed with Safinamide (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v5z">2v5z</a>), keeping 20 poses for each docked molecule. Optimization of the docked poses was carried out using a two-step protocol and SZYBKI:<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> first, optimization of ligand Cartesian coordinates was performed using a constraint of 1 kcal/(mol Å<sup>2</sup>), followed by optimization of the complex using with MMFF94s as force field, Poisson–Boltzmann model, and AM1BCC charges for the ligands. Protein side chains within 5 Å of the ligand were kept flexible. The resulting poses were ranked according to the predicted ligand—protein energy (LPE), and the pose with the lowest score was selected as the best pose for each molecule.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Biological Assays</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> MAO-A/B Inhibition Assay</h4><div class="NLM_p last">MAO-A and -B activities were measured using the Fluoro MAO Monoamine Oxidase A & B Detection Kit (Cell Technology Inc., Fremont, United States). Procedures were according to manufacturer’s recommendations with modifications. Human MAO-A and MAO-B recombinant proteins (Sigma-Aldrich) were incubated at 2nmol per min per mL in a volume of 50 μL with serially diluted novel compounds from concentrations from 0 to 50 μM in 96-well plates at room temperature for 1 h. Positive controls included deprenyl (MAO-B-specific irreversible inhibitor), safinamide (MAO-B-specific reversible inhibitor), and clorgyline (MAO-A-specific irreversible inhibitor). All positive controls or compounds were preincubated with recombinant human MAO-A or MAO-B proteins for 1 h at room temperature to achieve maximal binding and to ensure the reaction reached its equilibrium state. A comparison study of preincubation and immediate binding showed that 1 h preincubation is critical in generating consistent IC<sub>50</sub> values in the enzyme inhibition assay (data not shown). In addition, we compared the IC<sub>50</sub> values generated using either subsaturating (2 ×  Michaelis constant (Km)) or saturating (2.5 mM) substrate concentrations and determined the same IC<sub>50</sub> values under both conditions (data not shown). Substrates (tyramine (final concentration 2.5 mM) for MAO-A and benzylamine (final concentration 2.5 mM) for MAO-B) were metabolized by recombinant MAOs to generate H<sub>2</sub>O<sub>2</sub>. The coupling enzyme, HRP, uses the H<sub>2</sub>O<sub>2</sub> formed to convert resazurin into highly fluorescent resorufin in a concentration-dependent manner. The reaction cocktails (50 μL) contained 1× HRP, 5 mM substrate (tyramine or benzylamine), and 1× (w/v) detection reagent in 1× reaction buffer supplied from the assay kit. After the 1 h preincubation step, reaction cocktails were added to preincubated reactions (total volume of 100 μL) and allowed to incubate for an additional 30 min at room temperature in the dark. The fluorescent signals were measured with a fluorescence plate reader with excitation and emission wavelengths of 570 and 590 nm. Signals were subtracted from background and normalized to 0 μM of compound (or nontreated) wells to calculate % inhibition. IC<sub>50</sub> values were determined using the curvatures of log (inhibitor) vs normalized response with a variable slope in Prism 5.02 (GraphPad Software). Initial compound concentrations of 0–50 μM were used for the IC<sub>50</sub> calculations because equilibrium between the compounds and MAO-A/B enzymes was reached during the 1 h preincubation step.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> P-gp Efflux Evaluation in MDCK-WT and MDCK-MDR1 II Cells</h4><div class="NLM_p last">Permeability assays were carried out as described in Feng et al.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> MDCK-WT cells were grown in MEM-α (Gibco) supplemented with 10% FBS (Gibco). MDCK-MDR1 II cells were maintained in DMEM (Gibco) supplemented with 10% FBS (Gibco). Cells were seeded at a density of 5 × 10<sup>5</sup> cells/mL on the apical or basolateral compartment of 12-well transwell plates (Costar). Cells were incubated in standard growth media at 37 °C with 95% humidity and 5% CO<sub>2</sub> and maintained for 3 days. Transepithelial electrical resistance (TEER) measurements were taken before and after the treatment to confirm the integrity and permeability of the monolayer established. The epithelial integrity of each well was also confirmed by addition of Lucifer yellow solution at 100 μM. Cells in both apical and basolateral compartments were washed with HBSS solution containing 10 mM HEPES for 30 min at 37 °C with 95% humidity and 5% CO<sub>2.</sub> Deprenyl, cetirizine, and compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> were added at a concentration of 10 μM to the apical (A) or basal (B) compartments in triplicates in each cell line. Additionally, a known P-gp inhibitor, verapamil, was used at 100 μM. At 1 h post-treatment, the supernatant of the samples was collected and analyzed by UPLC-MS/MS. The <i>P</i><sub>app</sub> values were calculated for both A-to-B and B-to-A transport directions. The ratio of <i>P</i><sub>app</sub> values was defined as the efflux ratio. The efflux ratio was calculated for each cell line in the presence and absence of verapamil. All calculations were determined using the formulas described below<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_m001.gif" alt="" id="_i72" /></img></span>where <i>V</i><sub>R</sub> = volume in the receiver compartment (mL) = 0.5 (in apical compartment) or 1.5 (in basal compartment), <i>A</i> = filter surface area (cm<sup>2</sup>) = 1.12 cm<sup>2</sup> for 12-well Transwell plate, <i>C</i><sub>o</sub> = initial concentration of test compound in the donor compartment, and d<i>C</i>/d<i>T</i> = change in compound concentration in receiver compartment over time (s) = 3600 s.<span class="NLM_disp-formula" id="ueq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_m002.gif" alt="" id="_i73" /></img></span>where <i>P</i><sub>app</sub> = apparent permeability coefficient, B = basolateral compartment, and A = apical compartment.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> Plasma Stability</h4><div class="NLM_p last">Mouse and human plasma stability was assessed using “loss of parent” approach by incubating the test compounds at 5 μM concentration in mouse or human plasma (100 μL) for up to 4 h at 37 °C. The reactions were initiated by the addition of the test compound to plasma followed by gentle vortexing and incubation at 37 °C with shaking at 100 rpm. At 0, 5, 15, 30, 60, 120, and 240 min of incubation at 37 °C, the reactions were terminated by the addition of 400 μL of ice-cold stop solution and vortexing briefly. The stop solution was acetonitrile containing 0.1% (v/v) formic acid and 0.5 μM compound <b>11</b> (internal standard). Only for the 0 min samples, the stop solution was added to plasma prior to the addition of the test compound. At the end of the assay, the samples were centrifuged and the supernatants were subjected to UPLC-MS/MS analysis. The positive control compounds for the plasma stability assays were enalapril and procaine in mouse and human plasma, respectively.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Metabolic Stability in Liver Microsomes</h4><div class="NLM_p last">Mouse and human liver microsomal stability assays were performed by incubating the test compounds at 1 μM concentration in 100 mM potassium phosphate buffer (pH 7.4) containing 3.3 mM MgCl<sub>2</sub>, 0.5 mg/mL microsomal protein (mouse/human), and 1 mM NADPH (cofactor) in a 100 μL volume at 37 °C. The reactions were initiated by the addition of NADPH followed by gentle vortexing and incubation at 37 °C with shaking at 100 rpm. At 0, 5, 15, 30, 45, and 60 min after incubation at 37 °C, the reactions were terminated by the addition of an equal volume (100 μL) of ice-cold stop solution and brief vortexing. The stop solution was acetonitrile containing 0.1% (v/v) formic acid and 0.5 μM of compound <b>11</b> (internal standard). In the case of 0 min samples, the stop solution was added prior to the addition of NADPH. The microsomal stability studies also included an additional “minus NADPH” control group for the 60 min time point. After centrifugation, the supernatants of the samples were subjected to UPLC-MS/MS analysis. Propranolol served as a positive control in both mouse and human liver microsomal stability assays.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Metabolic Stability in Cryopreserved Mouse Hepatocytes</h4><div class="NLM_p last">Mouse hepatocyte stability assays were conducted by incubating the test compounds with mouse hepatocytes in a modified Krebs–Henseleit buffer (InVitroGRO KHB from BioreclamationIVT, Baltimore, MD) at 37 °C for up to 60 min. The final incubation mixture consisted of the test compound at 1 μM concentration and 2.5 × 10<sup>5</sup> hepatocytes in 0.5 mL of InVitroGRO KHB. The reactions were initiated by the addition of hepatocyte suspension to solutions of test compounds in InVitroGRO KHB followed by gentle mixing and incubation at 37 °C with shaking at 100 rpm. At 0, 5, 15, 30, 45, and 60 min after incubation at 37 °C, 50 μL aliquots of the homogeneous incubation mixture, which included both the incubation buffer and cells, were obtained and transferred to the corresponding wells of another 96-well plate containing 2× volume (100 μL) of ice-cold stop solution and vortexed gently. The stop solution was acetonitrile containing 0.1% (v/v) formic acid and 0.5 μM of compound <b>11</b> (internal standard). The samples were centrifuged, and the supernatants were subjected to UPLC-MS/MS analysis. Propranolol was included as a positive control in hepatocyte stability assays.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Tolerability and Pharmacokinetics Study</h4><div class="NLM_p last">C57BL/6 mice (Charles River) that were 8–12 weeks old were housed at 3 animals per cage in a 12 h light/dark cycle and were given sterile food and water ad libitum. Prior to injections, animals were individually weighed to determine the injection dose at 57.5 μmol/kg (equivalent to 10.8 mg/kg for deprenyl, 24.5 mg/kg for compound <b>10j</b>, 23.4 mg/kg for compound <b>32</b>, 20.0 mg/kg for compound <b>10c</b>, and 22.0 mg/kg for compound <b>10k</b>) and were then injected intravenously (iv), subcutaneously (sc), or orally (po) as indicated. Animals were monitored for acute toxicity effects to assess tolerability of compounds. At the end of each indicated time point (5 min, 15 min, 30 min, 1 h, 4 h, and 24 h for iv and 1, 2, 4, 6, and 24 h for sc and po), animals were anesthetized with isofluorane and euthanized with CO<sub>2</sub> asphyxiation. Blood were collected in EDTA tubes by cardiac puncture and placed on ice. Plasma was generated by centrifuging blood samples at 1200 rcf for 15 min at 4 °C. The brains of animals were also harvested and flash frozen. Both plasma and brain samples were stored at −80 °C until further analysis. The methodology described has been reviewed and approved by the Institutional Animal Care Committee (IACC) at the University of British Columbia (UBC). The care, housing, and use of animals were also performed in accordance with the Canadian Council on Animal Care Guidelines.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Compound Measurement in Plasma and Brain Samples</h4><div class="NLM_p last">For the determination of compound concentrations in plasma, compounds were first extracted from plasma using the Ostro protein precipitation and phospholipid removal plate (Waters), followed by measurements using a Waters UPLC system equipped with an Acquity TQD mass spectrometer detector operated in multiple reaction monitoring (MRM) mode. For the determination of compound concentration from brain tissues, the brains were first weighed and then a portion of the brain was homogenized using a bead beater with Si/Zr beads in 50 mM ammonium formate buffer followed by extraction in acidified organic solvent. Quantitation was also performed using UPLC-MS/MS. Blood volume accounted for less than 1% changes in total compound measurements in the brain.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Pharmacokinetic Analysis</h4><div class="NLM_p last">Pharmacokinetic parameters were determined using a noncompartmental analysis with the Phoenix WinNonLin PK/PD Modeling and Simulation software. Pharmacokinetic curves were generated using GraphPad Prism. For better comparison between plasma and brain parameters, brain values were converted from the measured ng/g values to the reported ng/mL values, with the assumption that 1 g is approximately equal to 1 mL.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01588" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72403" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72403" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01588" class="ext-link">10.1021/acs.jmedchem.7b01588</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">SMILES string for the 25 final compounds described in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01588/suppl_file/jm7b01588_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Molecular modeling (Docking) studies and <sup>1</sup>H and <sup>13</sup>C NMR spectral data for the 25 final compounds <b>10a</b>–<b>s</b>, <b>21</b>, <b>22</b>, <b>25</b>, <b>26</b>, <b>29</b>, and <b>32</b> and all synthetic intermediates described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>; HPLC data to establish final product purity(<a href="/doi/suppl/10.1021/acs.jmedchem.7b01588/suppl_file/jm7b01588_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01588/suppl_file/jm7b01588_si_001.csv">jm7b01588_si_001.csv (1.39 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01588/suppl_file/jm7b01588_si_002.pdf">jm7b01588_si_002.pdf (9.07 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01588" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42468" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42468" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David S. Grierson</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, The University
of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4745-4240" title="Orcid link">http://orcid.org/0000-0002-4745-4240</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#4d292a3f24283f3e220d202c242163382f2e632e2c"><span class="__cf_email__" data-cfemail="6c080b1e05091e1f032c010d050042190e0f420f0d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward E. Putnins</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Dentistry, The University of British
Columbia, 2199 Wesbrook
Mall, Vancouver,  British
Columbia V6T 1Z3, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8613-324X" title="Orcid link">http://orcid.org/0000-0001-8613-324X</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#2a5a5f5e444344596a4e4f445e43595e5853045f484904494b"><span class="__cf_email__" data-cfemail="710104051f181f023115141f0518020503085f0413125f1210">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronan Gealageas</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, The University
of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alice Devineau</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, The University
of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pauline P. L. So</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drug Research and Development, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catrina M. J. Kim</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drug Research and Development, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayakumar Surendradoss</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drug Research and Development, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Buchwalder</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Pharmaceutical Sciences, The University
of British Columbia, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5577-8870" title="Orcid link">http://orcid.org/0000-0001-5577-8870</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Heller</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drug Research and Development, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1307-8654" title="Orcid link">http://orcid.org/0000-0002-1307-8654</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Verena Goebeler</span> - <span class="hlFld-Affiliation affiliation">Faculty
of Dentistry, The University of British
Columbia, 2199 Wesbrook
Mall, Vancouver,  British
Columbia V6T 1Z3, Canada</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6847-3141" title="Orcid link">http://orcid.org/0000-0002-6847-3141</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edith M. Dullaghan</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drug Research and Development, 2405 Wesbrook Mall, Vancouver, British Columbia V6T 1Z3, Canada</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e7418-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i82">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65826" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65826" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank the Canadian Institutes of Health Research (CIHR) (CIHR MOP-123397 and CIHR PPP-136713) and The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL) for generously providing the MDCK-MDR1 II cell line. We acknowledge the Centre for Drug Research and Development (CDRD) and the Pfizer-CDRD Innovation Fund for financial support. We thank Elaine Tung for technical support.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">BnBr</td><td class="NLM_def"><p class="first last">benzyl bromide</p></td></tr><tr><td class="NLM_term">TsCl</td><td class="NLM_def"><p class="first last">tosyl chloride</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">flavin adenine dinucleotide</p></td></tr><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine</p></td></tr><tr><td class="NLM_term">NADPH</td><td class="NLM_def"><p class="first last">β-nicotinamide adenine dinucleotide phosphate</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, toxicity</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last"><i>per os</i> (oral)</p></td></tr><tr><td class="NLM_term">sc</td><td class="NLM_def"><p class="first last">subcutaneous</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor-alpha</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin-Darby Canine Kidney</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance gene</p></td></tr><tr><td class="NLM_term">HBSS</td><td class="NLM_def"><p class="first last">Hanks’ Balanced Salt Solution</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HRP</td><td class="NLM_def"><p class="first last">horseradish peroxidase</p></td></tr><tr><td class="NLM_term">MEM</td><td class="NLM_def"><p class="first last">minimum essential Eagle’s medium</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle’s Medium</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">P<sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability coefficient</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wild-type</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>m</sub></td><td class="NLM_def"><p class="first last">Michaelis constant</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44648" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44648" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boor, P. J.</span></span> <span> </span><span class="NLM_article-title">The Role of Amine Oxidases in Xenobiotic Metabolism</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1517/17425255.2.4.559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1517%2F17425255.2.4.559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=16859404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1ahsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=559-571&author=B.+Gongauthor=P.+J.+Boor&title=The+Role+of+Amine+Oxidases+in+Xenobiotic+Metabolism&doi=10.1517%2F17425255.2.4.559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of amine oxidases in xenobiotic metabolism</span></div><div class="casAuthors">Gong, Bin; Boor, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-571</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amine oxidases of mammalian tissues are a heterogeneous family of enzymes that metabolize various monoamines, diamines and polyamines produced endogenously, or being absorbed as dietary or xenobiotic substances.  The heterogeneous class of amine oxidases can be divided on an arbitrary basis of the chem. nature of their cofactors into two types.  Monoamine oxidase (MAO) and an intracellular form of polyamine oxidase (PAO) contain FAD as their cofactor, whereas a second group of amine oxidases without FAD contain a cofactor possessing one or more carbonyl groups, making them sensitive to inhibition by carbonyl reagents such as semicarbazide; this group includes semicarbazide-sensitive amine oxidase (SSAO) and the connective tissue enzyme, lysyl oxidase.  This article focuses on the general aspects of MAO's contribution to the metab. of foreign toxic substances including toxins and illegal drugs.  Another main objective of this review is to discuss the properties of PAO and SSAO and their involvement in the metab. of xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVIpGnff-1HbVg90H21EOLACvtfcHk0ljF9NWCJuhVgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1ahsLw%253D&md5=be246766d62dd72a47f9f60feb492d96</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1517%2F17425255.2.4.559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2.4.559%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DB.%26aulast%3DBoor%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520Role%2520of%2520Amine%2520Oxidases%2520in%2520Xenobiotic%2520Metabolism%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2006%26volume%3D2%26spage%3D559%26epage%3D571%26doi%3D10.1517%2F17425255.2.4.559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisar, Z.</span></span> <span> </span><span class="NLM_article-title">Drugs Related to Monoamine Oxidase Activity</span>. <i>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1016/j.pnpbp.2016.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2Fj.pnpbp.2016.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=26944656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVOltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2016&pages=112-124&author=Z.+Fisar&title=Drugs+Related+to+Monoamine+Oxidase+Activity&doi=10.1016%2Fj.pnpbp.2016.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs related to monoamine oxidase activity</span></div><div class="casAuthors">Fisar, Zdenek</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112-124</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Progress in understanding the role of monoamine neurotransmission in pathophysiol. of neuropsychiatric disorders was made after the discovery of the mechanisms of action of psychoactive drugs, including monoamine oxidase (MAO) inhibitors.  The increase in monoamine neurotransmitter availability, decrease in hydrogen peroxide prodn., and neuroprotective effects evoked by MAO inhibitors represent an important approach in the development of new drugs for the treatment of mental disorders and neurodegenerative diseases.  New drugs are synthesized by acting as multitarget-directed ligands, with MAO, acetylcholinesterase, and iron chelation as targets.  Basic information is summarized in this paper about the drug-induced regulation of monoaminergic systems in the brain, with a focus on MAO inhibition.  Desirable effects of MAO inhibition include increased availability of monoamine neurotransmitters, decreased oxidative stress, decreased formation of neurotoxins, induction of pro-survival genes and antiapoptotic factors, and improved mitochondrial functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0XNTg1Wh-6LVg90H21EOLACvtfcHk0ljF9NWCJuhVgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVOltrY%253D&md5=eda253e0dde104fbc1add538d50a28b1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2016.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2016.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DFisar%26aufirst%3DZ.%26atitle%3DDrugs%2520Related%2520to%2520Monoamine%2520Oxidase%2520Activity%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2016%26volume%3D69%26spage%3D112%26epage%3D124%26doi%3D10.1016%2Fj.pnpbp.2016.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological Implications</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.2174/13816128113190990406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.2174%2F13816128113190990406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=23701542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=155-160&author=D.+E.+Edmondson&title=Hydrogen+Peroxide+Produced+by+Mitochondrial+Monoamine+Oxidase+Catalysis%3A+Biological+Implications&doi=10.2174%2F13816128113190990406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological Implications</span></div><div class="casAuthors">Edmondson, Dale E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-160</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The biol. roles of mitochondrial-produced reactive oxygen species continue to receive intensive investigation since one of the products (H2O2) has important cellular signaling roles as well as contributing to apoptotic responses.  In general, the source of mitochondrial reactive oxygen species is thought to be the superoxide anion produced from Complex I and Complex III components of the electron transport chain.  Superoxide anion readily dismutates to H2O2 with subsequent transformation to the hydroxyl radical by Fenton chem.  An overlooked source of H2O2 in the mitochondrion is its prodn. as a catalytic reaction product from the outer membrane enzymes: monoamine oxidases A and B.  The literature is reviewed to document identified degenerative reactions attributed to H2O2 produced by MAO A and by MAO B catalysis.  Available information on the topologies of these enzymes in the mitochondrial outer membrane is also discussed with relevance to H2O2 prodn. and involvement in cell signaling functions as well as degenerative effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomHat4RJctm7Vg90H21EOLACvtfcHk0ljF9NWCJuhVgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOmtb4%253D&md5=75d670b395b063ff5c876121a7d6dd0b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F13816128113190990406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13816128113190990406%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26atitle%3DHydrogen%2520Peroxide%2520Produced%2520by%2520Mitochondrial%2520Monoamine%2520Oxidase%2520Catalysis%253A%2520Biological%2520Implications%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D155%26epage%3D160%26doi%3D10.2174%2F13816128113190990406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tipton, K. F.</span></span> <span> </span><span class="NLM_article-title">The Therapeutic Potential of Monoamine Oxidase Inhibitors</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1038/nrn1883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1038%2Fnrn1883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=16552415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=295-309&author=M.+B.+Youdimauthor=D.+Edmondsonauthor=K.+F.+Tipton&title=The+Therapeutic+Potential+of+Monoamine+Oxidase+Inhibitors&doi=10.1038%2Fnrn1883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of monoamine oxidase inhibitors</span></div><div class="casAuthors">Youdim, Moussa B. H.; Edmondson, Dale; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-309</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase inhibitors were among the first antidepressants to be discovered and have long been used as such.  It now seems that many of these agents might have therapeutic value in several common neurodegenerative conditions, independently of their inhibition of monoamine oxidase activity.  However, many claims and some counter-claims have been made about the physiol. importance of these enzymes and the potential of their inhibitors.  We evaluate these arguments in the light of what we know, and still have to learn, of the structure, function and genetics of the monoamine oxidases and the disparate actions of their inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3A0wRL6nnL7Vg90H21EOLACvtfcHk0ljF9NWCJuhVgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D&md5=b35546920d95fa031ff2f884949372a7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrn1883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1883%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DEdmondson%26aufirst%3DD.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520Therapeutic%2520Potential%2520of%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D295%26epage%3D309%26doi%3D10.1038%2Fnrn1883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knull, J.</span></span> <span> </span><span class="NLM_article-title">(−)Deprenyl (Selegiline), a Catecholaminergic Activity Enhancer (CAE) Substance Acting in the Brain</span>. <i>Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0773.1998.tb01399.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1111%2Fj.1600-0773.1998.tb01399.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=9498233" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1998&pages=57-66&author=J.+Knull&title=%28%E2%88%92%29Deprenyl+%28Selegiline%29%2C+a+Catecholaminergic+Activity+Enhancer+%28CAE%29+Substance+Acting+in+the+Brain&doi=10.1111%2Fj.1600-0773.1998.tb01399.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1998.tb01399.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1998.tb01399.x%26sid%3Dliteratum%253Aachs%26aulast%3DKnull%26aufirst%3DJ.%26atitle%3D%2528%25E2%2588%2592%2529Deprenyl%2520%2528Selegiline%2529%252C%2520a%2520Catecholaminergic%2520Activity%2520Enhancer%2520%2528CAE%2529%2520Substance%2520Acting%2520in%2520the%2520Brain%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D1998%26volume%3D82%26spage%3D57%26epage%3D66%26doi%3D10.1111%2Fj.1600-0773.1998.tb01399.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villegier, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belluzzi, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tassin, J. P.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase Inhibitors Allow Locomotor and Rewarding Responses to Nicotine</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1704</span>– <span class="NLM_lpage">1713</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1300987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1038%2Fsj.npp.1300987" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=1704-1713&author=A.+S.+Villegierauthor=L.+Salomonauthor=S.+Granonauthor=J.+P.+Changeuxauthor=J.+D.+Belluzziauthor=F.+M.+Leslieauthor=J.+P.+Tassin&title=Monoamine+Oxidase+Inhibitors+Allow+Locomotor+and+Rewarding+Responses+to+Nicotine&doi=10.1038%2Fsj.npp.1300987"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300987%26sid%3Dliteratum%253Aachs%26aulast%3DVillegier%26aufirst%3DA.%2BS.%26aulast%3DSalomon%26aufirst%3DL.%26aulast%3DGranon%26aufirst%3DS.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DBelluzzi%26aufirst%3DJ.%2BD.%26aulast%3DLeslie%26aufirst%3DF.%2BM.%26aulast%3DTassin%26aufirst%3DJ.%2BP.%26atitle%3DMonoamine%2520Oxidase%2520Inhibitors%2520Allow%2520Locomotor%2520and%2520Rewarding%2520Responses%2520to%2520Nicotine%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D1704%26epage%3D1713%26doi%3D10.1038%2Fsj.npp.1300987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span> <span> </span><span class="NLM_article-title">Molecular Aspects of Monoamine Oxidase B</span>. <i>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.pnpbp.2016.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2Fj.pnpbp.2016.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=26891670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2016&pages=81-89&author=R.+R.+Ramsay&title=Molecular+Aspects+of+Monoamine+Oxidase+B&doi=10.1016%2Fj.pnpbp.2016.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular aspects of monoamine oxidase B</span></div><div class="casAuthors">Ramsay, Rona R.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-89</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Monoamine oxidases (MAO) influence the monoamine levels in brain by virtue of their role in neurotransmitter breakdown.  MAO B is the predominant form in glial cells and in platelets.  MAO B structure, function and kinetics are described as a background for the effect of alterations in its activity on behavior.  The need to inhibit MAO B to combat decreased brain amines continues to drive the search for new drugs.  Reversible and irreversible inhibitors are now designed using data-mining, computational screening, docking and mol. dynamics.  Multi-target ligands designed to combat the elevated activity of MAO B in Alzheimer's and Parkinson's Diseases incorporate MAO inhibition (usually irreversible) as well as iron chelation, antioxidant or neuroprotective properties.  The main focus of drug design is the catalytic activity of MAO, but the imidazoline I2 site in the entrance cavity of MAO B is also a pharmacol. target.  Endogenous regulation of MAO B expression is discussed briefly in light of new studies measuring mRNA, protein, or activity in healthy and degenerative samples, including the effect of DNA methylation on the expression.  Overall, this review focuses on examples of recent research on the mol. aspects of the expression, activity, and inhibition of MAO B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWqBth0WA0EbVg90H21EOLACvtfcHk0lgLrTTJRo0fUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKhurw%253D&md5=53857d746ee164dcc74469832516a0cd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2016.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2016.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26atitle%3DMolecular%2520Aspects%2520of%2520Monoamine%2520Oxidase%2520B%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2016%26volume%3D69%26spage%3D81%26epage%3D89%26doi%3D10.1016%2Fj.pnpbp.2016.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sivasubramaniam, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finch, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billett, E. E.</span></span> <span> </span><span class="NLM_article-title">A Comparative Study of the Expression of Monoamine Oxidase-A and -B mRNA and Protein in non-CNS Human Tissues</span>. <i>Cell Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1007/s00441-003-0765-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2Fs00441-003-0765-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=12898212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlyktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2003&pages=291-300&author=S.+D.+Sivasubramaniamauthor=C.+C.+Finchauthor=M.+J.+Rodriguezauthor=N.+Mahyauthor=E.+E.+Billett&title=A+Comparative+Study+of+the+Expression+of+Monoamine+Oxidase-A+and+-B+mRNA+and+Protein+in+non-CNS+Human+Tissues&doi=10.1007%2Fs00441-003-0765-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of the expression of monoamine oxidase-A and -B mRNA and protein in non-CNS human tissues</span></div><div class="casAuthors">Sivasubramaniam, S. D.; Finch, C. C.; Rodriguez, M. J.; Mahy, N.; Billett, E. E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-300</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The distributions of monoamine oxidase (MAO)-A and -B proteins and mRNAs in human heart, lung, liver, duodenum, kidney and vasculature were compared using immunohistochem. and cRNA in situ hybridization.  MAO-A and -B mRNA were detected in all tissues, to differing extents, but particularly in glomeruli, hepatocytes, and the crypts, muscularis mucosa and muscularis externa of duodenum.  Renal proximal and distal tubules and loops of Henle had more intense labeling for mRNA of MAO-B than MAO-A; this was reflected in MAO protein expression.  Little immunoreactivity was detected in glomeruli.  Hepatocytes expressed MAO-A moderately, but MAO-B strongly.  In lungs, similar moderately intense labeling for both MAO mRNAs and immunoreactivities was evident in pneumocytes, and epithelial and smooth muscle cells.  Cardiomyocytes contained both MAO isoforms, but with more, albeit moderate, labeling for MAO-A.  Both isoforms were expressed equally in duodenal villi, crypts, muscularis externa and mucosa; lower level expression occurred in mucosal and submucosal cells.  MAO-A and -B mRNA were detected in endothelia, adventitia and media of a renal interlobular artery, but protein immunoreactivities were chiefly in the adventitia.  The data reveal widespread tissue distribution of MAO mRNAs and proteins, but indicate that presence of MAO mRNAs does not invariably reflect quant. its protein expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplfGXhTXCwErVg90H21EOLACvtfcHk0lgLrTTJRo0fUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlyktr0%253D&md5=f8e3a550d34fc082d4cba22b5c28c918</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00441-003-0765-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-003-0765-6%26sid%3Dliteratum%253Aachs%26aulast%3DSivasubramaniam%26aufirst%3DS.%2BD.%26aulast%3DFinch%26aufirst%3DC.%2BC.%26aulast%3DRodriguez%26aufirst%3DM.%2BJ.%26aulast%3DMahy%26aufirst%3DN.%26aulast%3DBillett%26aufirst%3DE.%2BE.%26atitle%3DA%2520Comparative%2520Study%2520of%2520the%2520Expression%2520of%2520Monoamine%2520Oxidase-A%2520and%2520-B%2520mRNA%2520and%2520Protein%2520in%2520non-CNS%2520Human%2520Tissues%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2003%26volume%3D313%26spage%3D291%26epage%3D300%26doi%3D10.1007%2Fs00441-003-0765-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volkow, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. J.</span></span> <span> </span><span class="NLM_article-title">Translational Neuroimaging: Positron Emission Tomography Studies of Monoamine Oxidase</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1007/s11307-005-0016-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2Fs11307-005-0016-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=16265597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A280%3ADC%252BD287gvFentQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=377-387&author=J.+S.+Fowlerauthor=J.+Loganauthor=N.+D.+Volkowauthor=G.+J.+Wang&title=Translational+Neuroimaging%3A+Positron+Emission+Tomography+Studies+of+Monoamine+Oxidase&doi=10.1007%2Fs11307-005-0016-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Translational neuroimaging: positron emission tomography studies of monoamine oxidase</span></div><div class="casAuthors">Fowler Joanna S; Logan Jean; Volkow Nora D; Wang Gene-Jack</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">377-87</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Positron emission tomography (PET) using radiotracers with high molecular specificity is an important scientific tool in studies of monoamine oxidase (MAO), an important enzyme in the regulation of the neurotransmitters dopamine, norepinephrine, and serotonin as well as the dietary amine, tyramine.  MAO occurs in two different subtypes, MAO A and MAO B, which have different substrate and inhibitor specificity and which are different gene products.  The highly variable subtype distribution with different species makes human studies of special value.  MAO A and B can be imaged in the human brain and certain peripheral organs using PET and carbon-11 (half-life 20.4 minutes) labeled mechanism-based irreversible inhibitors, clorgyline and L -deprenyl, respectively.  In this article we introduce MAO and describe the development of these radiotracers and their translation from preclinical studies to the investigation of variables affecting MAO in the human brain and peripheral organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8qmr10OyrWYkFb3mqPUYDfW6udTcc2eZc1qMquhxg8bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287gvFentQ%253D%253D&md5=5d2ebce788abf1ddb96ad8215433fa51</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs11307-005-0016-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-005-0016-1%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26atitle%3DTranslational%2520Neuroimaging%253A%2520Positron%2520Emission%2520Tomography%2520Studies%2520of%2520Monoamine%2520Oxidase%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2005%26volume%3D7%26spage%3D377%26epage%3D387%26doi%3D10.1007%2Fs11307-005-0016-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westlund, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochersperger, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denney, R. M.</span></span> <span> </span><span class="NLM_article-title">Immunocytochemical Localization of Monoamine Oxidases A and B in Human Peripheral Tissues and Brain</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1177/35.1.3025289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1177%2F35.1.3025289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=3025289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADyaL2sXmsVOitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1987&pages=23-32&author=L.+W.+Thorpeauthor=K.+N.+Westlundauthor=L.+M.+Kocherspergerauthor=C.+W.+Abellauthor=R.+M.+Denney&title=Immunocytochemical+Localization+of+Monoamine+Oxidases+A+and+B+in+Human+Peripheral+Tissues+and+Brain&doi=10.1177%2F35.1.3025289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain</span></div><div class="casAuthors">Thorpe, Larry W.; Westlund, Karin N.; Kochersperger, Lynn M.; Abell, C. W.; Denney, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    </div><div class="casAbstract">Monoclonal antibodies specific for human MAO (EC 1.4.3.4) A or B and immunocytochem. techniques were used to visualize the resp. enzymes in human placenta, platelets, lymphocytes, liver, brain, and a human hepatoma cell line.  MAO A was obsd. in the syncytiotrophoblast layer of term placenta, liver, and a subset of neurons in brain, but was not obsd. in platelets or lymphocytes, which are known to lack type A enzyme.  MAO B was obsd. in platelets, lymphocytes, and liver but not in placenta, which contains little or no MAO B.  MAO B was also obsd. in a subset of neurons in the brain that was distinct from that which contained MAO A.  MAO A and B were also obsd. in some glia.  Unlike most tissues examd., liver cells appeared to contain both forms of the enzyme.  Thus, MAO A and B can be specifically visualized by immunocytochem. means in a variety of human cells and tissues and can provide a graphic demonstration of the high degree of cell specificity of expression of the 2 forms of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqILpKOR_oeJrVg90H21EOLACvtfcHk0lg9fvai1hP3rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmsVOitA%253D%253D&md5=602ceb3af2043ba50686e2f1236f93dd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1177%2F35.1.3025289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F35.1.3025289%26sid%3Dliteratum%253Aachs%26aulast%3DThorpe%26aufirst%3DL.%2BW.%26aulast%3DWestlund%26aufirst%3DK.%2BN.%26aulast%3DKochersperger%26aufirst%3DL.%2BM.%26aulast%3DAbell%26aufirst%3DC.%2BW.%26aulast%3DDenney%26aufirst%3DR.%2BM.%26atitle%3DImmunocytochemical%2520Localization%2520of%2520Monoamine%2520Oxidases%2520A%2520and%2520B%2520in%2520Human%2520Peripheral%2520Tissues%2520and%2520Brain%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D1987%26volume%3D35%26spage%3D23%26epage%3D32%26doi%3D10.1177%2F35.1.3025289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billett, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finch, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahy, N.</span></span> <span> </span><span class="NLM_article-title">Cellular Localization of Monoamine Oxidase A and B in Human Tissues Outside of the Central Nervous System</span>. <i>Cell Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>304</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1007/s004410100361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2Fs004410100361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=11396715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtVGktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2001&pages=215-220&author=M.+J.+Rodriguezauthor=J.+Sauraauthor=E.+E.+Billettauthor=C.+C.+Finchauthor=N.+Mahy&title=Cellular+Localization+of+Monoamine+Oxidase+A+and+B+in+Human+Tissues+Outside+of+the+Central+Nervous+System&doi=10.1007%2Fs004410100361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular localization of monoamine oxidase A and B in human tissues outside of the central nervous system</span></div><div class="casAuthors">Rodriguez, Manuel J.; Saura, Josep; Billett, Ellen E.; Finch, Cheryl C.; Mahy, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The localization of monoamine oxidase (MAO) A and B in human heart, liver, duodenum, blood vessels, and kidney was studied by immunohistochem.  The primary antibodies used were mouse monoclonal anti-human MAO-A (6G11/E1) and anti-human MAO-B (3F12/G10/2E3).  Samples were obtained from 6 routine autopsy cases and fixed in 2% paraformaldehyde.  All cardiomyocytes and hepatocytes showed MAO-A and MAO-B immunoreactivity.  In the duodenum, both immunoreactivities were present in all cells of the villi, Lieberkuhn crypts, muscularis mucosae and muscular layers, whereas Brunner glands were devoid of MAO-A and MAO-B staining.  Endothelial cells of lymphatic vessels showed MAO-A but no MAO-B immunoreactivity, whereas arteries and veins presented MAO-A and MAO-B staining in muscular layers and fibroblasts but not in endothelial cells.  In the kidney, renal tubuli showed MAO-A and MAO-B immunoreactivities, whereas collecting ducts and the Bowman's capsule showed only MAO-A staining.  These data represent the 1st study of the cellular distribution of MAO-A and MAO-B in these human tissues.  They show that both enzymes have a widespread distribution in the human body with a matching pattern in many, but not all tissues, and with strong differences from the pattern of distribution in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3DYJ3BfMhFbVg90H21EOLACvtfcHk0lg9fvai1hP3rw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtVGktLw%253D&md5=e34f859c3cfb925e147c361ba3e3b495</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs004410100361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004410100361%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DM.%2BJ.%26aulast%3DSaura%26aufirst%3DJ.%26aulast%3DBillett%26aufirst%3DE.%2BE.%26aulast%3DFinch%26aufirst%3DC.%2BC.%26aulast%3DMahy%26aufirst%3DN.%26atitle%3DCellular%2520Localization%2520of%2520Monoamine%2520Oxidase%2520A%2520and%2520B%2520in%2520Human%2520Tissues%2520Outside%2520of%2520the%2520Central%2520Nervous%2520System%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2001%26volume%3D304%26spage%3D215%26epage%3D220%26doi%3D10.1007%2Fs004410100361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzer, J. P.</span></span> <span> </span><span class="NLM_article-title">MAO Inhibitors and Their Wider Applications: A Patent Review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1080/13543776.2018.1427735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1080%2F13543776.2018.1427735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=29324067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFGmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=211-226&author=S.+Carradoriauthor=D.+Secciauthor=J.+P.+Petzer&title=MAO+Inhibitors+and+Their+Wider+Applications%3A+A+Patent+Review&doi=10.1080%2F13543776.2018.1427735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">MAO inhibitors and their wider applications: a patent review</span></div><div class="casAuthors">Carradori, Simone; Secci, Daniela; Petzer, Jacques P.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Monoamine oxidase (MAO) inhibitors, after the initial 'golden age', are currently used as third-line antidepressants (selective MAO-A inhibitors) or clin. enrolled as co-adjuvants for neurodegenerative diseases (selective MAO-B inhibitors).  However, the research within this field is always increasing due to their pivotal role in modulating synaptic functions and monoamines metab.: In this paper, MAO inhibitors (2015-2017) are disclosed ordering all the patents according to their chem. scaffold.  Structure-activity relationships (SARs) are extrapolated for the most investigated chemotypes (coumarins, pyrazole/oxazepinones, (hetero)arylamides). 108 Compds. are divided into two main groups: newly synthesized mols. and naturally-occurring metabolites.  Finally, new therapeutic options are outlined to ensure a more complete view on the potential of these inhibitors.: New proposed MAO inhibitors are endowed with a marked isoform selectivity, with innovative therapeutic potential toward other targets (gliomas, inflammation, muscle dystrophies, migraine, chronic pain, pseudobulbar affect), and with a promising ability to address multi-faceted pathologies such as Alzheimer's disease.  The increasing no. of patents is analyzed collecting data from 2002 to 2017.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP5v4KQmzIhLVg90H21EOLACvtfcHk0lggyI9vHxXcmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFGmt74%253D&md5=2f47a3d4054d6e12bba77d34da51ebc4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1080%2F13543776.2018.1427735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2018.1427735%26sid%3Dliteratum%253Aachs%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DMAO%2520Inhibitors%2520and%2520Their%2520Wider%2520Applications%253A%2520A%2520Patent%2520Review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2018%26volume%3D28%26spage%3D211%26epage%3D226%26doi%3D10.1080%2F13543776.2018.1427735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lieb, J.</span></span> <span> </span><span class="NLM_article-title">Remission of Rheumatoid Arthritis and Other Disorders of Immunity in Patients Taking Monoamine Oxidase Inhibitors</span>. <i>Int. J. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/0192-0561(83)90039-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2F0192-0561%2883%2990039-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=6629596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A280%3ADyaL2c%252FjtFajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1983&pages=353-357&author=J.+Lieb&title=Remission+of+Rheumatoid+Arthritis+and+Other+Disorders+of+Immunity+in+Patients+Taking+Monoamine+Oxidase+Inhibitors&doi=10.1016%2F0192-0561%2883%2990039-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Remission of rheumatoid arthritis and other disorders of immunity in patients taking monoamine oxidase inhibitors</span></div><div class="casAuthors">Lieb J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of immunopharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-7</span>
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    </div><div class="casAbstract">Elevated levels of prostaglandin E2 (PGE2) play an important role in rheumatoid arthritis and other disorders of immunity.  By inhibiting the release of arachidonic acid from cells, monoamine oxidase inhibitors (MAOI's) inhibit PGE2 synthesis.  MAOI's appear to be capable of remitting the symptoms of rheumatoid arthritis and may have the potential to arrest it.  MAOI's also appear to be effective in other disturbances of immunity in which excessive synthesis of PGE2 plays a role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiNBSRUNnIcoHWj6b1v8uTfW6udTcc2eY2WNIEPmKPc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FjtFajsg%253D%253D&md5=e70ca4927fed1cb6a2014407258d4eb7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F0192-0561%2883%2990039-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0192-0561%252883%252990039-5%26sid%3Dliteratum%253Aachs%26aulast%3DLieb%26aufirst%3DJ.%26atitle%3DRemission%2520of%2520Rheumatoid%2520Arthritis%2520and%2520Other%2520Disorders%2520of%2520Immunity%2520in%2520Patients%2520Taking%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1983%26volume%3D5%26spage%3D353%26epage%3D357%26doi%3D10.1016%2F0192-0561%2883%2990039-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kast, R. E.</span></span> <span> </span><span class="NLM_article-title">Crohn’s Disease Remission with Phenelzine Treatment</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">1034</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.1016/S0016-5085(98)70292-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2FS0016-5085%2898%2970292-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1998&pages=1034-1035&author=R.+E.+Kast&title=Crohn%E2%80%99s+Disease+Remission+with+Phenelzine+Treatment&doi=10.1016%2FS0016-5085%2898%2970292-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0016-5085%2898%2970292-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5085%252898%252970292-6%26sid%3Dliteratum%253Aachs%26aulast%3DKast%26aufirst%3DR.%2BE.%26atitle%3DCrohn%25E2%2580%2599s%2520Disease%2520Remission%2520with%2520Phenelzine%2520Treatment%26jtitle%3DGastroenterology%26date%3D1998%26volume%3D115%26spage%3D1034%26epage%3D1035%26doi%3D10.1016%2FS0016-5085%2898%2970292-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaludercic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivakumaran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedja, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mario, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Lisa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolocci, N.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase B Prompts Mitochondrial and Cardiac Dysfunction in Pressure Overloaded Hearts</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1089/ars.2012.4616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1089%2Fars.2012.4616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=23581564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislOrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=267-280&author=N.+Kaludercicauthor=A.+Carpiauthor=T.+Nagayamaauthor=V.+Sivakumaranauthor=G.+Zhuauthor=E.+W.+Laiauthor=D.+Bedjaauthor=A.+De+Marioauthor=K.+Chenauthor=K.+L.+Gabrielsonauthor=M.+L.+Lindseyauthor=K.+Pacakauthor=E.+Takimotoauthor=J.+C.+Shihauthor=D.+A.+Kassauthor=F.+Di+Lisaauthor=N.+Paolocci&title=Monoamine+Oxidase+B+Prompts+Mitochondrial+and+Cardiac+Dysfunction+in+Pressure+Overloaded+Hearts&doi=10.1089%2Fars.2012.4616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine Oxidase B Prompts Mitochondrial and Cardiac Dysfunction in Pressure Overloaded Hearts</span></div><div class="casAuthors">Kaludercic, Nina; Carpi, Andrea; Nagayama, Takahiro; Sivakumaran, Vidhya; Zhu, Guangshuo; Lai, Edwin W.; Bedja, Djahida; De Mario, Agnese; Chen, Kevin; Gabrielson, Kathleen L.; Lindsey, Merry L.; Pacak, Karel; Takimoto, Eiki; Shih, Jean C.; Kass, David A.; Di Lisa, Fabio; Paolocci, Nazareno</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-280</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: Monoamine oxidases (MAOs) are mitochondrial flavoenzymes responsible for neurotransmitter and biogenic amines catabolism.  MAO-A contributes to heart failure progression via enhanced norepinephrine catabolism and oxidative stress.  The potential pathogenetic role of the isoenzyme MAO-B in cardiac diseases is currently unknown.  Moreover, it is has not been detd. yet whether MAO activation can directly affect mitochondrial function.  Results: In wild type mice, pressure overload induced by transverse aortic constriction (TAC) resulted in enhanced dopamine catabolism, left ventricular (LV) remodeling, and dysfunction.  Conversely, mice lacking MAO-B (MAO-B-/-) subjected to TAC maintained concentric hypertrophy accompanied by extracellular signal regulated kinase (ERK)1/2 activation, and preserved LV function, both at early (3 wk) and late stages (9 wk).  Enhanced MAO activation triggered oxidative stress, and dropped mitochondrial membrane potential in the presence of ATP synthase inhibitor oligomycin both in neonatal and adult cardiomyocytes.  The MAO-B inhibitor pargyline completely offset this change, suggesting that MAO activation induces a latent mitochondrial dysfunction, causing these organelles to hydrolyze ATP.  Moreover, MAO-dependent aldehyde formation due to inhibition of aldehyde dehydrogenase 2 activity also contributed to alter mitochondrial bioenergetics.  Innovation: Our study unravels a novel role for MAO-B in the pathogenesis of heart failure, showing that both MAO-driven reactive oxygen species prodn. and impaired aldehyde metab. affect mitochondrial function.  Conclusion: Under conditions of chronic hemodynamic stress, enhanced MAO-B activity is a major determinant of cardiac structural and functional disarrangement.  Both increased oxidative stress and the accumulation of aldehyde intermediates are likely liable for these adverse morphol. and mech. changes by directly targeting mitochondria.  Antioxid. Redox Signal. 20, 267-280.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JiMLBoVkHLVg90H21EOLACvtfcHk0ljaV4JIuocmRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislOrsg%253D%253D&md5=c4291634416e80c5daa1b0f18f8bc6ae</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.4616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.4616%26sid%3Dliteratum%253Aachs%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DCarpi%26aufirst%3DA.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DSivakumaran%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DLai%26aufirst%3DE.%2BW.%26aulast%3DBedja%26aufirst%3DD.%26aulast%3DDe%2BMario%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DK.%2BL.%26aulast%3DLindsey%26aufirst%3DM.%2BL.%26aulast%3DPacak%26aufirst%3DK.%26aulast%3DTakimoto%26aufirst%3DE.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26aulast%3DKass%26aufirst%3DD.%2BA.%26aulast%3DDi%2BLisa%26aufirst%3DF.%26aulast%3DPaolocci%26aufirst%3DN.%26atitle%3DMonoamine%2520Oxidase%2520B%2520Prompts%2520Mitochondrial%2520and%2520Cardiac%2520Dysfunction%2520in%2520Pressure%2520Overloaded%2520Hearts%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D20%26spage%3D267%26epage%3D280%26doi%3D10.1089%2Fars.2012.4616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ro, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho-Chung, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span> <span> </span><span class="NLM_article-title">Gene Expression Profiling of Oxidative Stress on Atrial Fibrillation in Humans</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1038/emm.2003.45</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1038%2Femm.2003.45" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=14646586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFClur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=336-349&author=Y.+H.+Kimauthor=D.+S.+Limauthor=J.+H.+Leeauthor=W.+J.+Shimauthor=Y.+M.+Roauthor=G.+H.+Parkauthor=K.+G.+Beckerauthor=Y.+S.+Cho-Chungauthor=M.+K.+Kim&title=Gene+Expression+Profiling+of+Oxidative+Stress+on+Atrial+Fibrillation+in+Humans&doi=10.1038%2Femm.2003.45"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression profiling of oxidative stress on atrial fibrillation in humans</span></div><div class="casAuthors">Kim, Young Hoon; Lee, Ji Hye; Lim, Do Sun; Shim, Wan Joo; Ro, Young Moo; Park, Gil Hong; Becker, Kevin G.; Cho-chung, Yoon S.; Kim, Meyoung-kon</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Molecular Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">336-349</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1226-3613</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Medical Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Atrial Fibrillation (AF) is thought be caused by oxidative stress.  Oxidative stress at the cellular level results from many factors, including exposure to alc., medications, cold, toxins or radiation.  In this study the authors investigated gene transcriptional profiles on the human myocardial tissues from AF and oxidative stress conditions.  Right atrial appendages were obtained from AF patients (n = 26) undergoing the Maze procedure, and from control patients (n = 26) who were in normal sinus rhythm and undergoing coronary artery bypass graft operation.  To examine the effects of oxidative stress on AF, the authors used radioactive complementary DNA (cDNA) microarrays to evaluate changes in the expression of 1,152 known genes.  This technol., which monitors thousands of genes simultaneously, gives us a better picture of the interactions between AF and oxidative stress.  Total RNAs prepd. from the retrieved tissues were used to synthesize 33P-labeled cDNAs by reverse transcription and hybridized to cDNA microarrays.  Gene expression profiles showed that 30 genes were upregulated and 25 were downregulated in AF patients compared with control patients.  Moreover, comparison rank anal. revealed that the expression of 5 genes related to reactive oxygen species (ROS)-including flavin contg. monooxygenase 1, monoamine oxidase B, ubiquitin specific protease 8, tyrosinase-related protein 1, and tyrosine 3-monooxygenase-increased by more than 2.0 of the Z-ratio, and 2 genes related to antioxidants including glutathione peroxidase 1, and heme oxygenase 2-decreased to the Z-ratio levels of ≤ -2.0.  Apparently, a balanced regulation of pro- and anti-oxidn. can be shifted toward pro-oxidn. and can result in serious damage similar to that of human AF.  Western blotting anal. confirmed the upregulation of tyrosinase-related protein 1 and tyrosine 3-monooxygenase and the downregulation of heme oxygenase 2.  These results suggested that the gene expression pattern of myocardial tissues in AF patients can be assocd. with oxidative stress, resulting in a significant increase in ROS.  Thus, the cDNA microarray technique was useful for investigating transcription profiles in AF.  It showed that the intracellular mechanism of oxidative stress plays a pivotal role in the pathol. progression of AF and offers novel insight into potential treatment with antioxidants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ2oTbhKFiRbVg90H21EOLACvtfcHk0ljaV4JIuocmRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFClur4%253D&md5=fb74215d8196cc7d97dc3ed7cddb4e24</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Femm.2003.45&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femm.2003.45%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DLim%26aufirst%3DD.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DShim%26aufirst%3DW.%2BJ.%26aulast%3DRo%26aufirst%3DY.%2BM.%26aulast%3DPark%26aufirst%3DG.%2BH.%26aulast%3DBecker%26aufirst%3DK.%2BG.%26aulast%3DCho-Chung%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DM.%2BK.%26atitle%3DGene%2520Expression%2520Profiling%2520of%2520Oxidative%2520Stress%2520on%2520Atrial%2520Fibrillation%2520in%2520Humans%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2003%26volume%3D35%26spage%3D336%26epage%3D349%26doi%3D10.1038%2Femm.2003.45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deshwal, S.</span>; <span class="NLM_string-name">Forkink, M.</span>; <span class="NLM_string-name">Hu, C. H.</span>; <span class="NLM_string-name">Buonincontri, G.</span>; <span class="NLM_string-name">Antonucci, S.</span>; <span class="NLM_string-name">Di Sante, M.</span>; <span class="NLM_string-name">Murphy, M. P.</span>; <span class="NLM_string-name">Paolocci, N.</span>; <span class="NLM_string-name">Mochly-Rosen, D.</span>; <span class="NLM_string-name">Krieg, T.</span>; <span class="NLM_string-name">Di
Lisa, F.</span>; <span class="NLM_string-name">Kaludercic, N.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase-Dependent Endoplasmic Reticulum-Mitochondria Dysfunction and Mast Cell Degranulation Lead to Adverse Cardiac Remodeling in Diabetes</span>.  <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2018</span><span class="refDoi"> DOI: 10.1038/s41418-018-0071-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1038%2Fs41418-018-0071-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=29459772" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Deshwal&author=M.+Forkink&author=C.+H.+Hu&author=G.+Buonincontri&author=S.+Antonucci&author=M.+Di+Sante&author=M.+P.+Murphy&author=N.+Paolocci&author=D.+Mochly-Rosen&author=T.+Krieg&author=F.+Di%0ALisa&author=N.+Kaludercic&title=Monoamine+Oxidase-Dependent+Endoplasmic+Reticulum-Mitochondria+Dysfunction+and+Mast+Cell+Degranulation+Lead+to+Adverse+Cardiac+Remodeling+in+Diabetes&doi=10.1038%2Fs41418-018-0071-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41418-018-0071-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-018-0071-1%26sid%3Dliteratum%253Aachs%26aulast%3DDeshwal%26aufirst%3DS.%26atitle%3DMonoamine%2520Oxidase-Dependent%2520Endoplasmic%2520Reticulum-Mitochondria%2520Dysfunction%2520and%2520Mast%2520Cell%2520Degranulation%2520Lead%2520to%2520Adverse%2520Cardiac%2520Remodeling%2520in%2520Diabetes%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2018%26doi%3D10.1038%2Fs41418-018-0071-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ekuni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firth, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomofuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanbe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vielkind, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putnins, E. E.</span></span> <span> </span><span class="NLM_article-title">Lipopolysaccharide-Induced Epithelial Monoamine Oxidase Mediates Alveolar Bone Loss in a Rat Chronic Wound Model</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">1398</span>– <span class="NLM_lpage">1409</span>, <span class="refDoi"> DOI: 10.2353/ajpath.2009.090108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.2353%2Fajpath.2009.090108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=19779138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWitbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2009&pages=1398-1409&author=D.+Ekuniauthor=J.+D.+Firthauthor=T.+Nayerauthor=T.+Tomofujiauthor=T.+Sanbeauthor=K.+Irieauthor=T.+Yamamotoauthor=T.+Okaauthor=Z.+Liuauthor=J.+Vielkindauthor=E.+E.+Putnins&title=Lipopolysaccharide-Induced+Epithelial+Monoamine+Oxidase+Mediates+Alveolar+Bone+Loss+in+a+Rat+Chronic+Wound+Model&doi=10.2353%2Fajpath.2009.090108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model</span></div><div class="casAuthors">Ekuni, Disuke; Firth, James D.; Nayer, Tarun; Tomofuji, Takaaki; Sanbe, Toshihiro; Irie, Koichiro; Yamamoto, Tatsuo; Oka, Takashi; Liu, Zhenzi; Vielkind, Juergen; Putnins, Edward E.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1398-1409</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) prodn. is an antimicrobial response to pathogenic challenge that may, in the case of persistent infection, have deleterious effects on the tissue of origin.  A rat periodontal disease model was used to study ROS-induced chronic epithelial inflammation and bone loss.  Lipopolysaccharide (LPS) was applied for 8 wk into the gingival sulcus, and histol. anal. confirmed the onset of chronic disease.  Junctional epithelium was collected from healthy and diseased animals using laser-capture microdissection, and expression microarray anal. was performed.  Of 19,730 genes changed in disease, 42 were up-regulated ≥4-fold.  Three of the top 10 LPS-induced genes, monoamine oxidase B (MAO/B) and flavin-contg. monooxygenase 1 and 2, are implicated in ROS signaling.  LPS-assocd. induction of the ROS mediator H2O2, as well as MAO/B and tumor necrosis factor (TNF)-α levels were validated in the rat histol. sections and a porcine junctional epithelial cell culture model.  Topical MAO inhibitors significantly counteracted LPS-assocd. elevation of H2O2 prodn. and TNF-α expression in vivo and in vitro, inhibited disease-assocd. apical migration and proliferation of junctional epithelium and inhibited induced systemic H2O2 levels and alveolar bone loss in vivo.  These results suggest that LPS induces chronic wounds via elevated MAO/B-mediated increases in H2O2 and TNF-α activity by epithelial cells and is further assocd. with more distant effects on systemic oxidative stress and alveolar bone loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTzbboCkF0U7Vg90H21EOLACvtfcHk0ljaV4JIuocmRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWitbfF&md5=dd025c4b38a43534fba6434bdb17322a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2009.090108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2009.090108%26sid%3Dliteratum%253Aachs%26aulast%3DEkuni%26aufirst%3DD.%26aulast%3DFirth%26aufirst%3DJ.%2BD.%26aulast%3DNayer%26aufirst%3DT.%26aulast%3DTomofuji%26aufirst%3DT.%26aulast%3DSanbe%26aufirst%3DT.%26aulast%3DIrie%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DVielkind%26aufirst%3DJ.%26aulast%3DPutnins%26aufirst%3DE.%2BE.%26atitle%3DLipopolysaccharide-Induced%2520Epithelial%2520Monoamine%2520Oxidase%2520Mediates%2520Alveolar%2520Bone%2520Loss%2520in%2520a%2520Rat%2520Chronic%2520Wound%2520Model%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2009%26volume%3D175%26spage%3D1398%26epage%3D1409%26doi%3D10.2353%2Fajpath.2009.090108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, J. C.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Monoamine Oxidase-B by Selegiline Reduces Cigarette Smoke-Induced Oxidative Stress and Inflammation in Airway Epithelial Cells</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2017.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2Fj.toxlet.2017.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=28108387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVekt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2017&pages=44-50&author=Y.+Cuiauthor=K.+W.+Liuauthor=Y.+Liangauthor=M.+S.+Ipauthor=J.+C.+Mak&title=Inhibition+of+Monoamine+Oxidase-B+by+Selegiline+Reduces+Cigarette+Smoke-Induced+Oxidative+Stress+and+Inflammation+in+Airway+Epithelial+Cells&doi=10.1016%2Fj.toxlet.2017.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase-B by selegiline reduces cigarette smoke-induced oxidative stress and inflammation in airway epithelial cells</span></div><div class="casAuthors">Cui, Yuting; Liu, Kenneth W. K.; Liang, Yingmin; Ip, Mary S. M.; Mak, Judith C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44-50</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) is caused by the build-up of oxidative stress-induced damages due to cigarette smoking, but how monoamine oxidase (MAO)-B signaling is involved remains unclear.  This study aims to establish the involvement of MAO-B signaling pathways in cigarette smoke medium (CSM)-induced oxidative stress and inflammation in human airway epithelial cells (AECs).  CSM treatment increased MAO-B activity, ROS levels and IL-8 release in AECs.  Pretreatment with MAO-B selective inhibitor selegiline reversed the CSM-induced changes in MAO-B activity, ROS levels and IL-8 release in a dose-dependent manner.  Selegiline also reversed CSM-induced changes of anti-oxidant enzymes superoxide dismutase (SOD) and catalase (CAT) activities, GSH/GSSG ratio, as well expression of heme oxygenase-1 (HO-1) and NAD(P)H quinone dehydrogenase 1 (NQO1).  The effects of selegiline are partially driven through the nuclear factor erythroid 2 related factor 2 (Nrf2) and cytosol translocation of its neg. regulator, BTB and CNC homolog 1 (Bach1).  Nevertheless, selegiline fully reversed the CSM-induced effects on IKK, cytoplasmic IκB expression, and nuclear translocation of nuclear factor-κB (NF-κB) p65 subunit.  The authors' study demonstrated that in AECs, inhibition of MAO-B using selegiline reversed the CSM-induced oxidative stress and inflammation.  These data may provide a novel strategy for therapy in COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4_Gu22VmFmrVg90H21EOLACvtfcHk0lh6XpDOPmbUXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVekt7Y%253D&md5=f0143dbab6ee8e92e575c1be945f48e3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2017.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2017.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DK.%2BW.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DIp%26aufirst%3DM.%2BS.%26aulast%3DMak%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520Monoamine%2520Oxidase-B%2520by%2520Selegiline%2520Reduces%2520Cigarette%2520Smoke-Induced%2520Oxidative%2520Stress%2520and%2520Inflammation%2520in%2520Airway%2520Epithelial%2520Cells%26jtitle%3DToxicol.%2520Lett.%26date%3D2017%26volume%3D268%26spage%3D44%26epage%3D50%26doi%3D10.1016%2Fj.toxlet.2017.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosmans, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jongh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, M.</span></span> <span> </span><span class="NLM_article-title">The In Vitro Immunosuppressive Effects of Moclobemide in Healthy Volunteers</span>. <i>J. Affective Disord.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/S0165-0327(99)00076-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2FS0165-0327%2899%2900076-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10760560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A280%3ADC%252BD3c3isFyitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=69-74&author=A.+Linauthor=C.+Songauthor=G.+Kenisauthor=E.+Bosmansauthor=R.+De+Jonghauthor=S.+Scharpeauthor=M.+Maes&title=The+In+Vitro+Immunosuppressive+Effects+of+Moclobemide+in+Healthy+Volunteers&doi=10.1016%2FS0165-0327%2899%2900076-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The in vitro immunosuppressive effects of moclobemide in healthy volunteers</span></div><div class="casAuthors">Lin A; Song C; Kenis G; Bosmans E; De Jongh R; Scharpe S; Maes M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of affective disorders</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-74</span>
        ISSN:<span class="NLM_cas:issn">0165-0327</span>.
    </div><div class="casAbstract">BACKGROUND:  Many studies have demonstrated that major depression is related to an activation of the inflammatory response system (IRS) with an increased production of proinflammatory cytokines.  It has been shown that tricyclic antidepressants and serotonin reuptake inhibitors suppress the activation of the IRS in depression and have negative immunoregulatory effects in vitro.  Little is known on the immune effects of moclobemide, a reversible monoamine oxidase A inhibitor.  METHODS:  We examined, in nine normal volunteers, the in vitro effects of moclobemide on the production of interleukin-6 (IL-6), IL-8, tumor necrosis factor-alpha (TNFalpha), interferon-gamma (IFNgamma), IL-10 and the IL-1 receptor antagonist (IL-1RA) by diluted whole blood stimulated or not with lipopolysaccharide (LPS)+phytohemagglutinin (PHA).  RESULTS:  Moclobemide 10(-3) and 10(-5) M significantly suppressed the unstimulated production of TNFalpha and IL-8, and significantly enhanced the stimulated-production of IL-10.  The production of IL-6, IL-1RA and IFNgamma was not significantly affected either in the unstimulated or stimulated conditions.  CONCLUSIONS:  Moclobemide has negative immunoregulatory capacities through inhibition of the production of proinflammatory cytokines, i.e.  TNFalpha and IL-8, and through enhancement of the production of IL-10, an anti-inflammatory cytokine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSO_KITbD42TA20zIbnCCI3fW6udTcc2eZugLVdJzSG2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3isFyitg%253D%253D&md5=8354c336c83db55f3825235dfb0f3b89</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0165-0327%2899%2900076-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0327%252899%252900076-2%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DKenis%26aufirst%3DG.%26aulast%3DBosmans%26aufirst%3DE.%26aulast%3DDe%2BJongh%26aufirst%3DR.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DMaes%26aufirst%3DM.%26atitle%3DThe%2520In%2520Vitro%2520Immunosuppressive%2520Effects%2520of%2520Moclobemide%2520in%2520Healthy%2520Volunteers%26jtitle%3DJ.%2520Affective%2520Disord.%26date%3D2000%26volume%3D58%26spage%3D69%26epage%3D74%26doi%3D10.1016%2FS0165-0327%2899%2900076-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bielecka, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul-Samojedny, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obuchowicz, E.</span></span> <span> </span><span class="NLM_article-title">Moclobemide Exerts Anti-Inflammatory Effect in Lipopolysaccharide-Activated Primary Mixed Glial Cell Culture</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>382</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">417</span>, <span class="refDoi"> DOI: 10.1007/s00210-010-0535-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2Fs00210-010-0535-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=20811738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKkt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2010&pages=409-417&author=A.+M.+Bieleckaauthor=M.+Paul-Samojednyauthor=E.+Obuchowicz&title=Moclobemide+Exerts+Anti-Inflammatory+Effect+in+Lipopolysaccharide-Activated+Primary+Mixed+Glial+Cell+Culture&doi=10.1007%2Fs00210-010-0535-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture</span></div><div class="casAuthors">Bielecka, A. M.; Paul-Samojedny, M.; Obuchowicz, E.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">409-417</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">An increasing body of evidence indicates that glial activation and neuroinflammation play an important role in the pathogenesis of psychiatric and neurodegenerative diseases.  Activated glial cells secrete various cytokines that influence neurotransmission, hypothalamus-pituitary-adrenal axis activity, neuronal plasticity and neurogenesis.  It has been suggested that alterations in cytokine networks are involved in the mechanism of action of antidepressant drugs.  Until now, only a few studies demonstrated that some tricyclic antidepressants and selective serotonin reuptake inhibitors reduced prodn. of pro-inflammatory cytokines in brain glia cells.  We have investigated for the first time whether the antidepressant, moclobemide (a reversible selective inhibitor of monoamine oxidase-A) has an influence on pro-inflammatory cytokines [interleukin (IL)-1β and tumor necrosis factor (TNF)-α] and anti-inflammatory cytokine (IL-10) in primary rat mixed glial cell cultures stimulated by lipopolysaccharide (LPS).  Our results showed that moclobemide used in a wide range of concns. diminished LPS-stimulated IL-1β and TNF-α mRNAs expression in cellular exts. and remarkably reduced the levels of both pro-inflammatory cytokines in culture medium.  In opposite to this, the drug had no influence on IL-10 mRNA and slightly reduced IL-10 concn.  Moreover, moclobemide decreased LPS-stimulated translocation of NFκB p65 subunit into cellular nuclei.  These results suggest that moclobemide exerts anti-inflammatory effect in the central nervous system because it affects the balance between pro- and anti-inflammatory cytokines (IL-1β, TNF-α/IL-10) in primary mixed glial cell cultures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6ef6zCuUdXbVg90H21EOLACvtfcHk0lh6XpDOPmbUXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKkt7zE&md5=56c4f255a0fbe0c2bd0093535ec9407d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00210-010-0535-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-010-0535-4%26sid%3Dliteratum%253Aachs%26aulast%3DBielecka%26aufirst%3DA.%2BM.%26aulast%3DPaul-Samojedny%26aufirst%3DM.%26aulast%3DObuchowicz%26aufirst%3DE.%26atitle%3DMoclobemide%2520Exerts%2520Anti-Inflammatory%2520Effect%2520in%2520Lipopolysaccharide-Activated%2520Primary%2520Mixed%2520Glial%2520Cell%2520Culture%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2010%26volume%3D382%26spage%3D409%26epage%3D417%26doi%3D10.1007%2Fs00210-010-0535-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, M.</span></span> <span> </span><span class="NLM_article-title">The Serotonin Syndrome</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1120</span>, <span class="refDoi"> DOI: 10.1056/NEJMra041867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1056%2FNEJMra041867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=15784664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1OjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1112-1120&author=E.+W.+Boyerauthor=M.+Shannon&title=The+Serotonin+Syndrome&doi=10.1056%2FNEJMra041867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin syndrome</span></div><div class="casAuthors">Boyer, Edward W.; Shannon, Michael</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1112-1120</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on definition and epidemiol. of the serotonin syndrome, manifestations of the serotonin syndrome from mild symptoms to life-threatening toxicity, pathophysiol. and mol. mechanisms, diagnosis, management, and prevention of the serotonin syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZdpzQCyqkcrVg90H21EOLACvtfcHk0lgoRlYp3rItuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1OjsL8%253D&md5=f6e17de3cd031a3af2e007daaf2d12ed</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1056%2FNEJMra041867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra041867%26sid%3Dliteratum%253Aachs%26aulast%3DBoyer%26aufirst%3DE.%2BW.%26aulast%3DShannon%26aufirst%3DM.%26atitle%3DThe%2520Serotonin%2520Syndrome%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1112%26epage%3D1120%26doi%3D10.1056%2FNEJMra041867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bainbridge, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R. L.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruscin, J. M.</span></span> <span> </span><span class="NLM_article-title">Elucidating the Mechanism of Action and Potential Interactions of MAO-B Inhibitors</span>. <i>Neurol. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1016/j.ncl.2008.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2Fj.ncl.2008.05.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=85-96&author=J.+L.+Bainbridgeauthor=R.+L.+Pageauthor=J.+M.+Ruscin&title=Elucidating+the+Mechanism+of+Action+and+Potential+Interactions+of+MAO-B+Inhibitors&doi=10.1016%2Fj.ncl.2008.05.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ncl.2008.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ncl.2008.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DBainbridge%26aufirst%3DJ.%2BL.%26aulast%3DPage%26aufirst%3DR.%2BL.%26aulast%3DRuscin%26aufirst%3DJ.%2BM.%26atitle%3DElucidating%2520the%2520Mechanism%2520of%2520Action%2520and%2520Potential%2520Interactions%2520of%2520MAO-B%2520Inhibitors%26jtitle%3DNeurol.%2520Clin.%26date%3D2008%26volume%3D26%26spage%3D85%26epage%3D96%26doi%3D10.1016%2Fj.ncl.2008.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span> <span> </span><span class="NLM_article-title">Physicochemical, Pharmacological and Pharmacokinetic Properties of the Zwitterionic Antihistamines Cetirizine and Levocetirizine</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2173</span>– <span class="NLM_lpage">2191</span>, <span class="refDoi"> DOI: 10.2174/092986708785747625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.2174%2F092986708785747625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=18781943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSrs7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2173-2191&author=C.+Chen&title=Physicochemical%2C+Pharmacological+and+Pharmacokinetic+Properties+of+the+Zwitterionic+Antihistamines+Cetirizine+and+Levocetirizine&doi=10.2174%2F092986708785747625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical, pharmacological and pharmacokinetic properties of the zwitterionic antihistamines cetirizine and levocetirizine</span></div><div class="casAuthors">Chen, Chen</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2173-2191</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cetirizine, marketed as a racemic mixt. contg. both levocetirizine and dextrocetirizine, is a member of the second generation H1 antihistamines clin. used for the treatment of symptoms assocd. with seasonal allergic rhinitis.  Recently, its single R-enantiomer levocetirizine has been approved by the FDA as the newest antihistamine.  Cetirizine is a piperazine deriv. related to the first generation H1 antagonist hydroxyzine, and is the major metabolite in the blood circulation after hydroxyzine administration in humans.  The acid functionality of cetirizine in combination with one of the basic nitrogens of piperazine ring makes this compd. a very unique zwitterion.  The mol. structure of cetirizine allows its carboxylic group to interact with the basic nitrogen via folded conformers, therefore, it possesses relatively high lipophilicity at physiol. pH (LogD = 1.5).  While both cetirizine and hydroxyzine possess high affinity at the H1 receptor, the R-configured levocetirizine has much slower dissocn. rate from the H1 receptor than R-hydroxyzine, making it an insurmountable antagonist.  In addn., the pharmacokinetics of cetirizine significantly differs from those of the basic and lipophilic hydroxyzine.  For example, cetirizine has much lower CNS penetration than hydroxyzine, which may be explained by the zwitterionic structure of cetirizine and its P-glycoprotein activity.  Cetirizine exhibits high intestinal absorption in humans and its oral bioavailability is estd. to be greater than 70%.  Very importantly, cetirizine, esp. levocetirizine, has a negligible interaction with the liver enzymes, and is mainly excreted in the urine as the parent despite its high plasma protein binding (88∼96%).  The recommended dose of levocetirizine is 5 mg once daily, while its pharmacokinetic half-life is about 7 h in humans.  This review will focus on the physicochem., pharmacol. and pharmacokinetic properties of cetirizine and levocetirizine in comparison with those of hydroxyzine.  The zwitterionic cetirizine displays distinct advantages over the basic hydroxyzine in several categories such as slow receptor dissocn. rate, high selectivity, negligible liver enzyme interaction and low CNS penetration.  Therefore, cetirizine, or its single isomer levocetirizine, might serve a good example for medicinal chemists to design zwitterionic drugs from a basic, acidic or neutral lead mol. for peripheral biol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNUFT93tbtXrVg90H21EOLACvtfcHk0lgoRlYp3rItuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSrs7fF&md5=40fa022542b0f0ab8e67e721ceac31ce</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F092986708785747625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785747625%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26atitle%3DPhysicochemical%252C%2520Pharmacological%2520and%2520Pharmacokinetic%2520Properties%2520of%2520the%2520Zwitterionic%2520Antihistamines%2520Cetirizine%2520and%2520Levocetirizine%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2173%26epage%3D2191%26doi%3D10.2174%2F092986708785747625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massingham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammarlund-Udenaes, M.</span></span> <span> </span><span class="NLM_article-title">Brain Distribution of Cetirizine Enantiomers: Comparison of Three Different Tissue-to-Plasma Partition Coefficients: K(p), K(p,u), and K(p,uu)</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1124/dmd.105.007211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1124%2Fdmd.105.007211" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=318-323&author=A.+Guptaauthor=P.+Chatelainauthor=R.+Massinghamauthor=E.+N.+Jonssonauthor=M.+Hammarlund-Udenaes&title=Brain+Distribution+of+Cetirizine+Enantiomers%3A+Comparison+of+Three+Different+Tissue-to-Plasma+Partition+Coefficients%3A+K%28p%29%2C+K%28p%2Cu%29%2C+and+K%28p%2Cuu%29&doi=10.1124%2Fdmd.105.007211"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.007211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.007211%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DChatelain%26aufirst%3DP.%26aulast%3DMassingham%26aufirst%3DR.%26aulast%3DJonsson%26aufirst%3DE.%2BN.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DBrain%2520Distribution%2520of%2520Cetirizine%2520Enantiomers%253A%2520Comparison%2520of%2520Three%2520Different%2520Tissue-to-Plasma%2520Partition%2520Coefficients%253A%2520K%2528p%2529%252C%2520K%2528p%252Cu%2529%252C%2520and%2520K%2528p%252Cuu%2529%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D318%26epage%3D323%26doi%3D10.1124%2Fdmd.105.007211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pagliara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrupt, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolliet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tillement, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rihoux, J. P.</span></span> <span> </span><span class="NLM_article-title">Molecular Properties and Pharmacokinetic Behavior of Cetirizine, a Zwitterionic H1-Receptor Antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">853</span>– <span class="NLM_lpage">863</span>, <span class="refDoi"> DOI: 10.1021/jm9704311</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9704311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=853-863&author=A.+Pagliaraauthor=B.+Testaauthor=P.+A.+Carruptauthor=P.+Jollietauthor=C.+Morinauthor=D.+Morinauthor=S.+Urienauthor=J.+P.+Tillementauthor=J.+P.+Rihoux&title=Molecular+Properties+and+Pharmacokinetic+Behavior+of+Cetirizine%2C+a+Zwitterionic+H1-Receptor+Antagonist&doi=10.1021%2Fjm9704311"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm9704311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9704311%26sid%3Dliteratum%253Aachs%26aulast%3DPagliara%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DJolliet%26aufirst%3DP.%26aulast%3DMorin%26aufirst%3DC.%26aulast%3DMorin%26aufirst%3DD.%26aulast%3DUrien%26aufirst%3DS.%26aulast%3DTillement%26aufirst%3DJ.%2BP.%26aulast%3DRihoux%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520Properties%2520and%2520Pharmacokinetic%2520Behavior%2520of%2520Cetirizine%252C%2520a%2520Zwitterionic%2520H1-Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D853%26epage%3D863%26doi%3D10.1021%2Fjm9704311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanni, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollack, G. M.</span></span> <span> </span><span class="NLM_article-title">Fexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein after Fexofenadine and Terfenadine Administration</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1124/dmd.107.019893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1124%2Fdmd.107.019893" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=529-535&author=R.+Zhaoauthor=J.+C.+Kalvassauthor=S.+B.+Yanniauthor=A.+S.+Bridgesauthor=G.+M.+Pollack&title=Fexofenadine+Brain+Exposure+and+the+Influence+of+Blood-Brain+Barrier+P-Glycoprotein+after+Fexofenadine+and+Terfenadine+Administration&doi=10.1124%2Fdmd.107.019893"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.019893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.019893%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DYanni%26aufirst%3DS.%2BB.%26aulast%3DBridges%26aufirst%3DA.%2BS.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26atitle%3DFexofenadine%2520Brain%2520Exposure%2520and%2520the%2520Influence%2520of%2520Blood-Brain%2520Barrier%2520P-Glycoprotein%2520after%2520Fexofenadine%2520and%2520Terfenadine%2520Administration%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D529%26epage%3D535%26doi%3D10.1124%2Fdmd.107.019893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzig, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan Class</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1767</span>– <span class="NLM_lpage">1774</span>, <span class="refDoi"> DOI: 10.1021/jm031087c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031087c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1767-1774&author=C.+Bindaauthor=F.+Hubalekauthor=M.+Liauthor=Y.+Herzigauthor=J.+Sterlingauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Crystal+Structures+of+Monoamine+Oxidase+B+in+Complex+with+Four+Inhibitors+of+the+N-Propargylaminoindan+Class&doi=10.1021%2Fjm031087c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan Class</span></div><div class="casAuthors">Binda, Claudia; Hubalek, Frantisek; Li, Min; Herzig, Yaacov; Sterling, Jeffrey; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1767-1774</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is an outer mitochondrial membrane enzyme that catalyzes the oxidn. of arylalkylamine neurotransmitters.  The crystal structures of MAO B in complex with four of the N-propargylaminoindan class of MAO covalent inhibitors (rasagiline, N-propargyl-1(S)-aminoindan, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan) have been detd. at a resoln. of better than 2.1 Å.  Rasagiline, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan adopt essentially the same conformation with the extended propargyl chain covalently bound to the flavin and the indan ring located in the rear of the substrate cavity.  N-Propargyl-1(S)-aminoindan binds with the indan ring in a flipped conformation with respect to the other inhibitors, which causes a slight movement of the Tyr326 side chain.  Four ordered water mols. are an integral part of the active site and establish H-bond interactions to the inhibitor atoms.  These structural studies may guide future drug design to improve selectivity and efficacy by introducing appropriate substituents on the rasagiline mol. scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkiXn0OI5eubVg90H21EOLACvtfcHk0lixs7HKYRR9_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D&md5=7b3df3c611e3f0dd59342a59096402dd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm031087c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031087c%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DCrystal%2520Structures%2520of%2520Monoamine%2520Oxidase%2520B%2520in%2520Complex%2520with%2520Four%2520Inhibitors%2520of%2520the%2520N-Propargylaminoindan%2520Class%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1767%26epage%3D1774%26doi%3D10.1021%2Fjm031087c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span> <i>ADMET
Predictor</i>, version 7.0; <span class="NLM_publisher-name">Simulations
Plus, Inc.</span>: <span class="NLM_publisher-loc">Lancaster, CA</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+ADMET%0APredictor%2C+version+7.0%3B+Simulations%0APlus%2C+Inc.%3A+Lancaster%2C+CA%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DADMET%250APredictor%26pub%3DSimulations%250APlus%252C%2520Inc%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumberg, P. M.</span></span> <span> </span><span class="NLM_article-title">General and Stereospecific Route to 9-Substituted, 8,9-Disubstituted, and 9,10-Disubstituted Analogues of Benzolactam-V8</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">6366</span>– <span class="NLM_lpage">6373</span>, <span class="refDoi"> DOI: 10.1021/jo990605h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo990605h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=6366-6373&author=D.+W.+Maauthor=T.+J.+Tangauthor=A.+P.+Kozikowskiauthor=N.+E.+Lewinauthor=P.+M.+Blumberg&title=General+and+Stereospecific+Route+to+9-Substituted%2C+8%2C9-Disubstituted%2C+and+9%2C10-Disubstituted+Analogues+of+Benzolactam-V8&doi=10.1021%2Fjo990605h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjo990605h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo990605h%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%2BW.%26aulast%3DTang%26aufirst%3DT.%2BJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DLewin%26aufirst%3DN.%2BE.%26aulast%3DBlumberg%26aufirst%3DP.%2BM.%26atitle%3DGeneral%2520and%2520Stereospecific%2520Route%2520to%25209-Substituted%252C%25208%252C9-Disubstituted%252C%2520and%25209%252C10-Disubstituted%2520Analogues%2520of%2520Benzolactam-V8%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D6366%26epage%3D6373%26doi%3D10.1021%2Fjo990605h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desjardine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matainaho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, R. J.</span></span> <span> </span><span class="NLM_article-title">Tauramamide, a Lipopeptide Antibiotic Produced in Culture by Brevibacillus Laterosporus Isolated from a Marine Habitat: Structure Elucidation and Synthesis</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1850</span>– <span class="NLM_lpage">1853</span>, <span class="refDoi"> DOI: 10.1021/np070209r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np070209r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=1850-1853&author=K.+Desjardineauthor=A.+Pereiraauthor=H.+Wrightauthor=T.+Matainahoauthor=M.+Kellyauthor=R.+J.+Andersen&title=Tauramamide%2C+a+Lipopeptide+Antibiotic+Produced+in+Culture+by+Brevibacillus+Laterosporus+Isolated+from+a+Marine+Habitat%3A+Structure+Elucidation+and+Synthesis&doi=10.1021%2Fnp070209r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fnp070209r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp070209r%26sid%3Dliteratum%253Aachs%26aulast%3DDesjardine%26aufirst%3DK.%26aulast%3DPereira%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DH.%26aulast%3DMatainaho%26aufirst%3DT.%26aulast%3DKelly%26aufirst%3DM.%26aulast%3DAndersen%26aufirst%3DR.%2BJ.%26atitle%3DTauramamide%252C%2520a%2520Lipopeptide%2520Antibiotic%2520Produced%2520in%2520Culture%2520by%2520Brevibacillus%2520Laterosporus%2520Isolated%2520from%2520a%2520Marine%2520Habitat%253A%2520Structure%2520Elucidation%2520and%2520Synthesis%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D1850%26epage%3D1853%26doi%3D10.1021%2Fnp070209r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ousmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavoux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciufolini, M. A.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis of Tricyclic Azaspirane Derivatives of Tyrosine: FR901483 and TAN1251C</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">7534</span>– <span class="NLM_lpage">7538</span>, <span class="refDoi"> DOI: 10.1021/ja016030z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja016030z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVCmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=7534-7538&author=M.+Ousmerauthor=N.+A.+Braunauthor=C.+Bavouxauthor=M.+Perrinauthor=M.+A.+Ciufolini&title=Total+Synthesis+of+Tricyclic+Azaspirane+Derivatives+of+Tyrosine%3A+FR901483+and+TAN1251C&doi=10.1021%2Fja016030z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of Tricyclic Azaspirane Derivatives of Tyrosine: FR901483 and TAN1251C</span></div><div class="casAuthors">Ousmer, Malika; Braun, Norbert A.; Bavoux, Claude; Perrin, Monique; Ciufolini, Marco A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">7534-7538</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A soln. to the long-standing problem presented by the oxidative cyclization of a phenolic 3-arylpropionamide to a spirolactam has been developed in this lab. via oxazoline chem.  This research was motivated by our interest in some novel tricyclic azaspirane natural products formally derived from tyrosine, such as FR901483 and TAN1251C.  In this paper, we disclose full details of the total synthesis of these substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pBdvUXf1crVg90H21EOLACvtfcHk0ljgrqBk0qg7Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVCmur0%253D&md5=c868ae060db09f7f8fb40b0934a04f85</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja016030z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja016030z%26sid%3Dliteratum%253Aachs%26aulast%3DOusmer%26aufirst%3DM.%26aulast%3DBraun%26aufirst%3DN.%2BA.%26aulast%3DBavoux%26aufirst%3DC.%26aulast%3DPerrin%26aufirst%3DM.%26aulast%3DCiufolini%26aufirst%3DM.%2BA.%26atitle%3DTotal%2520Synthesis%2520of%2520Tricyclic%2520Azaspirane%2520Derivatives%2520of%2520Tyrosine%253A%2520FR901483%2520and%2520TAN1251C%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D7534%26epage%3D7538%26doi%3D10.1021%2Fja016030z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwakuma a, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span> <span> </span><span class="NLM_article-title">A Simple and Efficient Procedure for the Synthesis of Optically Active 4-Methoxy-α-Methylphenylethylamine from Tyrosine</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1935</span>– <span class="NLM_lpage">1945</span>, <span class="refDoi"> DOI: 10.1080/00397919808007167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1080%2F00397919808007167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlans70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1998&pages=1935-1945&author=H.+Kohnoauthor=T.+Iwakuma+aauthor=K.+Yamada&title=A+Simple+and+Efficient+Procedure+for+the+Synthesis+of+Optically+Active+4-Methoxy-%CE%B1-Methylphenylethylamine+from+Tyrosine&doi=10.1080%2F00397919808007167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A simple and efficient procedure for the synthesis of optically active 4-methoxy-α-methylphenylethylamine from tyrosine</span></div><div class="casAuthors">Kohno, Harumichi; Iwakuma, Takeo; Yamada, Koichiro</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1935-1945</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Optically active 4-methoxy-α-methylphenylethylamine, a useful chiral building block in medicinal chem., was synthesized in optically pure form from L- or D-tyrosine by using a simple and efficient procedure via one-pot zinc redn. of the corresponding O-tosylate in the presence of H2O and NaI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy7F0yd2S3jrVg90H21EOLACvtfcHk0ljgrqBk0qg7Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlans70%253D&md5=313b0d8b69798910b3b018b08ec4b175</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F00397919808007167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919808007167%26sid%3Dliteratum%253Aachs%26aulast%3DKohno%26aufirst%3DH.%26aulast%3DIwakuma%2Ba%26aufirst%3DT.%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DA%2520Simple%2520and%2520Efficient%2520Procedure%2520for%2520the%2520Synthesis%2520of%2520Optically%2520Active%25204-Methoxy-%25CE%25B1-Methylphenylethylamine%2520from%2520Tyrosine%26jtitle%3DSynth.%2520Commun.%26date%3D1998%26volume%3D28%26spage%3D1935%26epage%3D1945%26doi%3D10.1080%2F00397919808007167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quagliato, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrae, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matelan, E. M.</span></span> <span> </span><span class="NLM_article-title">Efficient Procedure for the Reduction of Alpha-Amino Acids to Enantiomerically Pure Alpha-Methylamines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">5037</span>– <span class="NLM_lpage">5042</span>, <span class="refDoi"> DOI: 10.1021/jo000242h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo000242h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=5037-5042&author=D.+A.+Quagliatoauthor=P.+M.+Andraeauthor=E.+M.+Matelan&title=Efficient+Procedure+for+the+Reduction+of+Alpha-Amino+Acids+to+Enantiomerically+Pure+Alpha-Methylamines&doi=10.1021%2Fjo000242h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo000242h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo000242h%26sid%3Dliteratum%253Aachs%26aulast%3DQuagliato%26aufirst%3DD.%2BA.%26aulast%3DAndrae%26aufirst%3DP.%2BM.%26aulast%3DMatelan%26aufirst%3DE.%2BM.%26atitle%3DEfficient%2520Procedure%2520for%2520the%2520Reduction%2520of%2520Alpha-Amino%2520Acids%2520to%2520Enantiomerically%2520Pure%2520Alpha-Methylamines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D5037%26epage%3D5042%26doi%3D10.1021%2Fjo000242h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yohannes, D.</span></span> <span> </span><span class="NLM_article-title">Studies on the Total Synthesis of Bouvardin and Deoxybouvardin - Cyclic Hexapeptide Cyclization Studies and Preparation of Key Partial Structures</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1021/jo00238a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00238a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=487-499&author=D.+L.+Bogerauthor=D.+Yohannes&title=Studies+on+the+Total+Synthesis+of+Bouvardin+and+Deoxybouvardin+-+Cyclic+Hexapeptide+Cyclization+Studies+and+Preparation+of+Key+Partial+Structures&doi=10.1021%2Fjo00238a005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo00238a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00238a005%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DYohannes%26aufirst%3DD.%26atitle%3DStudies%2520on%2520the%2520Total%2520Synthesis%2520of%2520Bouvardin%2520and%2520Deoxybouvardin%2520-%2520Cyclic%2520Hexapeptide%2520Cyclization%2520Studies%2520and%2520Preparation%2520of%2520Key%2520Partial%2520Structures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D487%26epage%3D499%26doi%3D10.1021%2Fjo00238a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mireles, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Morais, S. M.</span></span> <span> </span><span class="NLM_article-title">In Vitro P-Glycoprotein Assays to Predict the In Vivo Interactions of P-Glycoprotein with Drugs in the Central Nervous System</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1124/dmd.107.017434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+Vitro+P-Glycoprotein+Assays+to+Predict+the+In+Vivo+Interactions+of+P-Glycoprotein+with+Drugs+in+the+Central+Nervous+System&doi=10.1124%2Fdmd.107.017434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lgAj0L-GljidA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520Vitro%2520P-Glycoprotein%2520Assays%2520to%2520Predict%2520the%2520In%2520Vivo%2520Interactions%2520of%2520P-Glycoprotein%2520with%2520Drugs%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275%26doi%3D10.1124%2Fdmd.107.017434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span> <span> </span><span class="NLM_article-title">P-Glycoprotein, a Gatekeeper in the Blood-Brain Barrier</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(98)00085-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2FS0169-409X%2898%2900085-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10837715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVCgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1999&pages=179-194&author=A.+H.+Schinkel&title=P-Glycoprotein%2C+a+Gatekeeper+in+the+Blood-Brain+Barrier&doi=10.1016%2FS0169-409X%2898%2900085-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">P-Glycoprotein, a gatekeeper in the blood-brain barrier</span></div><div class="casAuthors">Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2,3</span>),
    <span class="NLM_cas:pages">179-194</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 79 refs.  The blood-brain barrier is a major impediment to the entry of many therapeutic drugs into the brain.  P-Glycoprotein is an ATP-dependent drug transport protein that is predominantly found in the apical membranes of a no. of epithelial cell types in the body, including the blood luminal membrane of the brain capillary endothelial cells that make up the blood-brain barrier.  Since P-glycoprotein can actively transport a huge variety of hydrophobic amphipathic drugs out of the cell, it was hypothesized that it might be responsible for the very poor penetration of many relatively large (>400 Da) hydrophobic drugs in the brain, by performing active back-transport of these drugs to the blood.  Extensive expts. with in vitro models and with knockout mice lacking blood-brain barrier P-glycoprotein or other animal models treated with blockers of P-glycoprotein have fully confirmed this hypothesis.  Absence of functional P-glycoprotein in the blood-brain barrier leads to highly increased brain penetration of a no. of important drugs.  Depending on the pharmacol. target of these drugs in the central nervous system (CNS), this can result in dramatically increased neurotoxicity, or fundamentally altered pharmacol. effects of the drug.  Given the variety of drugs affected by P-glycoprotein transport, it may be of tremendous therapeutic value to apply these insights to the development of drugs that should have either very poor or very good brain penetration, whichever is preferred for pharmacotherapeutic purposes.  The clin. application of P-glycoprotein blockers should also be considered in order to improve the blood-brain barrier permeability of certain drugs that currently display insufficient brain penetration for effective therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpfL-5j3NCh7Vg90H21EOLACvtfcHk0liPrZ57dJreQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVCgu7Y%253D&md5=08a3305a4b236929ffbe404d2e6a5a28</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2898%2900085-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252898%252900085-4%26sid%3Dliteratum%253Aachs%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DP-Glycoprotein%252C%2520a%2520Gatekeeper%2520in%2520the%2520Blood-Brain%2520Barrier%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1999%26volume%3D36%26spage%3D179%26epage%3D194%26doi%3D10.1016%2FS0169-409X%2898%2900085-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thakker, D. R.</span></span> <span> </span><span class="NLM_article-title">Strategic Use of Preclinical Pharmacokinetic Studies and In Vitro Models in Optimizing ADME Properties of Lead Compounds</span>. <i>Optimizing the Drug-Like Properties of Leads in Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>IV</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1007/978-0-387-44961-6_1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2F978-0-387-44961-6_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=IV&publication_year=2006&pages=1-23&author=D.+R.+Thakker&title=Strategic+Use+of+Preclinical+Pharmacokinetic+Studies+and+In+Vitro+Models+in+Optimizing+ADME+Properties+of+Lead+Compounds&doi=10.1007%2F978-0-387-44961-6_1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-44961-6_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-0-387-44961-6_1%26sid%3Dliteratum%253Aachs%26aulast%3DThakker%26aufirst%3DD.%2BR.%26atitle%3DStrategic%2520Use%2520of%2520Preclinical%2520Pharmacokinetic%2520Studies%2520and%2520In%2520Vitro%2520Models%2520in%2520Optimizing%2520ADME%2520Properties%2520of%2520Lead%2520Compounds%26jtitle%3DOptimizing%2520the%2520Drug-Like%2520Properties%2520of%2520Leads%2520in%2520Drug%2520Discovery%26date%3D2006%26volume%3DIV%26spage%3D1%26epage%3D23%26doi%3D10.1007%2F978-0-387-44961-6_1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capaldi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolotti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muncipinto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellamare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span> <span> </span><span class="NLM_article-title">Solid-Phase Synthesis and Insights into Structure-Activity Relationships of Safinamide Analogues as Potent and Selective Inhibitors of Type B Monoamine Oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4909</span>– <span class="NLM_lpage">4916</span>, <span class="refDoi"> DOI: 10.1021/jm070725e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070725e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4909-4916&author=F.+Leonettiauthor=C.+Capaldiauthor=L.+Pisaniauthor=O.+Nicolottiauthor=G.+Muncipintoauthor=A.+Stefanachiauthor=S.+Cellamareauthor=C.+Cacciaauthor=A.+Carotti&title=Solid-Phase+Synthesis+and+Insights+into+Structure-Activity+Relationships+of+Safinamide+Analogues+as+Potent+and+Selective+Inhibitors+of+Type+B+Monoamine+Oxidase&doi=10.1021%2Fjm070725e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm070725e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070725e%26sid%3Dliteratum%253Aachs%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCapaldi%26aufirst%3DC.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DSolid-Phase%2520Synthesis%2520and%2520Insights%2520into%2520Structure-Activity%2520Relationships%2520of%2520Safinamide%2520Analogues%2520as%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Type%2520B%2520Monoamine%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4909%26epage%3D4916%26doi%3D10.1021%2Fjm070725e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5848</span>– <span class="NLM_lpage">5852</span>, <span class="refDoi"> DOI: 10.1021/jm070677y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+of+Human+Monoamine+Oxidase+B+Complexes+with+Selective+Noncovalent+Inhibitors%3A+Safinamide+and+Coumarin+Analogs&doi=10.1021%2Fjm070677y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span></div><div class="casAuthors">Binda, Claudia; Wang, Jin; Pisani, Leonardo; Caccia, Carla; Carotti, Angelo; Salvati, Patricia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5848-5852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivs., all sharing a common benzyloxy substituent, were detd. by x-ray crystallog.  These compds. competitively inhibit MAO B with Ki values in the 0.1-0.5 μM range that are 30-700-fold lower than those obsd. with MAO A.  The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPIubufo89bVg90H21EOLACvtfcHk0lh67MYtf77_3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI&md5=448f65696f4870e2301f46a6f015e35c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%2520Complexes%2520with%2520Selective%2520Noncovalent%2520Inhibitors%253A%2520Safinamide%2520and%2520Coumarin%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5848%26epage%3D5852%26doi%3D10.1021%2Fjm070677y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muncipinto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miscioscia, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolotti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto-Otero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez-Alvarez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passeleu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6685</span>– <span class="NLM_lpage">6706</span>, <span class="refDoi"> DOI: 10.1021/jm9010127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9010127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1artL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6685-6706&author=L.+Pisaniauthor=G.+Muncipintoauthor=T.+F.+Misciosciaauthor=O.+Nicolottiauthor=F.+Leonettiauthor=M.+Cattoauthor=C.+Cacciaauthor=P.+Salvatiauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=C.+Passeleuauthor=A.+Carotti&title=Discovery+of+a+Novel+Class+of+Potent+Coumarin+Monoamine+Oxidase+B+Inhibitors%3A+Development+and+Biopharmacological+Profiling+of+7-%5B%283-Chlorobenzyl%29oxy%5D-4-%5B%28methylamino%29methyl%5D-2H-chromen-2-one+Methanesulfonate+%28NW-1772%29+as+a+Highly+Potent%2C+Selective%2C+Reversible%2C+and+Orally+Active+Monoamine+Oxidase+B+Inhibitor&doi=10.1021%2Fjm9010127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor</span></div><div class="casAuthors">Pisani, Leonardo; Muncipinto, Giovanni; Miscioscia, Teresa Fabiola; Nicolotti, Orazio; Leonetti, Francesco; Catto, Marco; Caccia, Carla; Salvati, Patricia; Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Passeleu, Celine; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6685-6706</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to discover novel selective monoamine oxidase (MAO) B inhibitors with favorable physicochem. and pharmacokinetic profiles, 7-[(m-halogeno)benzyloxy]coumarins bearing properly selected polar substituents at position 4 were designed, synthesized, and evaluated as MAO inhibitors.  Several compds. with MAO-B inhibitory activity in the nanomolar range and excellent MAO-B selectivity (selectivity index SI > 400) were identified.  Structure-affinity relationships and docking simulations provided valuable insights into the enzyme-inhibitor binding interactions at position 4, which has been poorly explored.  Furthermore, computational and exptl. studies led to the identification and biopharmacol. characterization of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (I) (NW-1772) as an in vitro and in vivo potent and selective MAO-B inhibitor, with rapid blood-brain barrier penetration, short-acting and reversible inhibitory activity, slight inhibition of selected cytochrome P450s, and low in vitro toxicity.  On the basis of this preliminary preclin. profile, inhibitor I might be viewed as a promising clin. candidate for the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX-2hebE1dsbVg90H21EOLACvtfcHk0lh67MYtf77_3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1artL3N&md5=b5cdda9e190504fced3ed6c5157c3266</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm9010127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9010127%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DMiscioscia%26aufirst%3DT.%2BF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DPasseleu%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Potent%2520Coumarin%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%253A%2520Development%2520and%2520Biopharmacological%2520Profiling%2520of%25207-%255B%25283-Chlorobenzyl%2529oxy%255D-4-%255B%2528methylamino%2529methyl%255D-2H-chromen-2-one%2520Methanesulfonate%2520%2528NW-1772%2529%2520as%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520Reversible%252C%2520and%2520Orally%2520Active%2520Monoamine%2520Oxidase%2520B%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6685%26epage%3D6706%26doi%3D10.1021%2Fjm9010127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ascenzio, M.</span></span> <span> </span><span class="NLM_article-title">Patent-Related Survey on New Monoamine Oxidase Inhibitors and Their Therapeutic Potential</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1517/13543776.2012.698613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1517%2F13543776.2012.698613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=22702491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVGrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=759-801&author=S.+Carradoriauthor=D.+Secciauthor=A.+Bolascoauthor=P.+Chimentiauthor=M.+D%E2%80%99Ascenzio&title=Patent-Related+Survey+on+New+Monoamine+Oxidase+Inhibitors+and+Their+Therapeutic+Potential&doi=10.1517%2F13543776.2012.698613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential</span></div><div class="casAuthors">Carradori, Simone; Secci, Daniela; Bolasco, Adriana; Chimenti, Paola; D'Ascenzio, Melissa</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">759-801</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Monoamine oxidase (MAO) plays an important role in the control of intracellular concn. of monoaminergic neurotransmitters or neuromodulators and dietary amines.  The rapid degrdn. of these mols. ensures the proper functioning of synaptic neurotransmission and is crit. for the regulation of several mental and cognitive functions.  The byproducts of MAO-mediated reactions comprehend reactive and toxic chem. species.  As a consequence of this, the development of human MAO inhibitors led to important discoveries in the treatment of several neuropsychiatric and neurodegenerative disorders.Areas covered: This review highlights the recent MAO inhibitors-related patents (2010-2012) and reports on new assocns. of already known MAO inhibitors with other drugs, innovative therapeutic targets, MAO inhibitors obtained by plants extn., alternative administration routes and synthetic processes.Expert opinion: MAO inhibitors appear promising for further clin. development being often endowed with other pharmacol. functions (iron-chelating property, cholinesterase inhibition).  A new golden age' of MAO inhibitors recently started from (i) the discovery of new therapeutic targets (prostate cancer, diabetes, ischemia/reperfusion injury, tobacco dependence, transmissible spongiform encephalopathy); (ii) the recognized role of MAO as biomol. markers (insomnia, chronic alcoholism, obsessive-compulsive behavior); (iii) the activity of these enzymes in other tissues (platelets, prostate cells).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroVBvUJ7wd-7Vg90H21EOLACvtfcHk0ljJYMgjVw4F0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVGrtLo%253D&md5=a7eb2aa2d9a5f4e3f1308b467d78ca7d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.698613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.698613%26sid%3Dliteratum%253Aachs%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Ascenzio%26aufirst%3DM.%26atitle%3DPatent-Related%2520Survey%2520on%2520New%2520Monoamine%2520Oxidase%2520Inhibitors%2520and%2520Their%2520Therapeutic%2520Potential%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D759%26epage%3D801%26doi%3D10.1517%2F13543776.2012.698613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestri, R.</span></span> <span> </span><span class="NLM_article-title">New Frontiers in Selective Human MAO-B Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6717</span>– <span class="NLM_lpage">6732</span>, <span class="refDoi"> DOI: 10.1021/jm501690r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501690r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFGiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6717-6732&author=S.+Carradoriauthor=R.+Silvestri&title=New+Frontiers+in+Selective+Human+MAO-B+Inhibitors&doi=10.1021%2Fjm501690r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New Frontiers in Selective Human MAO-B Inhibitors</span></div><div class="casAuthors">Carradori, Simone; Silvestri, Romano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6717-6732</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Accumulating evidence shows a relationship between the human MAO-B (hMAO-B) enzyme and neuropsychiatric/degenerative disorder, personality traits, type II alcoholism, borderline personality disorders, aggressiveness and violence in crime, obsessive-compulsive disorder, depression, suicide, schizophrenia, anorexia nervosa, migraine, dementia, and PD.  Thus, MAO-B represents an attractive target for the treatment of a no. of human diseases.  The discovery, development, and therapeutic use of drugs that inhibit MAO-B are major challenges for future therapy.  Various compds. and drugs that selectively target this isoform have been discovered recently.  These agents are synthetic compds. or natural products and their analogs, including chalcones, pyrazoles, chromones, coumarins, xanthines, isatin derivs., thiazolidindiones, (thiazol-2-yl)hydrazones, and analogs of marketed drugs.  Despite considerable efforts in understanding the binding interaction with specific substrates or inhibitors, structural information available for the rational design of new hMAO-B inhibitors remains unsatisfactory.  Therefore, the quest for novel, potent, and selective hMAO-B inhibitors remains of high interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Xz4JhVXeRbVg90H21EOLACvtfcHk0ljJYMgjVw4F0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFGiurk%253D&md5=abe939ceae25d97e83243f9f0af6aef5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm501690r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501690r%26sid%3Dliteratum%253Aachs%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DNew%2520Frontiers%2520in%2520Selective%2520Human%2520MAO-B%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6717%26epage%3D6732%26doi%3D10.1021%2Fjm501690r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCrodden, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tipton, K. F.</span></span> <span> </span><span class="NLM_article-title">The Involvement of Intestinal Monoamine Oxidase in the Transport and Metabolism of Tyramine</span>. <i>J. Neural Transm Suppl</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=3162948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A280%3ADyaL1c7pvFGnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1988&pages=1-9&author=F.+Hasanauthor=J.+M.+McCroddenauthor=N.+P.+Kennedyauthor=K.+F.+Tipton&title=The+Involvement+of+Intestinal+Monoamine+Oxidase+in+the+Transport+and+Metabolism+of+Tyramine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The involvement of intestinal monoamine oxidase in the transport and metabolism of tyramine</span></div><div class="casAuthors">Hasan F; McCrodden J M; Kennedy N P; Tipton K F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission. Supplementum</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-9</span>
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    </div><div class="casAbstract">The monoamine oxidase activities were found to be similar in the crypt and villous cells of the different regions of rat small intestine.  In all cases the activity of the A-form of the enzyme constituted more than 70% of the total.  A similar proportion of that form of the enzyme was found in homogenates of biopsy samples of human intestine.  Studies with everted intestines showed that at concentrations above 10 microM over 70% of tyramine was deaminated during transport and the use of selective inhibitors confirmed the A-form of monoamine oxidase to play the dominant role in that process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTo0jAUBc0BxcRAV4D_Ins_fW6udTcc2eZWvGrLFk5Xvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c7pvFGnug%253D%253D&md5=4420494d6f41215ba630a87b04c1f321</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHasan%26aufirst%3DF.%26aulast%3DMcCrodden%26aufirst%3DJ.%2BM.%26aulast%3DKennedy%26aufirst%3DN.%2BP.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520Involvement%2520of%2520Intestinal%2520Monoamine%2520Oxidase%2520in%2520the%2520Transport%2520and%2520Metabolism%2520of%2520Tyramine%26jtitle%3DJ.%2520Neural%2520Transm%2520Suppl%26date%3D1988%26volume%3D26%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riederer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T.</span></span> <span> </span><span class="NLM_article-title">Use of Monoamine Oxidase Inhibitors in Chronic Neurodegeneration</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1080/17425255.2017.1273901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1080%2F17425255.2017.1273901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=27998194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFeqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=233-240&author=P.+Riedererauthor=T.+Muller&title=Use+of+Monoamine+Oxidase+Inhibitors+in+Chronic+Neurodegeneration&doi=10.1080%2F17425255.2017.1273901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Use of monoamine oxidase inhibitors in chronic neurodegeneration</span></div><div class="casAuthors">Riederer, Peter; Mueller, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-240</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Neurotransmission by biogenic monoamines is important for brain function.  Biogenic amine turnover employs the enzymes catechol-O-methyltransferase and monoamine oxidase in neuronal and glial cells.  Inhibition of these enzymes elevates biogenic amine levels in the synaptic cleft.  Subtype selectivity of inhibition is lost during long-term use of 'selective' monoamine oxidase inhibitors.  This narrative review discusses use of monoamine oxidase inhibitors in the context with chronic neurodegeneration.  Antidepressant drugs increase synaptic concns. of biogenic amines.  In the aging brain, then one of the two enzymes involved in degrading synaptic amines, catechol-O-Me transferase, increasingly catalyzes methylation processes.  Therefore, metab. by monoamine oxidase plays an incremental, predominant role in biogenic amine turnover, leading to greater oxidative stress.  In patients with chronic neurodegenerative disorders, symptoms, such as depression and apathy, are often treated with drugs that elevate biogenic amine levels.  This therapeutic strategy increases biogenic amine turnover, thereby generating neurotoxic aldehydes and enhanced oxidative stress, each of which influence and accelerate the course of neurodegeneration.  We propose that antidepressant therapy should be initiated first with monoamine oxidase inhibitors only.  If adequate clin. response is not achieved, only then they should be supplemented with a further antidepressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVLaXnBjuirrVg90H21EOLACvtfcHk0lhKXnSvGx8vXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFeqsQ%253D%253D&md5=0e0c8eb13e16b768b51bd17d494a482d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F17425255.2017.1273901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2017.1273901%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DT.%26atitle%3DUse%2520of%2520Monoamine%2520Oxidase%2520Inhibitors%2520in%2520Chronic%2520Neurodegeneration%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2017%26volume%3D13%26spage%3D233%26epage%3D240%26doi%3D10.1080%2F17425255.2017.1273901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wimbiscus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malone, D.</span></span> <span> </span><span class="NLM_article-title">MAO Inhibitors: Risks, Benefits, and lore</span>. <i>Cleve Clin J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.3949/ccjm.77a.09103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.3949%2Fccjm.77a.09103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=21147941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FktVehsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=859-882&author=M.+Wimbiscusauthor=O.+Kostenkoauthor=D.+Malone&title=MAO+Inhibitors%3A+Risks%2C+Benefits%2C+and+lore&doi=10.3949%2Fccjm.77a.09103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">MAO inhibitors: risks, benefits, and lore</span></div><div class="casAuthors">Wimbiscus Molly; Kostenko Olga; Malone Donald</div><div class="citationInfo"><span class="NLM_cas:title">Cleveland Clinic journal of medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">859-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Monoamine oxidase (MAO) inhibitors were the first antidepressants introduced, but their use has dwindled because of their reported side effects, their food and drug interactions, and the introduction of other classes of agents.  However, interest in MAO inhibitors is reviving.  Here, we discuss their use, risks, and benefits in clinical medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5l3ppB6CZKLmQt-ICR3qNfW6udTcc2eY1xkgOIEmHK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FktVehsw%253D%253D&md5=557ad1fb6c82cd0fa448fdc72252f690</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3949%2Fccjm.77a.09103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3949%252Fccjm.77a.09103%26sid%3Dliteratum%253Aachs%26aulast%3DWimbiscus%26aufirst%3DM.%26aulast%3DKostenko%26aufirst%3DO.%26aulast%3DMalone%26aufirst%3DD.%26atitle%3DMAO%2520Inhibitors%253A%2520Risks%252C%2520Benefits%252C%2520and%2520lore%26jtitle%3DCleve%2520Clin%2520J.%2520Med.%26date%3D2010%26volume%3D77%26spage%3D859%26epage%3D882%26doi%3D10.3949%2Fccjm.77a.09103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polli, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baughman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mote, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salisbury, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tippin, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serabjit-Singh, C. J.</span></span> <span> </span><span class="NLM_article-title">P-Glycoprotein Influences the Brain Concentrations of Cetirizine (Zyrtec), a Second-Generation Non-Sedating Antihistamine</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">2082</span>– <span class="NLM_lpage">2089</span>, <span class="refDoi"> DOI: 10.1002/jps.10453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1002%2Fjps.10453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=14502547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvFOms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=2082-2089&author=J.+W.+Polliauthor=T.+M.+Baughmanauthor=J.+E.+Humphreysauthor=K.+H.+Jordanauthor=A.+L.+Moteauthor=J.+A.+Salisburyauthor=T.+K.+Tippinauthor=C.+J.+Serabjit-Singh&title=P-Glycoprotein+Influences+the+Brain+Concentrations+of+Cetirizine+%28Zyrtec%29%2C+a+Second-Generation+Non-Sedating+Antihistamine&doi=10.1002%2Fjps.10453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine</span></div><div class="casAuthors">Polli, Joseph W.; Baughman, Todd M.; Humphreys, Joan E.; Jordan, Kelly H.; Mote, Angela L.; Salisbury, Jo A.; Tippin, Timothy K.; Serabjit-Singh, Cosette J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2082-2089</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Recent in vitro studies have suggested that P-glycoprotein (Pgp) and passive membrane permeability may influence the brain concns. of non-sedating (second-generation) antihistamines.  The purpose of this study was to det. the importance of Pgp-mediated efflux on the in vivo brain distribution of the non-sedating antihistamine cetirizine (Zyrtec), and the structurally related sedating (first-generation) antihistamine hydroxyzine (Atarax).  In vitro MDR1-MDCKII monolayer efflux assays demonstrated that cetirizine was a Pgp substrate (B → A/A → B + GF120918 ratio = 5.47) with low/moderate passive permeability (Papp B → A = 56.5 nm/s).  In vivo, the cetirizine brain-to-free plasma concn. ratios (0.367 to 4.30) were 2.3- to 8.7-fold higher in Pgp-deficient mice compared with wild-type mice.  In contrast, hydroxyzine was not a Pgp substrate in vitro (B → A/A → B ratio = 0.86), had high passive permeability (Papp B → A + GF120918=296 nm/s), and had brain-to-free plasma concn. ratios > 73 in both Pgp-deficient and wild-type mice.  These studies demonstrate that Pgp-mediated efflux and passive permeability contribute to the low cetirizine brain concns. in mice and that these properties account for the differences in the sedation side-effect profiles of cetirizine and hydroxyzine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhU1DjQY_bcrVg90H21EOLACvtfcHk0ljAn6BH-x9dDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvFOms7c%253D&md5=fee50eea6337aa009088c3afb9efcf3b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjps.10453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10453%26sid%3Dliteratum%253Aachs%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DBaughman%26aufirst%3DT.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DJordan%26aufirst%3DK.%2BH.%26aulast%3DMote%26aufirst%3DA.%2BL.%26aulast%3DSalisbury%26aufirst%3DJ.%2BA.%26aulast%3DTippin%26aufirst%3DT.%2BK.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26atitle%3DP-Glycoprotein%2520Influences%2520the%2520Brain%2520Concentrations%2520of%2520Cetirizine%2520%2528Zyrtec%2529%252C%2520a%2520Second-Generation%2520Non-Sedating%2520Antihistamine%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D2082%26epage%3D2089%26doi%3D10.1002%2Fjps.10453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span> <i>QUACPAC</i>, version 1.7.0.2; <span class="NLM_publisher-name">OpenEye Scientific
Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+QUACPAC%2C+version+1.7.0.2%3B+OpenEye+Scientific%0ASoftware%3A+Santa+Fe%2C+NM%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DQUACPAC%26pub%3DOpenEye%2520Scientific%250ASoftware%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span> <i>OMEGA</i>, version 2.5.1.4; <span class="NLM_publisher-name">OpenEye Scientific
Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+OMEGA%2C+version+2.5.1.4%3B+OpenEye+Scientific%0ASoftware%3A+Santa+Fe%2C+NM%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DOMEGA%26pub%3DOpenEye%2520Scientific%250ASoftware%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M. T.</span></span> <span> </span><span class="NLM_article-title">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1021/ci100031x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100031x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=572-584&author=P.%0AC.+Hawkinsauthor=A.+G.+Skillmanauthor=G.+L.+Warrenauthor=B.+A.+Ellingsonauthor=M.+T.+Stahl&title=Conformer+Generation+with+OMEGA%3A+Algorithm+and+Validation+Using+High+Quality+Structures+from+the+Protein+Databank+and+Cambridge+Structural+Database&doi=10.1021%2Fci100031x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Warren, Gregory L.; Ellingson, Benjamin A.; Stahl, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">572-584</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we present the algorithm and validation for OMEGA, a systematic, knowledge-based conformer generator.  The algorithm consists of three phases: assembly of an initial 3D structure from a library of fragments; exhaustive enumeration of all rotatable torsions using values drawn from a knowledge-based list of angles, thereby generating a large set of conformations; and sampling of this set by geometric and energy criteria.  Validation of conformer generators like OMEGA has often been undertaken by comparing computed conformer sets to exptl. mol. conformations from crystallog., usually from the Protein Databank (PDB).  Such an approach is fraught with difficulty due to the systematic problems with small mol. structures in the PDB.  Methods are presented to identify a diverse set of small mol. structures from cocomplexes in the PDB that has maximal reliability.  A challenging set of 197 high quality, carefully selected ligand structures from well-solved models was obtained using these methods.  This set will provide a sound basis for comparison and validation of conformer generators in the future.  Validation results from this set are compared to the results using structures of a set of druglike mols. extd. from the Cambridge Structural Database (CSD).  OMEGA is found to perform very well in reproducing the crystallog. conformations from both these data sets using two complementary metrics of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1SOwPH1NzrVg90H21EOLACvtfcHk0ljAn6BH-x9dDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D&md5=fb87ecc9c51eddef63b41fffcd9babee</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fci100031x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100031x%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26aulast%3DEllingson%26aufirst%3DB.%2BA.%26aulast%3DStahl%26aufirst%3DM.%2BT.%26atitle%3DConformer%2520Generation%2520with%2520OMEGA%253A%2520Algorithm%2520and%2520Validation%2520Using%2520High%2520Quality%2520Structures%2520from%2520the%2520Protein%2520Databank%2520and%2520Cambridge%2520Structural%2520Database%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D572%26epage%3D584%26doi%3D10.1021%2Fci100031x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span> <i>HYBRID</i>, version 3.2.0.2; <span class="NLM_publisher-name">OpenEye Scientific
Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+HYBRID%2C+version+3.2.0.2%3B+OpenEye+Scientific%0ASoftware%3A+Santa+Fe%2C+NM%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DHYBRID%26pub%3DOpenEye%2520Scientific%250ASoftware%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGann, M.</span></span> <span> </span><span class="NLM_article-title">FRED Pose Prediction and Virtual Screening Accuracy</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1021/ci100436p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100436p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFGqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=578-596&author=M.+McGann&title=FRED+Pose+Prediction+and+Virtual+Screening+Accuracy&doi=10.1021%2Fci100436p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">FRED Pose Prediction and Virtual Screening Accuracy</span></div><div class="casAuthors">McGann, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">578-596</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Results of a previous docking study are reanalyzed and extended to include results from the docking program FRED and a detailed statistical anal. of both structure reprodn. and virtual screening results.  FRED is run both in a traditional docking mode and in a hybrid mode that makes use of 16 the structure of a bound ligand in addn. to the protein structure to screen mols.  This anal. shows that most docking programs are effective overall but highly inconsistent, tending to do well on one system and poorly on the next.  Comparing methods, the difference in mean performance on DUD is found to be statistically significant (95% confidence) 61% of the time when using a global enrichment metric (AUC).  Early enrichment metrics are found to have relatively poor statistical power, with 0.5% early enrichment only able to distinguish methods to 95% confidence 14% of the time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVRPdIDmubh7Vg90H21EOLACvtfcHk0ljAn6BH-x9dDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFGqsbk%253D&md5=8f3ae5972583d0a89d50e35a4b01212e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fci100436p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100436p%26sid%3Dliteratum%253Aachs%26aulast%3DMcGann%26aufirst%3DM.%26atitle%3DFRED%2520Pose%2520Prediction%2520and%2520Virtual%2520Screening%2520Accuracy%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D578%26epage%3D596%26doi%3D10.1021%2Fci100436p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGann, M.</span></span> <span> </span><span class="NLM_article-title">FRED and HYBRID Docking Performance on Standardized Datasets</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1007/s10822-012-9584-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2Fs10822-012-9584-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=22669221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ens7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=897-906&author=M.+McGann&title=FRED+and+HYBRID+Docking+Performance+on+Standardized+Datasets&doi=10.1007%2Fs10822-012-9584-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">FRED and HYBRID docking performance on standardized datasets</span></div><div class="casAuthors">McGann, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">897-906</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The docking performance of the FRED and HYBRID programs are evaluated on two standardized datasets from the Docking and Scoring Symposium of the ACS Spring 2011 national meeting.  The evaluation includes cognate docking and virtual screening performance.  FRED docks 70 % of the structures to within 2 Å in the cognate docking test.  In the virtual screening test, FRED is found to have a mean AUC of 0.75.  The HYBRID program uses a modified version of FRED's algorithm that uses both ligand- and structure-based information to dock mols., which increases its mean AUC to 0.78.  HYBRID can also implicitly account for protein flexibility by making use of multiple crystal structures.  Using multiple crystal structures improves HYBRID's performance (mean AUC 0.80) with a negligible increase in docking time (∼15 %).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDNF1kmgp-WLVg90H21EOLACvtfcHk0lhPesHSHdtjpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ens7bO&md5=299f2e795ca922412f57df9434b52661</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs10822-012-9584-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-012-9584-8%26sid%3Dliteratum%253Aachs%26aulast%3DMcGann%26aufirst%3DM.%26atitle%3DFRED%2520and%2520HYBRID%2520Docking%2520Performance%2520on%2520Standardized%2520Datasets%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2012%26volume%3D26%26spage%3D897%26epage%3D906%26doi%3D10.1007%2Fs10822-012-9584-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span> <i>SZYBKI</i>, version 1.9.0.3; <span class="NLM_publisher-name">OpenEye Scientific
Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+SZYBKI%2C+version+1.9.0.3%3B+OpenEye+Scientific%0ASoftware%3A+Santa+Fe%2C+NM%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSZYBKI%26pub%3DOpenEye%2520Scientific%250ASoftware%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Elisa Sassetti, Mads H. Clausen, <span class="NLM_string-name hlFld-ContribAuthor">Luca Laraia</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Inhibitors of Reactive Oxygen Species Production. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5252-5275. <a href="https://doi.org/10.1021/acs.jmedchem.0c01914" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01914</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01914%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BInhibitors%252Bof%252BReactive%252BOxygen%252BSpecies%252BProduction%26aulast%3DSassetti%26aufirst%3DElisa%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D04112020%26date%3D15042021%26volume%3D64%26issue%3D9%26spage%3D5252%26epage%3D5275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mahyar  Ostadkarampour</span>, <span class="hlFld-ContribAuthor ">Edward E.  Putnins</span>. </span><span class="cited-content_cbyCitation_article-title">Monoamine Oxidase Inhibitors: A Review of Their Anti-Inflammatory Therapeutic Potential and Mechanisms of Action. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.676239" title="DOI URL">https://doi.org/10.3389/fphar.2021.676239</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.676239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.676239%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DMonoamine%252BOxidase%252BInhibitors%25253A%252BA%252BReview%252Bof%252BTheir%252BAnti-Inflammatory%252BTherapeutic%252BPotential%252Band%252BMechanisms%252Bof%252BAction%26aulast%3DOstadkarampour%26aufirst%3DMahyar%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Flor Paulina  Garrido González</span>, <span class="hlFld-ContribAuthor ">Teresa  Mancilla Percino</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, docking study and inhibitory activity of 2,6-diketopiperazines derived from α-amino acids on HDAC8. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>102 </em>, 104080. <a href="https://doi.org/10.1016/j.bioorg.2020.104080" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104080%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bdocking%252Bstudy%252Band%252Binhibitory%252Bactivity%252Bof%252B2%25252C6-diketopiperazines%252Bderived%252Bfrom%252B%2525CE%2525B1-amino%252Bacids%252Bon%252BHDAC8%26aulast%3DGarrido%2BGonz%25C3%25A1lez%26aufirst%3DFlor%2BPaulina%26date%3D2020%26volume%3D102%26spage%3D104080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Guglielmi</span>, <span class="hlFld-ContribAuthor ">Simone  Carradori</span>, <span class="hlFld-ContribAuthor ">Alessandra  Ammazzalorso</span>, <span class="hlFld-ContribAuthor ">Daniela  Secci</span>. </span><span class="cited-content_cbyCitation_article-title">Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement?. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2019,</strong> <em>14 </em>
                                    (10)
                                     , 995-1035. <a href="https://doi.org/10.1080/17460441.2019.1637415" title="DOI URL">https://doi.org/10.1080/17460441.2019.1637415</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2019.1637415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2019.1637415%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DNovel%252Bapproaches%252Bto%252Bthe%252Bdiscovery%252Bof%252Bselective%252Bhuman%252Bmonoamine%252Boxidase-B%252Binhibitors%25253A%252Bis%252Bthere%252Broom%252Bfor%252Bimprovement%25253F%26aulast%3DGuglielmi%26aufirst%3DPaolo%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D10%26spage%3D995%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emma K  Davison</span>, <span class="hlFld-ContribAuthor ">Margaret A  Brimble</span>. </span><span class="cited-content_cbyCitation_article-title">Natural product derived privileged scaffolds in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2019,</strong> <em>52 </em>, 1-8. <a href="https://doi.org/10.1016/j.cbpa.2018.12.007" title="DOI URL">https://doi.org/10.1016/j.cbpa.2018.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2018.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2018.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DNatural%252Bproduct%252Bderived%252Bprivileged%252Bscaffolds%252Bin%252Bdrug%252Bdiscovery%26aulast%3DDavison%26aufirst%3DEmma%2BK%26date%3D2019%26volume%3D52%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Cheng</span>, <span class="hlFld-ContribAuthor ">Shiyu  Li</span>, <span class="hlFld-ContribAuthor ">Xiao  Lv</span>, <span class="hlFld-ContribAuthor ">Yongbin  Tian</span>, <span class="hlFld-ContribAuthor ">Haiyan  Kong</span>, <span class="hlFld-ContribAuthor ">Xufeng  Huang</span>, <span class="hlFld-ContribAuthor ">Yajun  Duan</span>, <span class="hlFld-ContribAuthor ">Jihong  Han</span>, <span class="hlFld-ContribAuthor ">Zhouling  Xie</span>, <span class="hlFld-ContribAuthor ">Chenzhong  Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel human monoamine oxidase B inhibitors based on a fragment in an X-ray crystal structure. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (8)
                                     , 1012-1018. <a href="https://doi.org/10.1016/j.bmcl.2019.02.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bhuman%252Bmonoamine%252Boxidase%252BB%252Binhibitors%252Bbased%252Bon%252Ba%252Bfragment%252Bin%252Ban%252BX-ray%252Bcrystal%252Bstructure%26aulast%3DCheng%26aufirst%3DKai%26date%3D2019%26volume%3D29%26issue%3D8%26spage%3D1012%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0018.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) MAO activity and selective MAO-A/B inhibitors; (b) incorporation of a CO<sub>2</sub>H function into drug structures suppresses BBB penetration; (c) irreversible MAO inhibition by rasagiline.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of deprenyl, the polar deprenyl-inspired compounds <b>A</b> and <b>B</b>, and the <b>B</b>-type compound <b>10a</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0012.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) BnBr, K<sub>2</sub>CO<sub>3</sub>, acetone, RT 16 h then reflux 3 h, 85%; (ii) LAH, THF, RT, 95%; (iii) TsCl, <i>n</i>-Bu<sub>4</sub>NHSO<sub>4</sub>, 10% aq NaOH–C<sub>6</sub>H<sub>6</sub>, RT, 30 min, 67%; (iv) Zn dust, NaI, THF–H<sub>2</sub>O, reflux, 2.5 h, 94%; (v) LAH, THF, reflux, 4 h, 54%; (vi) <i>tert</i>-butyl bromoacetate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, RT, 15 h, 79%; (vii) Pd/C(cat), H<sub>2</sub>, MeOH, 99%; (viii) ArCH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, RT, 15 h, 36–99%; (ix) (for <b>9n</b>) 3-OMeBnOH, DIAD, PPh<sub>3</sub>, THF, RT, 3 min, 62%; (x) conc. HCl, THF, 0 °C, 3 h, 35–87%; (xi) Propargyl bromide, Cs<sub>2</sub>CO<sub>3</sub>, THF, RT 15h, 42%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) BnBr or 3-ClBnBr, K<sub>2</sub>CO<sub>3</sub>, acetone, RT 16 h than reflux 3 h, 95% for <b>13</b>, 100% for <b>14</b>; (ii) MeI, NaH, THF, RT, 15 h, 35% for <b>15</b>, 76% for <b>16</b>; (iii) SO<sub>2</sub>Cl, MeOH, RT, 15 h, 62% for both <b>17</b> and <b>18</b>; (iv) <i>tert</i>-butyl bromoacetate, Cs<sub>2</sub>CO<sub>3</sub>, DMF, RT, 15 h, 49% for <b>19</b>, 54% for <b>20</b>; (v) conc. HCl, THF, 0 °C, 3 h, 86% for <b>21</b>, 75% for <b>22</b>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) LAH, THF, reflux, 3 h, 88%; (ii) <i>tert</i>-butyl bromoacetate, Et<sub>3</sub>N, DMF, RT, 15 h, 80%; (iii) BnBr, NaH, THF, 15 h, then conc HCl, 2 h, 46%; (iv) <i>tert</i>-butyl bromoacetate, Cs<sub>2</sub>CO<sub>3</sub>, NaI (cat), DMF, 30 min, 90 °C, μW, 66%; (v) TsCl, Et<sub>3</sub>N, DMAP, DCM, RT, 15 h, 88%; (vi) KCN, 18-C-6, NaI (cat), DMF, 100 °C, 90 min, 80%; (vii) Pd/C, H<sub>2</sub> (1 atm), 90%; (viii) 3,4-diClBnBr, K<sub>2</sub>CO<sub>3</sub>, DMF, RT, 15 h, 88%; (ix) conc. HCl, THF, 0 °C, 3 h, 77% for <b>29</b>, 66% for <b>32</b>.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0003.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Inhibition of MAO-A and MAO-B enzyme activity by lead compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0004.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Permeability assays and calculated efflux ratios for compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> using wild-type MDCK-WT and MDCK-MDR1 II cell lines. Efflux ratio ≥ 2 identifies the compound as a P-gp substrate. Cultures were treated with (white) or without (black) verapamil (an established P-gp inhibitor). Values were indicated as mean ± standard deviation (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. In vitro metabolic stability of the novel compounds in plasma (mouse/human), liver microsomes (mouse/human), and hepatocytes (mouse). Positive control compounds were enalapril (mouse plasma), procaine (human plasma), and propranolol (mouse liver microsomes, human liver microsomes, and mouse hepatocytes). Data are shown as mean ± standard deviation (SD). Each experiment was done in triplicate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0006.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Plasma pharmacokinetic curves of deprenyl and compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> following a single 57.5 μmol/kg intravenous dose in C57BL/6 mice. Twenty-one animals were injected at 0 min, with 3 animals sacrificed at each time point, for a total of 7 time points (0 min, 5 min, 15 min, 30 min, 1 h, 4 h, 24 h). For the plotting of pharmacokinetic curves, values that were below the limit of quantification were plotted as one-half of the limit of quantification, while values that were above the limit of quantification or nondetected were omitted from the plots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0007.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Brain pharmacokinetic curves of deprenyl and compounds <b>10c</b>, <b>10j</b>, <b>10k</b>, and <b>32</b> following a single intravenously 57.5 μmol/kg dose in C57BL/6 mice. Twenty-one animals were injected at 0 min, with 3 animals sacrificed at each time point, for a total of 7 time points (0 min, 5 min, 15 min, 30 min, 1 h, 4 h, 24 h). For the plotting of pharmacokinetic curves, values that were below the limit of quantification were plotted as one-half of the limit of quantification, while values that were above the limit of quantification or nondetected were omitted from the plots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0008.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plasma pharmacokinetic curves of compound <b>10j</b> and compound <b>32</b> following a single 57.5 μmol/kg dose via subcutaneous (SC) and oral (PO) administration. Fifteen animals were injected at 0 min, with 3 animals sacrificed at each time point, for a total of 5 time points (1, 2, 4, 6, and 24 h). For the plotting of pharmacokinetic curves, values that were below the limit of quantification were plotted as one-half of the limit of quantification while values that were above the limit of quantification or nondetected were omitted from the plots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0009.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Brain pharmacokinetic curves of compound <b>10j</b> and compound <b>32</b> following a single 57.5 μmol/kg dose via subcutaneous and oral administration. Fifteen animals were injected at 0 min, with 3 animals sacrificed at each time point, for a total of 5 time points (1, 2, 4, 6, and 24 h). For the plotting of pharmacokinetic curves, values that were below the limit of quantification were plotted as one-half of the limit of quantification while values that were above the limit of quantification or nondetected were omitted from the plots.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0010.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structural comparison of compounds <b>10c</b>, <b>10j</b>, and <b>10k</b> with safinamide and compounds <b>21</b>, <b>22</b>, <b>25</b>, <b>26</b>, <b>29</b>, and <b>32</b> with the coumarin amide <b>33</b>. V-shaped wedges represent the constriction residues (Tyr 326 and Ile 199) in the MAO-B binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/medium/jm-2017-01588c_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0011.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Binding modes of safinamide (top panels, carbons shown in pink) in human MAO-B (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v5z">2v5z</a>) and predicted binding modes of <b>10j</b> (mid panels, carbons shown in cyan) and <b>32</b> (lower panels, carbons shown in cyan). For the docking, the coordinates of the safinamide–hMAO-B cocomplex were used (see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>). Hydrogen bonds and cation−π interactions are indicated by green and magenta dashed lines, respectively. For the cation−π interactions, the center of the aromatic ring is shown as a small sphere. Protein residues are labeled with the 3-letter code followed by the residue number.  N5 of FAD is indicated by an italicized label. Orientation of the structures has been rotated by roughly 180° between the left and the right panels in order to illustrate the predicted interactions to the protein for the docked poses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.7b01588/20180816/images/large/jm-2017-01588c_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01588&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i84">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boor, P. J.</span></span> <span> </span><span class="NLM_article-title">The Role of Amine Oxidases in Xenobiotic Metabolism</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">559</span>– <span class="NLM_lpage">571</span>, <span class="refDoi"> DOI: 10.1517/17425255.2.4.559</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1517%2F17425255.2.4.559" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=16859404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1ahsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=559-571&author=B.+Gongauthor=P.+J.+Boor&title=The+Role+of+Amine+Oxidases+in+Xenobiotic+Metabolism&doi=10.1517%2F17425255.2.4.559"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The role of amine oxidases in xenobiotic metabolism</span></div><div class="casAuthors">Gong, Bin; Boor, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">559-571</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The amine oxidases of mammalian tissues are a heterogeneous family of enzymes that metabolize various monoamines, diamines and polyamines produced endogenously, or being absorbed as dietary or xenobiotic substances.  The heterogeneous class of amine oxidases can be divided on an arbitrary basis of the chem. nature of their cofactors into two types.  Monoamine oxidase (MAO) and an intracellular form of polyamine oxidase (PAO) contain FAD as their cofactor, whereas a second group of amine oxidases without FAD contain a cofactor possessing one or more carbonyl groups, making them sensitive to inhibition by carbonyl reagents such as semicarbazide; this group includes semicarbazide-sensitive amine oxidase (SSAO) and the connective tissue enzyme, lysyl oxidase.  This article focuses on the general aspects of MAO's contribution to the metab. of foreign toxic substances including toxins and illegal drugs.  Another main objective of this review is to discuss the properties of PAO and SSAO and their involvement in the metab. of xenobiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVIpGnff-1HbVg90H21EOLACvtfcHk0lhXI8e65ntsWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1ahsLw%253D&md5=be246766d62dd72a47f9f60feb492d96</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1517%2F17425255.2.4.559&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425255.2.4.559%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DB.%26aulast%3DBoor%26aufirst%3DP.%2BJ.%26atitle%3DThe%2520Role%2520of%2520Amine%2520Oxidases%2520in%2520Xenobiotic%2520Metabolism%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2006%26volume%3D2%26spage%3D559%26epage%3D571%26doi%3D10.1517%2F17425255.2.4.559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fisar, Z.</span></span> <span> </span><span class="NLM_article-title">Drugs Related to Monoamine Oxidase Activity</span>. <i>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1016/j.pnpbp.2016.02.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2Fj.pnpbp.2016.02.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=26944656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC28XktVOltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2016&pages=112-124&author=Z.+Fisar&title=Drugs+Related+to+Monoamine+Oxidase+Activity&doi=10.1016%2Fj.pnpbp.2016.02.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs related to monoamine oxidase activity</span></div><div class="casAuthors">Fisar, Zdenek</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112-124</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Progress in understanding the role of monoamine neurotransmission in pathophysiol. of neuropsychiatric disorders was made after the discovery of the mechanisms of action of psychoactive drugs, including monoamine oxidase (MAO) inhibitors.  The increase in monoamine neurotransmitter availability, decrease in hydrogen peroxide prodn., and neuroprotective effects evoked by MAO inhibitors represent an important approach in the development of new drugs for the treatment of mental disorders and neurodegenerative diseases.  New drugs are synthesized by acting as multitarget-directed ligands, with MAO, acetylcholinesterase, and iron chelation as targets.  Basic information is summarized in this paper about the drug-induced regulation of monoaminergic systems in the brain, with a focus on MAO inhibition.  Desirable effects of MAO inhibition include increased availability of monoamine neurotransmitters, decreased oxidative stress, decreased formation of neurotoxins, induction of pro-survival genes and antiapoptotic factors, and improved mitochondrial functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0XNTg1Wh-6LVg90H21EOLACvtfcHk0lhXI8e65ntsWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktVOltrY%253D&md5=eda253e0dde104fbc1add538d50a28b1</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2016.02.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2016.02.012%26sid%3Dliteratum%253Aachs%26aulast%3DFisar%26aufirst%3DZ.%26atitle%3DDrugs%2520Related%2520to%2520Monoamine%2520Oxidase%2520Activity%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2016%26volume%3D69%26spage%3D112%26epage%3D124%26doi%3D10.1016%2Fj.pnpbp.2016.02.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span> <span> </span><span class="NLM_article-title">Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological Implications</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">160</span>, <span class="refDoi"> DOI: 10.2174/13816128113190990406</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.2174%2F13816128113190990406" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=23701542" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFOmtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=155-160&author=D.+E.+Edmondson&title=Hydrogen+Peroxide+Produced+by+Mitochondrial+Monoamine+Oxidase+Catalysis%3A+Biological+Implications&doi=10.2174%2F13816128113190990406"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological Implications</span></div><div class="casAuthors">Edmondson, Dale E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-160</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The biol. roles of mitochondrial-produced reactive oxygen species continue to receive intensive investigation since one of the products (H2O2) has important cellular signaling roles as well as contributing to apoptotic responses.  In general, the source of mitochondrial reactive oxygen species is thought to be the superoxide anion produced from Complex I and Complex III components of the electron transport chain.  Superoxide anion readily dismutates to H2O2 with subsequent transformation to the hydroxyl radical by Fenton chem.  An overlooked source of H2O2 in the mitochondrion is its prodn. as a catalytic reaction product from the outer membrane enzymes: monoamine oxidases A and B.  The literature is reviewed to document identified degenerative reactions attributed to H2O2 produced by MAO A and by MAO B catalysis.  Available information on the topologies of these enzymes in the mitochondrial outer membrane is also discussed with relevance to H2O2 prodn. and involvement in cell signaling functions as well as degenerative effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomHat4RJctm7Vg90H21EOLACvtfcHk0lhXI8e65ntsWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFOmtb4%253D&md5=75d670b395b063ff5c876121a7d6dd0b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2174%2F13816128113190990406&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13816128113190990406%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26atitle%3DHydrogen%2520Peroxide%2520Produced%2520by%2520Mitochondrial%2520Monoamine%2520Oxidase%2520Catalysis%253A%2520Biological%2520Implications%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D20%26spage%3D155%26epage%3D160%26doi%3D10.2174%2F13816128113190990406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Youdim, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tipton, K. F.</span></span> <span> </span><span class="NLM_article-title">The Therapeutic Potential of Monoamine Oxidase Inhibitors</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1038/nrn1883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1038%2Fnrn1883" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=16552415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=295-309&author=M.+B.+Youdimauthor=D.+Edmondsonauthor=K.+F.+Tipton&title=The+Therapeutic+Potential+of+Monoamine+Oxidase+Inhibitors&doi=10.1038%2Fnrn1883"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The therapeutic potential of monoamine oxidase inhibitors</span></div><div class="casAuthors">Youdim, Moussa B. H.; Edmondson, Dale; Tipton, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-309</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Monoamine oxidase inhibitors were among the first antidepressants to be discovered and have long been used as such.  It now seems that many of these agents might have therapeutic value in several common neurodegenerative conditions, independently of their inhibition of monoamine oxidase activity.  However, many claims and some counter-claims have been made about the physiol. importance of these enzymes and the potential of their inhibitors.  We evaluate these arguments in the light of what we know, and still have to learn, of the structure, function and genetics of the monoamine oxidases and the disparate actions of their inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3A0wRL6nnL7Vg90H21EOLACvtfcHk0lhXI8e65ntsWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xis1Gksrs%253D&md5=b35546920d95fa031ff2f884949372a7</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnrn1883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn1883%26sid%3Dliteratum%253Aachs%26aulast%3DYoudim%26aufirst%3DM.%2BB.%26aulast%3DEdmondson%26aufirst%3DD.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520Therapeutic%2520Potential%2520of%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2006%26volume%3D7%26spage%3D295%26epage%3D309%26doi%3D10.1038%2Fnrn1883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Knull, J.</span></span> <span> </span><span class="NLM_article-title">(−)Deprenyl (Selegiline), a Catecholaminergic Activity Enhancer (CAE) Substance Acting in the Brain</span>. <i>Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1111/j.1600-0773.1998.tb01399.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1111%2Fj.1600-0773.1998.tb01399.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=9498233" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1998&pages=57-66&author=J.+Knull&title=%28%E2%88%92%29Deprenyl+%28Selegiline%29%2C+a+Catecholaminergic+Activity+Enhancer+%28CAE%29+Substance+Acting+in+the+Brain&doi=10.1111%2Fj.1600-0773.1998.tb01399.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1998.tb01399.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1998.tb01399.x%26sid%3Dliteratum%253Aachs%26aulast%3DKnull%26aufirst%3DJ.%26atitle%3D%2528%25E2%2588%2592%2529Deprenyl%2520%2528Selegiline%2529%252C%2520a%2520Catecholaminergic%2520Activity%2520Enhancer%2520%2528CAE%2529%2520Substance%2520Acting%2520in%2520the%2520Brain%26jtitle%3DPharmacol.%2520Toxicol.%26date%3D1998%26volume%3D82%26spage%3D57%26epage%3D66%26doi%3D10.1111%2Fj.1600-0773.1998.tb01399.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villegier, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salomon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changeux, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belluzzi, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tassin, J. P.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase Inhibitors Allow Locomotor and Rewarding Responses to Nicotine</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1704</span>– <span class="NLM_lpage">1713</span>, <span class="refDoi"> DOI: 10.1038/sj.npp.1300987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1038%2Fsj.npp.1300987" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=1704-1713&author=A.+S.+Villegierauthor=L.+Salomonauthor=S.+Granonauthor=J.+P.+Changeuxauthor=J.+D.+Belluzziauthor=F.+M.+Leslieauthor=J.+P.+Tassin&title=Monoamine+Oxidase+Inhibitors+Allow+Locomotor+and+Rewarding+Responses+to+Nicotine&doi=10.1038%2Fsj.npp.1300987"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.npp.1300987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.npp.1300987%26sid%3Dliteratum%253Aachs%26aulast%3DVillegier%26aufirst%3DA.%2BS.%26aulast%3DSalomon%26aufirst%3DL.%26aulast%3DGranon%26aufirst%3DS.%26aulast%3DChangeux%26aufirst%3DJ.%2BP.%26aulast%3DBelluzzi%26aufirst%3DJ.%2BD.%26aulast%3DLeslie%26aufirst%3DF.%2BM.%26aulast%3DTassin%26aufirst%3DJ.%2BP.%26atitle%3DMonoamine%2520Oxidase%2520Inhibitors%2520Allow%2520Locomotor%2520and%2520Rewarding%2520Responses%2520to%2520Nicotine%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D1704%26epage%3D1713%26doi%3D10.1038%2Fsj.npp.1300987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span> <span> </span><span class="NLM_article-title">Molecular Aspects of Monoamine Oxidase B</span>. <i>Prog. Neuro-Psychopharmacol. Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1016/j.pnpbp.2016.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2Fj.pnpbp.2016.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=26891670" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtlKhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2016&pages=81-89&author=R.+R.+Ramsay&title=Molecular+Aspects+of+Monoamine+Oxidase+B&doi=10.1016%2Fj.pnpbp.2016.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular aspects of monoamine oxidase B</span></div><div class="casAuthors">Ramsay, Rona R.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neuro-Psychopharmacology & Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">81-89</span>CODEN:
                <span class="NLM_cas:coden">PNPPD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-5846</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Monoamine oxidases (MAO) influence the monoamine levels in brain by virtue of their role in neurotransmitter breakdown.  MAO B is the predominant form in glial cells and in platelets.  MAO B structure, function and kinetics are described as a background for the effect of alterations in its activity on behavior.  The need to inhibit MAO B to combat decreased brain amines continues to drive the search for new drugs.  Reversible and irreversible inhibitors are now designed using data-mining, computational screening, docking and mol. dynamics.  Multi-target ligands designed to combat the elevated activity of MAO B in Alzheimer's and Parkinson's Diseases incorporate MAO inhibition (usually irreversible) as well as iron chelation, antioxidant or neuroprotective properties.  The main focus of drug design is the catalytic activity of MAO, but the imidazoline I2 site in the entrance cavity of MAO B is also a pharmacol. target.  Endogenous regulation of MAO B expression is discussed briefly in light of new studies measuring mRNA, protein, or activity in healthy and degenerative samples, including the effect of DNA methylation on the expression.  Overall, this review focuses on examples of recent research on the mol. aspects of the expression, activity, and inhibition of MAO B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWqBth0WA0EbVg90H21EOLACvtfcHk0ljrNJNNWMlTEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtlKhurw%253D&md5=53857d746ee164dcc74469832516a0cd</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.pnpbp.2016.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pnpbp.2016.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26atitle%3DMolecular%2520Aspects%2520of%2520Monoamine%2520Oxidase%2520B%26jtitle%3DProg.%2520Neuro-Psychopharmacol.%2520Biol.%2520Psychiatry%26date%3D2016%26volume%3D69%26spage%3D81%26epage%3D89%26doi%3D10.1016%2Fj.pnpbp.2016.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sivasubramaniam, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finch, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billett, E. E.</span></span> <span> </span><span class="NLM_article-title">A Comparative Study of the Expression of Monoamine Oxidase-A and -B mRNA and Protein in non-CNS Human Tissues</span>. <i>Cell Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1007/s00441-003-0765-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2Fs00441-003-0765-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=12898212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntlyktr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2003&pages=291-300&author=S.+D.+Sivasubramaniamauthor=C.+C.+Finchauthor=M.+J.+Rodriguezauthor=N.+Mahyauthor=E.+E.+Billett&title=A+Comparative+Study+of+the+Expression+of+Monoamine+Oxidase-A+and+-B+mRNA+and+Protein+in+non-CNS+Human+Tissues&doi=10.1007%2Fs00441-003-0765-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">A comparative study of the expression of monoamine oxidase-A and -B mRNA and protein in non-CNS human tissues</span></div><div class="casAuthors">Sivasubramaniam, S. D.; Finch, C. C.; Rodriguez, M. J.; Mahy, N.; Billett, E. E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-300</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The distributions of monoamine oxidase (MAO)-A and -B proteins and mRNAs in human heart, lung, liver, duodenum, kidney and vasculature were compared using immunohistochem. and cRNA in situ hybridization.  MAO-A and -B mRNA were detected in all tissues, to differing extents, but particularly in glomeruli, hepatocytes, and the crypts, muscularis mucosa and muscularis externa of duodenum.  Renal proximal and distal tubules and loops of Henle had more intense labeling for mRNA of MAO-B than MAO-A; this was reflected in MAO protein expression.  Little immunoreactivity was detected in glomeruli.  Hepatocytes expressed MAO-A moderately, but MAO-B strongly.  In lungs, similar moderately intense labeling for both MAO mRNAs and immunoreactivities was evident in pneumocytes, and epithelial and smooth muscle cells.  Cardiomyocytes contained both MAO isoforms, but with more, albeit moderate, labeling for MAO-A.  Both isoforms were expressed equally in duodenal villi, crypts, muscularis externa and mucosa; lower level expression occurred in mucosal and submucosal cells.  MAO-A and -B mRNA were detected in endothelia, adventitia and media of a renal interlobular artery, but protein immunoreactivities were chiefly in the adventitia.  The data reveal widespread tissue distribution of MAO mRNAs and proteins, but indicate that presence of MAO mRNAs does not invariably reflect quant. its protein expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplfGXhTXCwErVg90H21EOLACvtfcHk0ljrNJNNWMlTEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntlyktr0%253D&md5=f8e3a550d34fc082d4cba22b5c28c918</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1007%2Fs00441-003-0765-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-003-0765-6%26sid%3Dliteratum%253Aachs%26aulast%3DSivasubramaniam%26aufirst%3DS.%2BD.%26aulast%3DFinch%26aufirst%3DC.%2BC.%26aulast%3DRodriguez%26aufirst%3DM.%2BJ.%26aulast%3DMahy%26aufirst%3DN.%26aulast%3DBillett%26aufirst%3DE.%2BE.%26atitle%3DA%2520Comparative%2520Study%2520of%2520the%2520Expression%2520of%2520Monoamine%2520Oxidase-A%2520and%2520-B%2520mRNA%2520and%2520Protein%2520in%2520non-CNS%2520Human%2520Tissues%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2003%26volume%3D313%26spage%3D291%26epage%3D300%26doi%3D10.1007%2Fs00441-003-0765-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fowler, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volkow, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. J.</span></span> <span> </span><span class="NLM_article-title">Translational Neuroimaging: Positron Emission Tomography Studies of Monoamine Oxidase</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">387</span>, <span class="refDoi"> DOI: 10.1007/s11307-005-0016-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2Fs11307-005-0016-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=16265597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A280%3ADC%252BD287gvFentQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2005&pages=377-387&author=J.+S.+Fowlerauthor=J.+Loganauthor=N.+D.+Volkowauthor=G.+J.+Wang&title=Translational+Neuroimaging%3A+Positron+Emission+Tomography+Studies+of+Monoamine+Oxidase&doi=10.1007%2Fs11307-005-0016-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Translational neuroimaging: positron emission tomography studies of monoamine oxidase</span></div><div class="casAuthors">Fowler Joanna S; Logan Jean; Volkow Nora D; Wang Gene-Jack</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">377-87</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">Positron emission tomography (PET) using radiotracers with high molecular specificity is an important scientific tool in studies of monoamine oxidase (MAO), an important enzyme in the regulation of the neurotransmitters dopamine, norepinephrine, and serotonin as well as the dietary amine, tyramine.  MAO occurs in two different subtypes, MAO A and MAO B, which have different substrate and inhibitor specificity and which are different gene products.  The highly variable subtype distribution with different species makes human studies of special value.  MAO A and B can be imaged in the human brain and certain peripheral organs using PET and carbon-11 (half-life 20.4 minutes) labeled mechanism-based irreversible inhibitors, clorgyline and L -deprenyl, respectively.  In this article we introduce MAO and describe the development of these radiotracers and their translation from preclinical studies to the investigation of variables affecting MAO in the human brain and peripheral organs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT8qmr10OyrWYkFb3mqPUYDfW6udTcc2eb542IoiKEnJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287gvFentQ%253D%253D&md5=5d2ebce788abf1ddb96ad8215433fa51</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs11307-005-0016-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-005-0016-1%26sid%3Dliteratum%253Aachs%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DVolkow%26aufirst%3DN.%2BD.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26atitle%3DTranslational%2520Neuroimaging%253A%2520Positron%2520Emission%2520Tomography%2520Studies%2520of%2520Monoamine%2520Oxidase%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2005%26volume%3D7%26spage%3D377%26epage%3D387%26doi%3D10.1007%2Fs11307-005-0016-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorpe, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westlund, K. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kochersperger, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abell, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denney, R. M.</span></span> <span> </span><span class="NLM_article-title">Immunocytochemical Localization of Monoamine Oxidases A and B in Human Peripheral Tissues and Brain</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.1177/35.1.3025289</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1177%2F35.1.3025289" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=3025289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADyaL2sXmsVOitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1987&pages=23-32&author=L.+W.+Thorpeauthor=K.+N.+Westlundauthor=L.+M.+Kocherspergerauthor=C.+W.+Abellauthor=R.+M.+Denney&title=Immunocytochemical+Localization+of+Monoamine+Oxidases+A+and+B+in+Human+Peripheral+Tissues+and+Brain&doi=10.1177%2F35.1.3025289"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain</span></div><div class="casAuthors">Thorpe, Larry W.; Westlund, Karin N.; Kochersperger, Lynn M.; Abell, C. W.; Denney, Richard M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-32</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    </div><div class="casAbstract">Monoclonal antibodies specific for human MAO (EC 1.4.3.4) A or B and immunocytochem. techniques were used to visualize the resp. enzymes in human placenta, platelets, lymphocytes, liver, brain, and a human hepatoma cell line.  MAO A was obsd. in the syncytiotrophoblast layer of term placenta, liver, and a subset of neurons in brain, but was not obsd. in platelets or lymphocytes, which are known to lack type A enzyme.  MAO B was obsd. in platelets, lymphocytes, and liver but not in placenta, which contains little or no MAO B.  MAO B was also obsd. in a subset of neurons in the brain that was distinct from that which contained MAO A.  MAO A and B were also obsd. in some glia.  Unlike most tissues examd., liver cells appeared to contain both forms of the enzyme.  Thus, MAO A and B can be specifically visualized by immunocytochem. means in a variety of human cells and tissues and can provide a graphic demonstration of the high degree of cell specificity of expression of the 2 forms of the enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqILpKOR_oeJrVg90H21EOLACvtfcHk0li6ZUZpMwZ7Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmsVOitA%253D%253D&md5=602ceb3af2043ba50686e2f1236f93dd</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1177%2F35.1.3025289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F35.1.3025289%26sid%3Dliteratum%253Aachs%26aulast%3DThorpe%26aufirst%3DL.%2BW.%26aulast%3DWestlund%26aufirst%3DK.%2BN.%26aulast%3DKochersperger%26aufirst%3DL.%2BM.%26aulast%3DAbell%26aufirst%3DC.%2BW.%26aulast%3DDenney%26aufirst%3DR.%2BM.%26atitle%3DImmunocytochemical%2520Localization%2520of%2520Monoamine%2520Oxidases%2520A%2520and%2520B%2520in%2520Human%2520Peripheral%2520Tissues%2520and%2520Brain%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D1987%26volume%3D35%26spage%3D23%26epage%3D32%26doi%3D10.1177%2F35.1.3025289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Billett, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finch, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahy, N.</span></span> <span> </span><span class="NLM_article-title">Cellular Localization of Monoamine Oxidase A and B in Human Tissues Outside of the Central Nervous System</span>. <i>Cell Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>304</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1007/s004410100361</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2Fs004410100361" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=11396715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjtVGktLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2001&pages=215-220&author=M.+J.+Rodriguezauthor=J.+Sauraauthor=E.+E.+Billettauthor=C.+C.+Finchauthor=N.+Mahy&title=Cellular+Localization+of+Monoamine+Oxidase+A+and+B+in+Human+Tissues+Outside+of+the+Central+Nervous+System&doi=10.1007%2Fs004410100361"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cellular localization of monoamine oxidase A and B in human tissues outside of the central nervous system</span></div><div class="casAuthors">Rodriguez, Manuel J.; Saura, Josep; Billett, Ellen E.; Finch, Cheryl C.; Mahy, Nicole</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">304</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">The localization of monoamine oxidase (MAO) A and B in human heart, liver, duodenum, blood vessels, and kidney was studied by immunohistochem.  The primary antibodies used were mouse monoclonal anti-human MAO-A (6G11/E1) and anti-human MAO-B (3F12/G10/2E3).  Samples were obtained from 6 routine autopsy cases and fixed in 2% paraformaldehyde.  All cardiomyocytes and hepatocytes showed MAO-A and MAO-B immunoreactivity.  In the duodenum, both immunoreactivities were present in all cells of the villi, Lieberkuhn crypts, muscularis mucosae and muscular layers, whereas Brunner glands were devoid of MAO-A and MAO-B staining.  Endothelial cells of lymphatic vessels showed MAO-A but no MAO-B immunoreactivity, whereas arteries and veins presented MAO-A and MAO-B staining in muscular layers and fibroblasts but not in endothelial cells.  In the kidney, renal tubuli showed MAO-A and MAO-B immunoreactivities, whereas collecting ducts and the Bowman's capsule showed only MAO-A staining.  These data represent the 1st study of the cellular distribution of MAO-A and MAO-B in these human tissues.  They show that both enzymes have a widespread distribution in the human body with a matching pattern in many, but not all tissues, and with strong differences from the pattern of distribution in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3DYJ3BfMhFbVg90H21EOLACvtfcHk0li6ZUZpMwZ7Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjtVGktLw%253D&md5=e34f859c3cfb925e147c361ba3e3b495</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs004410100361&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs004410100361%26sid%3Dliteratum%253Aachs%26aulast%3DRodriguez%26aufirst%3DM.%2BJ.%26aulast%3DSaura%26aufirst%3DJ.%26aulast%3DBillett%26aufirst%3DE.%2BE.%26aulast%3DFinch%26aufirst%3DC.%2BC.%26aulast%3DMahy%26aufirst%3DN.%26atitle%3DCellular%2520Localization%2520of%2520Monoamine%2520Oxidase%2520A%2520and%2520B%2520in%2520Human%2520Tissues%2520Outside%2520of%2520the%2520Central%2520Nervous%2520System%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2001%26volume%3D304%26spage%3D215%26epage%3D220%26doi%3D10.1007%2Fs004410100361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzer, J. P.</span></span> <span> </span><span class="NLM_article-title">MAO Inhibitors and Their Wider Applications: A Patent Review</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">226</span>, <span class="refDoi"> DOI: 10.1080/13543776.2018.1427735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1080%2F13543776.2018.1427735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=29324067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFGmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=211-226&author=S.+Carradoriauthor=D.+Secciauthor=J.+P.+Petzer&title=MAO+Inhibitors+and+Their+Wider+Applications%3A+A+Patent+Review&doi=10.1080%2F13543776.2018.1427735"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">MAO inhibitors and their wider applications: a patent review</span></div><div class="casAuthors">Carradori, Simone; Secci, Daniela; Petzer, Jacques P.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">211-226</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Monoamine oxidase (MAO) inhibitors, after the initial 'golden age', are currently used as third-line antidepressants (selective MAO-A inhibitors) or clin. enrolled as co-adjuvants for neurodegenerative diseases (selective MAO-B inhibitors).  However, the research within this field is always increasing due to their pivotal role in modulating synaptic functions and monoamines metab.: In this paper, MAO inhibitors (2015-2017) are disclosed ordering all the patents according to their chem. scaffold.  Structure-activity relationships (SARs) are extrapolated for the most investigated chemotypes (coumarins, pyrazole/oxazepinones, (hetero)arylamides). 108 Compds. are divided into two main groups: newly synthesized mols. and naturally-occurring metabolites.  Finally, new therapeutic options are outlined to ensure a more complete view on the potential of these inhibitors.: New proposed MAO inhibitors are endowed with a marked isoform selectivity, with innovative therapeutic potential toward other targets (gliomas, inflammation, muscle dystrophies, migraine, chronic pain, pseudobulbar affect), and with a promising ability to address multi-faceted pathologies such as Alzheimer's disease.  The increasing no. of patents is analyzed collecting data from 2002 to 2017.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP5v4KQmzIhLVg90H21EOLACvtfcHk0liRNI353WWotw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFGmt74%253D&md5=2f47a3d4054d6e12bba77d34da51ebc4</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1080%2F13543776.2018.1427735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F13543776.2018.1427735%26sid%3Dliteratum%253Aachs%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DPetzer%26aufirst%3DJ.%2BP.%26atitle%3DMAO%2520Inhibitors%2520and%2520Their%2520Wider%2520Applications%253A%2520A%2520Patent%2520Review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2018%26volume%3D28%26spage%3D211%26epage%3D226%26doi%3D10.1080%2F13543776.2018.1427735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lieb, J.</span></span> <span> </span><span class="NLM_article-title">Remission of Rheumatoid Arthritis and Other Disorders of Immunity in Patients Taking Monoamine Oxidase Inhibitors</span>. <i>Int. J. Immunopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/0192-0561(83)90039-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2F0192-0561%2883%2990039-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=6629596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A280%3ADyaL2c%252FjtFajsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1983&pages=353-357&author=J.+Lieb&title=Remission+of+Rheumatoid+Arthritis+and+Other+Disorders+of+Immunity+in+Patients+Taking+Monoamine+Oxidase+Inhibitors&doi=10.1016%2F0192-0561%2883%2990039-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Remission of rheumatoid arthritis and other disorders of immunity in patients taking monoamine oxidase inhibitors</span></div><div class="casAuthors">Lieb J</div><div class="citationInfo"><span class="NLM_cas:title">International journal of immunopharmacology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-7</span>
        ISSN:<span class="NLM_cas:issn">0192-0561</span>.
    </div><div class="casAbstract">Elevated levels of prostaglandin E2 (PGE2) play an important role in rheumatoid arthritis and other disorders of immunity.  By inhibiting the release of arachidonic acid from cells, monoamine oxidase inhibitors (MAOI's) inhibit PGE2 synthesis.  MAOI's appear to be capable of remitting the symptoms of rheumatoid arthritis and may have the potential to arrest it.  MAOI's also appear to be effective in other disturbances of immunity in which excessive synthesis of PGE2 plays a role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSiNBSRUNnIcoHWj6b1v8uTfW6udTcc2eZCeO7ytDyHK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c%252FjtFajsg%253D%253D&md5=e70ca4927fed1cb6a2014407258d4eb7</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F0192-0561%2883%2990039-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0192-0561%252883%252990039-5%26sid%3Dliteratum%253Aachs%26aulast%3DLieb%26aufirst%3DJ.%26atitle%3DRemission%2520of%2520Rheumatoid%2520Arthritis%2520and%2520Other%2520Disorders%2520of%2520Immunity%2520in%2520Patients%2520Taking%2520Monoamine%2520Oxidase%2520Inhibitors%26jtitle%3DInt.%2520J.%2520Immunopharmacol.%26date%3D1983%26volume%3D5%26spage%3D353%26epage%3D357%26doi%3D10.1016%2F0192-0561%2883%2990039-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kast, R. E.</span></span> <span> </span><span class="NLM_article-title">Crohn’s Disease Remission with Phenelzine Treatment</span>. <i>Gastroenterology</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">1034</span>– <span class="NLM_lpage">1035</span>, <span class="refDoi"> DOI: 10.1016/S0016-5085(98)70292-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2FS0016-5085%2898%2970292-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=1998&pages=1034-1035&author=R.+E.+Kast&title=Crohn%E2%80%99s+Disease+Remission+with+Phenelzine+Treatment&doi=10.1016%2FS0016-5085%2898%2970292-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0016-5085%2898%2970292-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5085%252898%252970292-6%26sid%3Dliteratum%253Aachs%26aulast%3DKast%26aufirst%3DR.%2BE.%26atitle%3DCrohn%25E2%2580%2599s%2520Disease%2520Remission%2520with%2520Phenelzine%2520Treatment%26jtitle%3DGastroenterology%26date%3D1998%26volume%3D115%26spage%3D1034%26epage%3D1035%26doi%3D10.1016%2FS0016-5085%2898%2970292-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaludercic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagayama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivakumaran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedja, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Mario, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabrielson, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsey, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacak, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Lisa, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paolocci, N.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase B Prompts Mitochondrial and Cardiac Dysfunction in Pressure Overloaded Hearts</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">280</span>, <span class="refDoi"> DOI: 10.1089/ars.2012.4616</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1089%2Fars.2012.4616" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=23581564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislOrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=267-280&author=N.+Kaludercicauthor=A.+Carpiauthor=T.+Nagayamaauthor=V.+Sivakumaranauthor=G.+Zhuauthor=E.+W.+Laiauthor=D.+Bedjaauthor=A.+De+Marioauthor=K.+Chenauthor=K.+L.+Gabrielsonauthor=M.+L.+Lindseyauthor=K.+Pacakauthor=E.+Takimotoauthor=J.+C.+Shihauthor=D.+A.+Kassauthor=F.+Di+Lisaauthor=N.+Paolocci&title=Monoamine+Oxidase+B+Prompts+Mitochondrial+and+Cardiac+Dysfunction+in+Pressure+Overloaded+Hearts&doi=10.1089%2Fars.2012.4616"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Monoamine Oxidase B Prompts Mitochondrial and Cardiac Dysfunction in Pressure Overloaded Hearts</span></div><div class="casAuthors">Kaludercic, Nina; Carpi, Andrea; Nagayama, Takahiro; Sivakumaran, Vidhya; Zhu, Guangshuo; Lai, Edwin W.; Bedja, Djahida; De Mario, Agnese; Chen, Kevin; Gabrielson, Kathleen L.; Lindsey, Merry L.; Pacak, Karel; Takimoto, Eiki; Shih, Jean C.; Kass, David A.; Di Lisa, Fabio; Paolocci, Nazareno</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-280</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: Monoamine oxidases (MAOs) are mitochondrial flavoenzymes responsible for neurotransmitter and biogenic amines catabolism.  MAO-A contributes to heart failure progression via enhanced norepinephrine catabolism and oxidative stress.  The potential pathogenetic role of the isoenzyme MAO-B in cardiac diseases is currently unknown.  Moreover, it is has not been detd. yet whether MAO activation can directly affect mitochondrial function.  Results: In wild type mice, pressure overload induced by transverse aortic constriction (TAC) resulted in enhanced dopamine catabolism, left ventricular (LV) remodeling, and dysfunction.  Conversely, mice lacking MAO-B (MAO-B-/-) subjected to TAC maintained concentric hypertrophy accompanied by extracellular signal regulated kinase (ERK)1/2 activation, and preserved LV function, both at early (3 wk) and late stages (9 wk).  Enhanced MAO activation triggered oxidative stress, and dropped mitochondrial membrane potential in the presence of ATP synthase inhibitor oligomycin both in neonatal and adult cardiomyocytes.  The MAO-B inhibitor pargyline completely offset this change, suggesting that MAO activation induces a latent mitochondrial dysfunction, causing these organelles to hydrolyze ATP.  Moreover, MAO-dependent aldehyde formation due to inhibition of aldehyde dehydrogenase 2 activity also contributed to alter mitochondrial bioenergetics.  Innovation: Our study unravels a novel role for MAO-B in the pathogenesis of heart failure, showing that both MAO-driven reactive oxygen species prodn. and impaired aldehyde metab. affect mitochondrial function.  Conclusion: Under conditions of chronic hemodynamic stress, enhanced MAO-B activity is a major determinant of cardiac structural and functional disarrangement.  Both increased oxidative stress and the accumulation of aldehyde intermediates are likely liable for these adverse morphol. and mech. changes by directly targeting mitochondria.  Antioxid. Redox Signal. 20, 267-280.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3JiMLBoVkHLVg90H21EOLACvtfcHk0ljRbuTOUXtv6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislOrsg%253D%253D&md5=c4291634416e80c5daa1b0f18f8bc6ae</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1089%2Fars.2012.4616&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2012.4616%26sid%3Dliteratum%253Aachs%26aulast%3DKaludercic%26aufirst%3DN.%26aulast%3DCarpi%26aufirst%3DA.%26aulast%3DNagayama%26aufirst%3DT.%26aulast%3DSivakumaran%26aufirst%3DV.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DLai%26aufirst%3DE.%2BW.%26aulast%3DBedja%26aufirst%3DD.%26aulast%3DDe%2BMario%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DK.%2BL.%26aulast%3DLindsey%26aufirst%3DM.%2BL.%26aulast%3DPacak%26aufirst%3DK.%26aulast%3DTakimoto%26aufirst%3DE.%26aulast%3DShih%26aufirst%3DJ.%2BC.%26aulast%3DKass%26aufirst%3DD.%2BA.%26aulast%3DDi%2BLisa%26aufirst%3DF.%26aulast%3DPaolocci%26aufirst%3DN.%26atitle%3DMonoamine%2520Oxidase%2520B%2520Prompts%2520Mitochondrial%2520and%2520Cardiac%2520Dysfunction%2520in%2520Pressure%2520Overloaded%2520Hearts%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D20%26spage%3D267%26epage%3D280%26doi%3D10.1089%2Fars.2012.4616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shim, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ro, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho-Chung, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M. K.</span></span> <span> </span><span class="NLM_article-title">Gene Expression Profiling of Oxidative Stress on Atrial Fibrillation in Humans</span>. <i>Exp. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">336</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1038/emm.2003.45</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1038%2Femm.2003.45" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=14646586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpsFClur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=336-349&author=Y.+H.+Kimauthor=D.+S.+Limauthor=J.+H.+Leeauthor=W.+J.+Shimauthor=Y.+M.+Roauthor=G.+H.+Parkauthor=K.+G.+Beckerauthor=Y.+S.+Cho-Chungauthor=M.+K.+Kim&title=Gene+Expression+Profiling+of+Oxidative+Stress+on+Atrial+Fibrillation+in+Humans&doi=10.1038%2Femm.2003.45"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression profiling of oxidative stress on atrial fibrillation in humans</span></div><div class="casAuthors">Kim, Young Hoon; Lee, Ji Hye; Lim, Do Sun; Shim, Wan Joo; Ro, Young Moo; Park, Gil Hong; Becker, Kevin G.; Cho-chung, Yoon S.; Kim, Meyoung-kon</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Molecular Medicine</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">336-349</span>CODEN:
                <span class="NLM_cas:coden">EMMEF3</span>;
        ISSN:<span class="NLM_cas:issn">1226-3613</span>.
    
            (<span class="NLM_cas:orgname">Korean Society of Medical Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Atrial Fibrillation (AF) is thought be caused by oxidative stress.  Oxidative stress at the cellular level results from many factors, including exposure to alc., medications, cold, toxins or radiation.  In this study the authors investigated gene transcriptional profiles on the human myocardial tissues from AF and oxidative stress conditions.  Right atrial appendages were obtained from AF patients (n = 26) undergoing the Maze procedure, and from control patients (n = 26) who were in normal sinus rhythm and undergoing coronary artery bypass graft operation.  To examine the effects of oxidative stress on AF, the authors used radioactive complementary DNA (cDNA) microarrays to evaluate changes in the expression of 1,152 known genes.  This technol., which monitors thousands of genes simultaneously, gives us a better picture of the interactions between AF and oxidative stress.  Total RNAs prepd. from the retrieved tissues were used to synthesize 33P-labeled cDNAs by reverse transcription and hybridized to cDNA microarrays.  Gene expression profiles showed that 30 genes were upregulated and 25 were downregulated in AF patients compared with control patients.  Moreover, comparison rank anal. revealed that the expression of 5 genes related to reactive oxygen species (ROS)-including flavin contg. monooxygenase 1, monoamine oxidase B, ubiquitin specific protease 8, tyrosinase-related protein 1, and tyrosine 3-monooxygenase-increased by more than 2.0 of the Z-ratio, and 2 genes related to antioxidants including glutathione peroxidase 1, and heme oxygenase 2-decreased to the Z-ratio levels of ≤ -2.0.  Apparently, a balanced regulation of pro- and anti-oxidn. can be shifted toward pro-oxidn. and can result in serious damage similar to that of human AF.  Western blotting anal. confirmed the upregulation of tyrosinase-related protein 1 and tyrosine 3-monooxygenase and the downregulation of heme oxygenase 2.  These results suggested that the gene expression pattern of myocardial tissues in AF patients can be assocd. with oxidative stress, resulting in a significant increase in ROS.  Thus, the cDNA microarray technique was useful for investigating transcription profiles in AF.  It showed that the intracellular mechanism of oxidative stress plays a pivotal role in the pathol. progression of AF and offers novel insight into potential treatment with antioxidants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ2oTbhKFiRbVg90H21EOLACvtfcHk0ljRbuTOUXtv6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpsFClur4%253D&md5=fb74215d8196cc7d97dc3ed7cddb4e24</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Femm.2003.45&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femm.2003.45%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BH.%26aulast%3DLim%26aufirst%3DD.%2BS.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DShim%26aufirst%3DW.%2BJ.%26aulast%3DRo%26aufirst%3DY.%2BM.%26aulast%3DPark%26aufirst%3DG.%2BH.%26aulast%3DBecker%26aufirst%3DK.%2BG.%26aulast%3DCho-Chung%26aufirst%3DY.%2BS.%26aulast%3DKim%26aufirst%3DM.%2BK.%26atitle%3DGene%2520Expression%2520Profiling%2520of%2520Oxidative%2520Stress%2520on%2520Atrial%2520Fibrillation%2520in%2520Humans%26jtitle%3DExp.%2520Mol.%2520Med.%26date%3D2003%26volume%3D35%26spage%3D336%26epage%3D349%26doi%3D10.1038%2Femm.2003.45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deshwal, S.</span>; <span class="NLM_string-name">Forkink, M.</span>; <span class="NLM_string-name">Hu, C. H.</span>; <span class="NLM_string-name">Buonincontri, G.</span>; <span class="NLM_string-name">Antonucci, S.</span>; <span class="NLM_string-name">Di Sante, M.</span>; <span class="NLM_string-name">Murphy, M. P.</span>; <span class="NLM_string-name">Paolocci, N.</span>; <span class="NLM_string-name">Mochly-Rosen, D.</span>; <span class="NLM_string-name">Krieg, T.</span>; <span class="NLM_string-name">Di
Lisa, F.</span>; <span class="NLM_string-name">Kaludercic, N.</span></span> <span> </span><span class="NLM_article-title">Monoamine Oxidase-Dependent Endoplasmic Reticulum-Mitochondria Dysfunction and Mast Cell Degranulation Lead to Adverse Cardiac Remodeling in Diabetes</span>.  <i>Cell Death Differ.</i> <span class="NLM_year" style="font-weight: bold;">2018</span><span class="refDoi"> DOI: 10.1038/s41418-018-0071-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1038%2Fs41418-018-0071-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=29459772" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=S.+Deshwal&author=M.+Forkink&author=C.+H.+Hu&author=G.+Buonincontri&author=S.+Antonucci&author=M.+Di+Sante&author=M.+P.+Murphy&author=N.+Paolocci&author=D.+Mochly-Rosen&author=T.+Krieg&author=F.+Di%0ALisa&author=N.+Kaludercic&title=Monoamine+Oxidase-Dependent+Endoplasmic+Reticulum-Mitochondria+Dysfunction+and+Mast+Cell+Degranulation+Lead+to+Adverse+Cardiac+Remodeling+in+Diabetes&doi=10.1038%2Fs41418-018-0071-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fs41418-018-0071-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41418-018-0071-1%26sid%3Dliteratum%253Aachs%26aulast%3DDeshwal%26aufirst%3DS.%26atitle%3DMonoamine%2520Oxidase-Dependent%2520Endoplasmic%2520Reticulum-Mitochondria%2520Dysfunction%2520and%2520Mast%2520Cell%2520Degranulation%2520Lead%2520to%2520Adverse%2520Cardiac%2520Remodeling%2520in%2520Diabetes%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2018%26doi%3D10.1038%2Fs41418-018-0071-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ekuni, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firth, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomofuji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanbe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vielkind, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putnins, E. E.</span></span> <span> </span><span class="NLM_article-title">Lipopolysaccharide-Induced Epithelial Monoamine Oxidase Mediates Alveolar Bone Loss in a Rat Chronic Wound Model</span>. <i>Am. J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>175</i></span>,  <span class="NLM_fpage">1398</span>– <span class="NLM_lpage">1409</span>, <span class="refDoi"> DOI: 10.2353/ajpath.2009.090108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.2353%2Fajpath.2009.090108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=19779138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlWitbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2009&pages=1398-1409&author=D.+Ekuniauthor=J.+D.+Firthauthor=T.+Nayerauthor=T.+Tomofujiauthor=T.+Sanbeauthor=K.+Irieauthor=T.+Yamamotoauthor=T.+Okaauthor=Z.+Liuauthor=J.+Vielkindauthor=E.+E.+Putnins&title=Lipopolysaccharide-Induced+Epithelial+Monoamine+Oxidase+Mediates+Alveolar+Bone+Loss+in+a+Rat+Chronic+Wound+Model&doi=10.2353%2Fajpath.2009.090108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Lipopolysaccharide-induced epithelial monoamine oxidase mediates alveolar bone loss in a rat chronic wound model</span></div><div class="casAuthors">Ekuni, Disuke; Firth, James D.; Nayer, Tarun; Tomofuji, Takaaki; Sanbe, Toshihiro; Irie, Koichiro; Yamamoto, Tatsuo; Oka, Takashi; Liu, Zhenzi; Vielkind, Juergen; Putnins, Edward E.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">175</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1398-1409</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) prodn. is an antimicrobial response to pathogenic challenge that may, in the case of persistent infection, have deleterious effects on the tissue of origin.  A rat periodontal disease model was used to study ROS-induced chronic epithelial inflammation and bone loss.  Lipopolysaccharide (LPS) was applied for 8 wk into the gingival sulcus, and histol. anal. confirmed the onset of chronic disease.  Junctional epithelium was collected from healthy and diseased animals using laser-capture microdissection, and expression microarray anal. was performed.  Of 19,730 genes changed in disease, 42 were up-regulated ≥4-fold.  Three of the top 10 LPS-induced genes, monoamine oxidase B (MAO/B) and flavin-contg. monooxygenase 1 and 2, are implicated in ROS signaling.  LPS-assocd. induction of the ROS mediator H2O2, as well as MAO/B and tumor necrosis factor (TNF)-α levels were validated in the rat histol. sections and a porcine junctional epithelial cell culture model.  Topical MAO inhibitors significantly counteracted LPS-assocd. elevation of H2O2 prodn. and TNF-α expression in vivo and in vitro, inhibited disease-assocd. apical migration and proliferation of junctional epithelium and inhibited induced systemic H2O2 levels and alveolar bone loss in vivo.  These results suggest that LPS induces chronic wounds via elevated MAO/B-mediated increases in H2O2 and TNF-α activity by epithelial cells and is further assocd. with more distant effects on systemic oxidative stress and alveolar bone loss.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTzbboCkF0U7Vg90H21EOLACvtfcHk0lg_VkuRRMEvHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlWitbfF&md5=dd025c4b38a43534fba6434bdb17322a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2009.090108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2009.090108%26sid%3Dliteratum%253Aachs%26aulast%3DEkuni%26aufirst%3DD.%26aulast%3DFirth%26aufirst%3DJ.%2BD.%26aulast%3DNayer%26aufirst%3DT.%26aulast%3DTomofuji%26aufirst%3DT.%26aulast%3DSanbe%26aufirst%3DT.%26aulast%3DIrie%26aufirst%3DK.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DVielkind%26aufirst%3DJ.%26aulast%3DPutnins%26aufirst%3DE.%2BE.%26atitle%3DLipopolysaccharide-Induced%2520Epithelial%2520Monoamine%2520Oxidase%2520Mediates%2520Alveolar%2520Bone%2520Loss%2520in%2520a%2520Rat%2520Chronic%2520Wound%2520Model%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2009%26volume%3D175%26spage%3D1398%26epage%3D1409%26doi%3D10.2353%2Fajpath.2009.090108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, J. C.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Monoamine Oxidase-B by Selegiline Reduces Cigarette Smoke-Induced Oxidative Stress and Inflammation in Airway Epithelial Cells</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>268</i></span>,  <span class="NLM_fpage">44</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2017.01.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2Fj.toxlet.2017.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=28108387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVekt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=268&publication_year=2017&pages=44-50&author=Y.+Cuiauthor=K.+W.+Liuauthor=Y.+Liangauthor=M.+S.+Ipauthor=J.+C.+Mak&title=Inhibition+of+Monoamine+Oxidase-B+by+Selegiline+Reduces+Cigarette+Smoke-Induced+Oxidative+Stress+and+Inflammation+in+Airway+Epithelial+Cells&doi=10.1016%2Fj.toxlet.2017.01.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase-B by selegiline reduces cigarette smoke-induced oxidative stress and inflammation in airway epithelial cells</span></div><div class="casAuthors">Cui, Yuting; Liu, Kenneth W. K.; Liang, Yingmin; Ip, Mary S. M.; Mak, Judith C. W.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">268</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44-50</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Chronic obstructive pulmonary disease (COPD) is caused by the build-up of oxidative stress-induced damages due to cigarette smoking, but how monoamine oxidase (MAO)-B signaling is involved remains unclear.  This study aims to establish the involvement of MAO-B signaling pathways in cigarette smoke medium (CSM)-induced oxidative stress and inflammation in human airway epithelial cells (AECs).  CSM treatment increased MAO-B activity, ROS levels and IL-8 release in AECs.  Pretreatment with MAO-B selective inhibitor selegiline reversed the CSM-induced changes in MAO-B activity, ROS levels and IL-8 release in a dose-dependent manner.  Selegiline also reversed CSM-induced changes of anti-oxidant enzymes superoxide dismutase (SOD) and catalase (CAT) activities, GSH/GSSG ratio, as well expression of heme oxygenase-1 (HO-1) and NAD(P)H quinone dehydrogenase 1 (NQO1).  The effects of selegiline are partially driven through the nuclear factor erythroid 2 related factor 2 (Nrf2) and cytosol translocation of its neg. regulator, BTB and CNC homolog 1 (Bach1).  Nevertheless, selegiline fully reversed the CSM-induced effects on IKK, cytoplasmic IκB expression, and nuclear translocation of nuclear factor-κB (NF-κB) p65 subunit.  The authors' study demonstrated that in AECs, inhibition of MAO-B using selegiline reversed the CSM-induced oxidative stress and inflammation.  These data may provide a novel strategy for therapy in COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4_Gu22VmFmrVg90H21EOLACvtfcHk0lg_VkuRRMEvHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVekt7Y%253D&md5=f0143dbab6ee8e92e575c1be945f48e3</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2017.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2017.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DK.%2BW.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DIp%26aufirst%3DM.%2BS.%26aulast%3DMak%26aufirst%3DJ.%2BC.%26atitle%3DInhibition%2520of%2520Monoamine%2520Oxidase-B%2520by%2520Selegiline%2520Reduces%2520Cigarette%2520Smoke-Induced%2520Oxidative%2520Stress%2520and%2520Inflammation%2520in%2520Airway%2520Epithelial%2520Cells%26jtitle%3DToxicol.%2520Lett.%26date%3D2017%26volume%3D268%26spage%3D44%26epage%3D50%26doi%3D10.1016%2Fj.toxlet.2017.01.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenis, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosmans, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jongh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scharpe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, M.</span></span> <span> </span><span class="NLM_article-title">The In Vitro Immunosuppressive Effects of Moclobemide in Healthy Volunteers</span>. <i>J. Affective Disord.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">69</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.1016/S0165-0327(99)00076-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2FS0165-0327%2899%2900076-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10760560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A280%3ADC%252BD3c3isFyitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=69-74&author=A.+Linauthor=C.+Songauthor=G.+Kenisauthor=E.+Bosmansauthor=R.+De+Jonghauthor=S.+Scharpeauthor=M.+Maes&title=The+In+Vitro+Immunosuppressive+Effects+of+Moclobemide+in+Healthy+Volunteers&doi=10.1016%2FS0165-0327%2899%2900076-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">The in vitro immunosuppressive effects of moclobemide in healthy volunteers</span></div><div class="casAuthors">Lin A; Song C; Kenis G; Bosmans E; De Jongh R; Scharpe S; Maes M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of affective disorders</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-74</span>
        ISSN:<span class="NLM_cas:issn">0165-0327</span>.
    </div><div class="casAbstract">BACKGROUND:  Many studies have demonstrated that major depression is related to an activation of the inflammatory response system (IRS) with an increased production of proinflammatory cytokines.  It has been shown that tricyclic antidepressants and serotonin reuptake inhibitors suppress the activation of the IRS in depression and have negative immunoregulatory effects in vitro.  Little is known on the immune effects of moclobemide, a reversible monoamine oxidase A inhibitor.  METHODS:  We examined, in nine normal volunteers, the in vitro effects of moclobemide on the production of interleukin-6 (IL-6), IL-8, tumor necrosis factor-alpha (TNFalpha), interferon-gamma (IFNgamma), IL-10 and the IL-1 receptor antagonist (IL-1RA) by diluted whole blood stimulated or not with lipopolysaccharide (LPS)+phytohemagglutinin (PHA).  RESULTS:  Moclobemide 10(-3) and 10(-5) M significantly suppressed the unstimulated production of TNFalpha and IL-8, and significantly enhanced the stimulated-production of IL-10.  The production of IL-6, IL-1RA and IFNgamma was not significantly affected either in the unstimulated or stimulated conditions.  CONCLUSIONS:  Moclobemide has negative immunoregulatory capacities through inhibition of the production of proinflammatory cytokines, i.e.  TNFalpha and IL-8, and through enhancement of the production of IL-10, an anti-inflammatory cytokine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSO_KITbD42TA20zIbnCCI3fW6udTcc2ebTQ87rihw5cbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c3isFyitg%253D%253D&md5=8354c336c83db55f3825235dfb0f3b89</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0165-0327%2899%2900076-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0327%252899%252900076-2%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DC.%26aulast%3DKenis%26aufirst%3DG.%26aulast%3DBosmans%26aufirst%3DE.%26aulast%3DDe%2BJongh%26aufirst%3DR.%26aulast%3DScharpe%26aufirst%3DS.%26aulast%3DMaes%26aufirst%3DM.%26atitle%3DThe%2520In%2520Vitro%2520Immunosuppressive%2520Effects%2520of%2520Moclobemide%2520in%2520Healthy%2520Volunteers%26jtitle%3DJ.%2520Affective%2520Disord.%26date%3D2000%26volume%3D58%26spage%3D69%26epage%3D74%26doi%3D10.1016%2FS0165-0327%2899%2900076-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bielecka, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul-Samojedny, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obuchowicz, E.</span></span> <span> </span><span class="NLM_article-title">Moclobemide Exerts Anti-Inflammatory Effect in Lipopolysaccharide-Activated Primary Mixed Glial Cell Culture</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>382</i></span>,  <span class="NLM_fpage">409</span>– <span class="NLM_lpage">417</span>, <span class="refDoi"> DOI: 10.1007/s00210-010-0535-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2Fs00210-010-0535-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=20811738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVKkt7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2010&pages=409-417&author=A.+M.+Bieleckaauthor=M.+Paul-Samojednyauthor=E.+Obuchowicz&title=Moclobemide+Exerts+Anti-Inflammatory+Effect+in+Lipopolysaccharide-Activated+Primary+Mixed+Glial+Cell+Culture&doi=10.1007%2Fs00210-010-0535-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Moclobemide exerts anti-inflammatory effect in lipopolysaccharide-activated primary mixed glial cell culture</span></div><div class="casAuthors">Bielecka, A. M.; Paul-Samojedny, M.; Obuchowicz, E.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">5-6</span>),
    <span class="NLM_cas:pages">409-417</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">An increasing body of evidence indicates that glial activation and neuroinflammation play an important role in the pathogenesis of psychiatric and neurodegenerative diseases.  Activated glial cells secrete various cytokines that influence neurotransmission, hypothalamus-pituitary-adrenal axis activity, neuronal plasticity and neurogenesis.  It has been suggested that alterations in cytokine networks are involved in the mechanism of action of antidepressant drugs.  Until now, only a few studies demonstrated that some tricyclic antidepressants and selective serotonin reuptake inhibitors reduced prodn. of pro-inflammatory cytokines in brain glia cells.  We have investigated for the first time whether the antidepressant, moclobemide (a reversible selective inhibitor of monoamine oxidase-A) has an influence on pro-inflammatory cytokines [interleukin (IL)-1β and tumor necrosis factor (TNF)-α] and anti-inflammatory cytokine (IL-10) in primary rat mixed glial cell cultures stimulated by lipopolysaccharide (LPS).  Our results showed that moclobemide used in a wide range of concns. diminished LPS-stimulated IL-1β and TNF-α mRNAs expression in cellular exts. and remarkably reduced the levels of both pro-inflammatory cytokines in culture medium.  In opposite to this, the drug had no influence on IL-10 mRNA and slightly reduced IL-10 concn.  Moreover, moclobemide decreased LPS-stimulated translocation of NFκB p65 subunit into cellular nuclei.  These results suggest that moclobemide exerts anti-inflammatory effect in the central nervous system because it affects the balance between pro- and anti-inflammatory cytokines (IL-1β, TNF-α/IL-10) in primary mixed glial cell cultures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6ef6zCuUdXbVg90H21EOLACvtfcHk0lhMXSarW9gskw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVKkt7zE&md5=56c4f255a0fbe0c2bd0093535ec9407d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs00210-010-0535-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-010-0535-4%26sid%3Dliteratum%253Aachs%26aulast%3DBielecka%26aufirst%3DA.%2BM.%26aulast%3DPaul-Samojedny%26aufirst%3DM.%26aulast%3DObuchowicz%26aufirst%3DE.%26atitle%3DMoclobemide%2520Exerts%2520Anti-Inflammatory%2520Effect%2520in%2520Lipopolysaccharide-Activated%2520Primary%2520Mixed%2520Glial%2520Cell%2520Culture%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D2010%26volume%3D382%26spage%3D409%26epage%3D417%26doi%3D10.1007%2Fs00210-010-0535-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, M.</span></span> <span> </span><span class="NLM_article-title">The Serotonin Syndrome</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">1112</span>– <span class="NLM_lpage">1120</span>, <span class="refDoi"> DOI: 10.1056/NEJMra041867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1056%2FNEJMra041867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=15784664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD2MXit1OjsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2005&pages=1112-1120&author=E.+W.+Boyerauthor=M.+Shannon&title=The+Serotonin+Syndrome&doi=10.1056%2FNEJMra041867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonin syndrome</span></div><div class="casAuthors">Boyer, Edward W.; Shannon, Michael</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1112-1120</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">A review on definition and epidemiol. of the serotonin syndrome, manifestations of the serotonin syndrome from mild symptoms to life-threatening toxicity, pathophysiol. and mol. mechanisms, diagnosis, management, and prevention of the serotonin syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoZdpzQCyqkcrVg90H21EOLACvtfcHk0lhMXSarW9gskw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXit1OjsL8%253D&md5=f6e17de3cd031a3af2e007daaf2d12ed</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1056%2FNEJMra041867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra041867%26sid%3Dliteratum%253Aachs%26aulast%3DBoyer%26aufirst%3DE.%2BW.%26aulast%3DShannon%26aufirst%3DM.%26atitle%3DThe%2520Serotonin%2520Syndrome%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2005%26volume%3D352%26spage%3D1112%26epage%3D1120%26doi%3D10.1056%2FNEJMra041867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bainbridge, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, R. L.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruscin, J. M.</span></span> <span> </span><span class="NLM_article-title">Elucidating the Mechanism of Action and Potential Interactions of MAO-B Inhibitors</span>. <i>Neurol. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1016/j.ncl.2008.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2Fj.ncl.2008.05.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=85-96&author=J.+L.+Bainbridgeauthor=R.+L.+Pageauthor=J.+M.+Ruscin&title=Elucidating+the+Mechanism+of+Action+and+Potential+Interactions+of+MAO-B+Inhibitors&doi=10.1016%2Fj.ncl.2008.05.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ncl.2008.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ncl.2008.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DBainbridge%26aufirst%3DJ.%2BL.%26aulast%3DPage%26aufirst%3DR.%2BL.%26aulast%3DRuscin%26aufirst%3DJ.%2BM.%26atitle%3DElucidating%2520the%2520Mechanism%2520of%2520Action%2520and%2520Potential%2520Interactions%2520of%2520MAO-B%2520Inhibitors%26jtitle%3DNeurol.%2520Clin.%26date%3D2008%26volume%3D26%26spage%3D85%26epage%3D96%26doi%3D10.1016%2Fj.ncl.2008.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span> <span> </span><span class="NLM_article-title">Physicochemical, Pharmacological and Pharmacokinetic Properties of the Zwitterionic Antihistamines Cetirizine and Levocetirizine</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2173</span>– <span class="NLM_lpage">2191</span>, <span class="refDoi"> DOI: 10.2174/092986708785747625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.2174%2F092986708785747625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=18781943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVSrs7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=2173-2191&author=C.+Chen&title=Physicochemical%2C+Pharmacological+and+Pharmacokinetic+Properties+of+the+Zwitterionic+Antihistamines+Cetirizine+and+Levocetirizine&doi=10.2174%2F092986708785747625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical, pharmacological and pharmacokinetic properties of the zwitterionic antihistamines cetirizine and levocetirizine</span></div><div class="casAuthors">Chen, Chen</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2173-2191</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Cetirizine, marketed as a racemic mixt. contg. both levocetirizine and dextrocetirizine, is a member of the second generation H1 antihistamines clin. used for the treatment of symptoms assocd. with seasonal allergic rhinitis.  Recently, its single R-enantiomer levocetirizine has been approved by the FDA as the newest antihistamine.  Cetirizine is a piperazine deriv. related to the first generation H1 antagonist hydroxyzine, and is the major metabolite in the blood circulation after hydroxyzine administration in humans.  The acid functionality of cetirizine in combination with one of the basic nitrogens of piperazine ring makes this compd. a very unique zwitterion.  The mol. structure of cetirizine allows its carboxylic group to interact with the basic nitrogen via folded conformers, therefore, it possesses relatively high lipophilicity at physiol. pH (LogD = 1.5).  While both cetirizine and hydroxyzine possess high affinity at the H1 receptor, the R-configured levocetirizine has much slower dissocn. rate from the H1 receptor than R-hydroxyzine, making it an insurmountable antagonist.  In addn., the pharmacokinetics of cetirizine significantly differs from those of the basic and lipophilic hydroxyzine.  For example, cetirizine has much lower CNS penetration than hydroxyzine, which may be explained by the zwitterionic structure of cetirizine and its P-glycoprotein activity.  Cetirizine exhibits high intestinal absorption in humans and its oral bioavailability is estd. to be greater than 70%.  Very importantly, cetirizine, esp. levocetirizine, has a negligible interaction with the liver enzymes, and is mainly excreted in the urine as the parent despite its high plasma protein binding (88∼96%).  The recommended dose of levocetirizine is 5 mg once daily, while its pharmacokinetic half-life is about 7 h in humans.  This review will focus on the physicochem., pharmacol. and pharmacokinetic properties of cetirizine and levocetirizine in comparison with those of hydroxyzine.  The zwitterionic cetirizine displays distinct advantages over the basic hydroxyzine in several categories such as slow receptor dissocn. rate, high selectivity, negligible liver enzyme interaction and low CNS penetration.  Therefore, cetirizine, or its single isomer levocetirizine, might serve a good example for medicinal chemists to design zwitterionic drugs from a basic, acidic or neutral lead mol. for peripheral biol. targets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNUFT93tbtXrVg90H21EOLACvtfcHk0lhMXSarW9gskw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVSrs7fF&md5=40fa022542b0f0ab8e67e721ceac31ce</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F092986708785747625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986708785747625%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%26atitle%3DPhysicochemical%252C%2520Pharmacological%2520and%2520Pharmacokinetic%2520Properties%2520of%2520the%2520Zwitterionic%2520Antihistamines%2520Cetirizine%2520and%2520Levocetirizine%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2008%26volume%3D15%26spage%3D2173%26epage%3D2191%26doi%3D10.2174%2F092986708785747625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massingham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jonsson, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammarlund-Udenaes, M.</span></span> <span> </span><span class="NLM_article-title">Brain Distribution of Cetirizine Enantiomers: Comparison of Three Different Tissue-to-Plasma Partition Coefficients: K(p), K(p,u), and K(p,uu)</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">323</span>, <span class="refDoi"> DOI: 10.1124/dmd.105.007211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1124%2Fdmd.105.007211" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=318-323&author=A.+Guptaauthor=P.+Chatelainauthor=R.+Massinghamauthor=E.+N.+Jonssonauthor=M.+Hammarlund-Udenaes&title=Brain+Distribution+of+Cetirizine+Enantiomers%3A+Comparison+of+Three+Different+Tissue-to-Plasma+Partition+Coefficients%3A+K%28p%29%2C+K%28p%2Cu%29%2C+and+K%28p%2Cuu%29&doi=10.1124%2Fdmd.105.007211"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.007211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.007211%26sid%3Dliteratum%253Aachs%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DChatelain%26aufirst%3DP.%26aulast%3DMassingham%26aufirst%3DR.%26aulast%3DJonsson%26aufirst%3DE.%2BN.%26aulast%3DHammarlund-Udenaes%26aufirst%3DM.%26atitle%3DBrain%2520Distribution%2520of%2520Cetirizine%2520Enantiomers%253A%2520Comparison%2520of%2520Three%2520Different%2520Tissue-to-Plasma%2520Partition%2520Coefficients%253A%2520K%2528p%2529%252C%2520K%2528p%252Cu%2529%252C%2520and%2520K%2528p%252Cuu%2529%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D318%26epage%3D323%26doi%3D10.1124%2Fdmd.105.007211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pagliara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Testa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrupt, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jolliet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urien, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tillement, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rihoux, J. P.</span></span> <span> </span><span class="NLM_article-title">Molecular Properties and Pharmacokinetic Behavior of Cetirizine, a Zwitterionic H1-Receptor Antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">853</span>– <span class="NLM_lpage">863</span>, <span class="refDoi"> DOI: 10.1021/jm9704311</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9704311" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=853-863&author=A.+Pagliaraauthor=B.+Testaauthor=P.+A.+Carruptauthor=P.+Jollietauthor=C.+Morinauthor=D.+Morinauthor=S.+Urienauthor=J.+P.+Tillementauthor=J.+P.+Rihoux&title=Molecular+Properties+and+Pharmacokinetic+Behavior+of+Cetirizine%2C+a+Zwitterionic+H1-Receptor+Antagonist&doi=10.1021%2Fjm9704311"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm9704311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9704311%26sid%3Dliteratum%253Aachs%26aulast%3DPagliara%26aufirst%3DA.%26aulast%3DTesta%26aufirst%3DB.%26aulast%3DCarrupt%26aufirst%3DP.%2BA.%26aulast%3DJolliet%26aufirst%3DP.%26aulast%3DMorin%26aufirst%3DC.%26aulast%3DMorin%26aufirst%3DD.%26aulast%3DUrien%26aufirst%3DS.%26aulast%3DTillement%26aufirst%3DJ.%2BP.%26aulast%3DRihoux%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520Properties%2520and%2520Pharmacokinetic%2520Behavior%2520of%2520Cetirizine%252C%2520a%2520Zwitterionic%2520H1-Receptor%2520Antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D853%26epage%3D863%26doi%3D10.1021%2Fjm9704311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanni, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bridges, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollack, G. M.</span></span> <span> </span><span class="NLM_article-title">Fexofenadine Brain Exposure and the Influence of Blood-Brain Barrier P-Glycoprotein after Fexofenadine and Terfenadine Administration</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">535</span>, <span class="refDoi"> DOI: 10.1124/dmd.107.019893</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1124%2Fdmd.107.019893" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=529-535&author=R.+Zhaoauthor=J.+C.+Kalvassauthor=S.+B.+Yanniauthor=A.+S.+Bridgesauthor=G.+M.+Pollack&title=Fexofenadine+Brain+Exposure+and+the+Influence+of+Blood-Brain+Barrier+P-Glycoprotein+after+Fexofenadine+and+Terfenadine+Administration&doi=10.1124%2Fdmd.107.019893"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.019893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.019893%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26aulast%3DYanni%26aufirst%3DS.%2BB.%26aulast%3DBridges%26aufirst%3DA.%2BS.%26aulast%3DPollack%26aufirst%3DG.%2BM.%26atitle%3DFexofenadine%2520Brain%2520Exposure%2520and%2520the%2520Influence%2520of%2520Blood-Brain%2520Barrier%2520P-Glycoprotein%2520after%2520Fexofenadine%2520and%2520Terfenadine%2520Administration%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D529%26epage%3D535%26doi%3D10.1124%2Fdmd.107.019893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herzig, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sterling, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan Class</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">1767</span>– <span class="NLM_lpage">1774</span>, <span class="refDoi"> DOI: 10.1021/jm031087c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm031087c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1767-1774&author=C.+Bindaauthor=F.+Hubalekauthor=M.+Liauthor=Y.+Herzigauthor=J.+Sterlingauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Crystal+Structures+of+Monoamine+Oxidase+B+in+Complex+with+Four+Inhibitors+of+the+N-Propargylaminoindan+Class&doi=10.1021%2Fjm031087c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal Structures of Monoamine Oxidase B in Complex with Four Inhibitors of the N-Propargylaminoindan Class</span></div><div class="casAuthors">Binda, Claudia; Hubalek, Frantisek; Li, Min; Herzig, Yaacov; Sterling, Jeffrey; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1767-1774</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO B) is an outer mitochondrial membrane enzyme that catalyzes the oxidn. of arylalkylamine neurotransmitters.  The crystal structures of MAO B in complex with four of the N-propargylaminoindan class of MAO covalent inhibitors (rasagiline, N-propargyl-1(S)-aminoindan, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan) have been detd. at a resoln. of better than 2.1 Å.  Rasagiline, 6-hydroxy-N-propargyl-1(R)-aminoindan, and N-methyl-N-propargyl-1(R)-aminoindan adopt essentially the same conformation with the extended propargyl chain covalently bound to the flavin and the indan ring located in the rear of the substrate cavity.  N-Propargyl-1(S)-aminoindan binds with the indan ring in a flipped conformation with respect to the other inhibitors, which causes a slight movement of the Tyr326 side chain.  Four ordered water mols. are an integral part of the active site and establish H-bond interactions to the inhibitor atoms.  These structural studies may guide future drug design to improve selectivity and efficacy by introducing appropriate substituents on the rasagiline mol. scaffold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkiXn0OI5eubVg90H21EOLACvtfcHk0li9HVlmOjjUAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsFyit70%253D&md5=7b3df3c611e3f0dd59342a59096402dd</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm031087c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031087c%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHerzig%26aufirst%3DY.%26aulast%3DSterling%26aufirst%3DJ.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DCrystal%2520Structures%2520of%2520Monoamine%2520Oxidase%2520B%2520in%2520Complex%2520with%2520Four%2520Inhibitors%2520of%2520the%2520N-Propargylaminoindan%2520Class%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1767%26epage%3D1774%26doi%3D10.1021%2Fjm031087c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span> <i>ADMET
Predictor</i>, version 7.0; <span class="NLM_publisher-name">Simulations
Plus, Inc.</span>: <span class="NLM_publisher-loc">Lancaster, CA</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+ADMET%0APredictor%2C+version+7.0%3B+Simulations%0APlus%2C+Inc.%3A+Lancaster%2C+CA%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DADMET%250APredictor%26pub%3DSimulations%250APlus%252C%2520Inc%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewin, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumberg, P. M.</span></span> <span> </span><span class="NLM_article-title">General and Stereospecific Route to 9-Substituted, 8,9-Disubstituted, and 9,10-Disubstituted Analogues of Benzolactam-V8</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">6366</span>– <span class="NLM_lpage">6373</span>, <span class="refDoi"> DOI: 10.1021/jo990605h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo990605h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=6366-6373&author=D.+W.+Maauthor=T.+J.+Tangauthor=A.+P.+Kozikowskiauthor=N.+E.+Lewinauthor=P.+M.+Blumberg&title=General+and+Stereospecific+Route+to+9-Substituted%2C+8%2C9-Disubstituted%2C+and+9%2C10-Disubstituted+Analogues+of+Benzolactam-V8&doi=10.1021%2Fjo990605h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjo990605h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo990605h%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DD.%2BW.%26aulast%3DTang%26aufirst%3DT.%2BJ.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26aulast%3DLewin%26aufirst%3DN.%2BE.%26aulast%3DBlumberg%26aufirst%3DP.%2BM.%26atitle%3DGeneral%2520and%2520Stereospecific%2520Route%2520to%25209-Substituted%252C%25208%252C9-Disubstituted%252C%2520and%25209%252C10-Disubstituted%2520Analogues%2520of%2520Benzolactam-V8%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1999%26volume%3D64%26spage%3D6366%26epage%3D6373%26doi%3D10.1021%2Fjo990605h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desjardine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matainaho, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, R. J.</span></span> <span> </span><span class="NLM_article-title">Tauramamide, a Lipopeptide Antibiotic Produced in Culture by Brevibacillus Laterosporus Isolated from a Marine Habitat: Structure Elucidation and Synthesis</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1850</span>– <span class="NLM_lpage">1853</span>, <span class="refDoi"> DOI: 10.1021/np070209r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np070209r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=1850-1853&author=K.+Desjardineauthor=A.+Pereiraauthor=H.+Wrightauthor=T.+Matainahoauthor=M.+Kellyauthor=R.+J.+Andersen&title=Tauramamide%2C+a+Lipopeptide+Antibiotic+Produced+in+Culture+by+Brevibacillus+Laterosporus+Isolated+from+a+Marine+Habitat%3A+Structure+Elucidation+and+Synthesis&doi=10.1021%2Fnp070209r"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fnp070209r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp070209r%26sid%3Dliteratum%253Aachs%26aulast%3DDesjardine%26aufirst%3DK.%26aulast%3DPereira%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DH.%26aulast%3DMatainaho%26aufirst%3DT.%26aulast%3DKelly%26aufirst%3DM.%26aulast%3DAndersen%26aufirst%3DR.%2BJ.%26atitle%3DTauramamide%252C%2520a%2520Lipopeptide%2520Antibiotic%2520Produced%2520in%2520Culture%2520by%2520Brevibacillus%2520Laterosporus%2520Isolated%2520from%2520a%2520Marine%2520Habitat%253A%2520Structure%2520Elucidation%2520and%2520Synthesis%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D1850%26epage%3D1853%26doi%3D10.1021%2Fnp070209r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ousmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavoux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciufolini, M. A.</span></span> <span> </span><span class="NLM_article-title">Total Synthesis of Tricyclic Azaspirane Derivatives of Tyrosine: FR901483 and TAN1251C</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>123</i></span>,  <span class="NLM_fpage">7534</span>– <span class="NLM_lpage">7538</span>, <span class="refDoi"> DOI: 10.1021/ja016030z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja016030z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltVCmur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=2001&pages=7534-7538&author=M.+Ousmerauthor=N.+A.+Braunauthor=C.+Bavouxauthor=M.+Perrinauthor=M.+A.+Ciufolini&title=Total+Synthesis+of+Tricyclic+Azaspirane+Derivatives+of+Tyrosine%3A+FR901483+and+TAN1251C&doi=10.1021%2Fja016030z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Total Synthesis of Tricyclic Azaspirane Derivatives of Tyrosine: FR901483 and TAN1251C</span></div><div class="casAuthors">Ousmer, Malika; Braun, Norbert A.; Bavoux, Claude; Perrin, Monique; Ciufolini, Marco A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">7534-7538</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A soln. to the long-standing problem presented by the oxidative cyclization of a phenolic 3-arylpropionamide to a spirolactam has been developed in this lab. via oxazoline chem.  This research was motivated by our interest in some novel tricyclic azaspirane natural products formally derived from tyrosine, such as FR901483 and TAN1251C.  In this paper, we disclose full details of the total synthesis of these substances.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pBdvUXf1crVg90H21EOLACvtfcHk0liyiU9bnCM2vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltVCmur0%253D&md5=c868ae060db09f7f8fb40b0934a04f85</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja016030z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja016030z%26sid%3Dliteratum%253Aachs%26aulast%3DOusmer%26aufirst%3DM.%26aulast%3DBraun%26aufirst%3DN.%2BA.%26aulast%3DBavoux%26aufirst%3DC.%26aulast%3DPerrin%26aufirst%3DM.%26aulast%3DCiufolini%26aufirst%3DM.%2BA.%26atitle%3DTotal%2520Synthesis%2520of%2520Tricyclic%2520Azaspirane%2520Derivatives%2520of%2520Tyrosine%253A%2520FR901483%2520and%2520TAN1251C%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2001%26volume%3D123%26spage%3D7534%26epage%3D7538%26doi%3D10.1021%2Fja016030z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwakuma a, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamada, K.</span></span> <span> </span><span class="NLM_article-title">A Simple and Efficient Procedure for the Synthesis of Optically Active 4-Methoxy-α-Methylphenylethylamine from Tyrosine</span>. <i>Synth. Commun.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">1935</span>– <span class="NLM_lpage">1945</span>, <span class="refDoi"> DOI: 10.1080/00397919808007167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1080%2F00397919808007167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADyaK1cXjtlans70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1998&pages=1935-1945&author=H.+Kohnoauthor=T.+Iwakuma+aauthor=K.+Yamada&title=A+Simple+and+Efficient+Procedure+for+the+Synthesis+of+Optically+Active+4-Methoxy-%CE%B1-Methylphenylethylamine+from+Tyrosine&doi=10.1080%2F00397919808007167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A simple and efficient procedure for the synthesis of optically active 4-methoxy-α-methylphenylethylamine from tyrosine</span></div><div class="casAuthors">Kohno, Harumichi; Iwakuma, Takeo; Yamada, Koichiro</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1935-1945</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Optically active 4-methoxy-α-methylphenylethylamine, a useful chiral building block in medicinal chem., was synthesized in optically pure form from L- or D-tyrosine by using a simple and efficient procedure via one-pot zinc redn. of the corresponding O-tosylate in the presence of H2O and NaI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy7F0yd2S3jrVg90H21EOLACvtfcHk0liyiU9bnCM2vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjtlans70%253D&md5=313b0d8b69798910b3b018b08ec4b175</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1080%2F00397919808007167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919808007167%26sid%3Dliteratum%253Aachs%26aulast%3DKohno%26aufirst%3DH.%26aulast%3DIwakuma%2Ba%26aufirst%3DT.%26aulast%3DYamada%26aufirst%3DK.%26atitle%3DA%2520Simple%2520and%2520Efficient%2520Procedure%2520for%2520the%2520Synthesis%2520of%2520Optically%2520Active%25204-Methoxy-%25CE%25B1-Methylphenylethylamine%2520from%2520Tyrosine%26jtitle%3DSynth.%2520Commun.%26date%3D1998%26volume%3D28%26spage%3D1935%26epage%3D1945%26doi%3D10.1080%2F00397919808007167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Quagliato, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrae, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matelan, E. M.</span></span> <span> </span><span class="NLM_article-title">Efficient Procedure for the Reduction of Alpha-Amino Acids to Enantiomerically Pure Alpha-Methylamines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">5037</span>– <span class="NLM_lpage">5042</span>, <span class="refDoi"> DOI: 10.1021/jo000242h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo000242h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=5037-5042&author=D.+A.+Quagliatoauthor=P.+M.+Andraeauthor=E.+M.+Matelan&title=Efficient+Procedure+for+the+Reduction+of+Alpha-Amino+Acids+to+Enantiomerically+Pure+Alpha-Methylamines&doi=10.1021%2Fjo000242h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo000242h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo000242h%26sid%3Dliteratum%253Aachs%26aulast%3DQuagliato%26aufirst%3DD.%2BA.%26aulast%3DAndrae%26aufirst%3DP.%2BM.%26aulast%3DMatelan%26aufirst%3DE.%2BM.%26atitle%3DEfficient%2520Procedure%2520for%2520the%2520Reduction%2520of%2520Alpha-Amino%2520Acids%2520to%2520Enantiomerically%2520Pure%2520Alpha-Methylamines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26spage%3D5037%26epage%3D5042%26doi%3D10.1021%2Fjo000242h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boger, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yohannes, D.</span></span> <span> </span><span class="NLM_article-title">Studies on the Total Synthesis of Bouvardin and Deoxybouvardin - Cyclic Hexapeptide Cyclization Studies and Preparation of Key Partial Structures</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">487</span>– <span class="NLM_lpage">499</span>, <span class="refDoi"> DOI: 10.1021/jo00238a005</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00238a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=487-499&author=D.+L.+Bogerauthor=D.+Yohannes&title=Studies+on+the+Total+Synthesis+of+Bouvardin+and+Deoxybouvardin+-+Cyclic+Hexapeptide+Cyclization+Studies+and+Preparation+of+Key+Partial+Structures&doi=10.1021%2Fjo00238a005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo00238a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00238a005%26sid%3Dliteratum%253Aachs%26aulast%3DBoger%26aufirst%3DD.%2BL.%26aulast%3DYohannes%26aufirst%3DD.%26atitle%3DStudies%2520on%2520the%2520Total%2520Synthesis%2520of%2520Bouvardin%2520and%2520Deoxybouvardin%2520-%2520Cyclic%2520Hexapeptide%2520Cyclization%2520Studies%2520and%2520Preparation%2520of%2520Key%2520Partial%2520Structures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1988%26volume%3D53%26spage%3D487%26epage%3D499%26doi%3D10.1021%2Fjo00238a005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mireles, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janiszewski, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Morais, S. M.</span></span> <span> </span><span class="NLM_article-title">In Vitro P-Glycoprotein Assays to Predict the In Vivo Interactions of P-Glycoprotein with Drugs in the Central Nervous System</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">268</span>– <span class="NLM_lpage">275</span>, <span class="refDoi"> DOI: 10.1124/dmd.107.017434</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+Vitro+P-Glycoprotein+Assays+to+Predict+the+In+Vivo+Interactions+of+P-Glycoprotein+with+Drugs+in+the+Central+Nervous+System&doi=10.1124%2Fdmd.107.017434"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0ljRz9eFXbH7SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520Vitro%2520P-Glycoprotein%2520Assays%2520to%2520Predict%2520the%2520In%2520Vivo%2520Interactions%2520of%2520P-Glycoprotein%2520with%2520Drugs%2520in%2520the%2520Central%2520Nervous%2520System%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275%26doi%3D10.1124%2Fdmd.107.017434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schinkel, A. H.</span></span> <span> </span><span class="NLM_article-title">P-Glycoprotein, a Gatekeeper in the Blood-Brain Barrier</span>. <i>Adv. Drug Delivery Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">179</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/S0169-409X(98)00085-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1016%2FS0169-409X%2898%2900085-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10837715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVCgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1999&pages=179-194&author=A.+H.+Schinkel&title=P-Glycoprotein%2C+a+Gatekeeper+in+the+Blood-Brain+Barrier&doi=10.1016%2FS0169-409X%2898%2900085-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">P-Glycoprotein, a gatekeeper in the blood-brain barrier</span></div><div class="casAuthors">Schinkel, Alfred H.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2,3</span>),
    <span class="NLM_cas:pages">179-194</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 79 refs.  The blood-brain barrier is a major impediment to the entry of many therapeutic drugs into the brain.  P-Glycoprotein is an ATP-dependent drug transport protein that is predominantly found in the apical membranes of a no. of epithelial cell types in the body, including the blood luminal membrane of the brain capillary endothelial cells that make up the blood-brain barrier.  Since P-glycoprotein can actively transport a huge variety of hydrophobic amphipathic drugs out of the cell, it was hypothesized that it might be responsible for the very poor penetration of many relatively large (>400 Da) hydrophobic drugs in the brain, by performing active back-transport of these drugs to the blood.  Extensive expts. with in vitro models and with knockout mice lacking blood-brain barrier P-glycoprotein or other animal models treated with blockers of P-glycoprotein have fully confirmed this hypothesis.  Absence of functional P-glycoprotein in the blood-brain barrier leads to highly increased brain penetration of a no. of important drugs.  Depending on the pharmacol. target of these drugs in the central nervous system (CNS), this can result in dramatically increased neurotoxicity, or fundamentally altered pharmacol. effects of the drug.  Given the variety of drugs affected by P-glycoprotein transport, it may be of tremendous therapeutic value to apply these insights to the development of drugs that should have either very poor or very good brain penetration, whichever is preferred for pharmacotherapeutic purposes.  The clin. application of P-glycoprotein blockers should also be considered in order to improve the blood-brain barrier permeability of certain drugs that currently display insufficient brain penetration for effective therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpfL-5j3NCh7Vg90H21EOLACvtfcHk0ljRz9eFXbH7SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVCgu7Y%253D&md5=08a3305a4b236929ffbe404d2e6a5a28</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2898%2900085-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252898%252900085-4%26sid%3Dliteratum%253Aachs%26aulast%3DSchinkel%26aufirst%3DA.%2BH.%26atitle%3DP-Glycoprotein%252C%2520a%2520Gatekeeper%2520in%2520the%2520Blood-Brain%2520Barrier%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1999%26volume%3D36%26spage%3D179%26epage%3D194%26doi%3D10.1016%2FS0169-409X%2898%2900085-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thakker, D. R.</span></span> <span> </span><span class="NLM_article-title">Strategic Use of Preclinical Pharmacokinetic Studies and In Vitro Models in Optimizing ADME Properties of Lead Compounds</span>. <i>Optimizing the Drug-Like Properties of Leads in Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>IV</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1007/978-0-387-44961-6_1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2F978-0-387-44961-6_1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=IV&publication_year=2006&pages=1-23&author=D.+R.+Thakker&title=Strategic+Use+of+Preclinical+Pharmacokinetic+Studies+and+In+Vitro+Models+in+Optimizing+ADME+Properties+of+Lead+Compounds&doi=10.1007%2F978-0-387-44961-6_1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1007%2F978-0-387-44961-6_1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-0-387-44961-6_1%26sid%3Dliteratum%253Aachs%26aulast%3DThakker%26aufirst%3DD.%2BR.%26atitle%3DStrategic%2520Use%2520of%2520Preclinical%2520Pharmacokinetic%2520Studies%2520and%2520In%2520Vitro%2520Models%2520in%2520Optimizing%2520ADME%2520Properties%2520of%2520Lead%2520Compounds%26jtitle%3DOptimizing%2520the%2520Drug-Like%2520Properties%2520of%2520Leads%2520in%2520Drug%2520Discovery%26date%3D2006%26volume%3DIV%26spage%3D1%26epage%3D23%26doi%3D10.1007%2F978-0-387-44961-6_1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capaldi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolotti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muncipinto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stefanachi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cellamare, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span> <span> </span><span class="NLM_article-title">Solid-Phase Synthesis and Insights into Structure-Activity Relationships of Safinamide Analogues as Potent and Selective Inhibitors of Type B Monoamine Oxidase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">4909</span>– <span class="NLM_lpage">4916</span>, <span class="refDoi"> DOI: 10.1021/jm070725e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070725e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4909-4916&author=F.+Leonettiauthor=C.+Capaldiauthor=L.+Pisaniauthor=O.+Nicolottiauthor=G.+Muncipintoauthor=A.+Stefanachiauthor=S.+Cellamareauthor=C.+Cacciaauthor=A.+Carotti&title=Solid-Phase+Synthesis+and+Insights+into+Structure-Activity+Relationships+of+Safinamide+Analogues+as+Potent+and+Selective+Inhibitors+of+Type+B+Monoamine+Oxidase&doi=10.1021%2Fjm070725e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm070725e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070725e%26sid%3Dliteratum%253Aachs%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCapaldi%26aufirst%3DC.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DStefanachi%26aufirst%3DA.%26aulast%3DCellamare%26aufirst%3DS.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DSolid-Phase%2520Synthesis%2520and%2520Insights%2520into%2520Structure-Activity%2520Relationships%2520of%2520Safinamide%2520Analogues%2520as%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Type%2520B%2520Monoamine%2520Oxidase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4909%26epage%3D4916%26doi%3D10.1021%2Fjm070725e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5848</span>– <span class="NLM_lpage">5852</span>, <span class="refDoi"> DOI: 10.1021/jm070677y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070677y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5848-5852&author=C.+Bindaauthor=J.+Wangauthor=L.+Pisaniauthor=C.+Cacciaauthor=A.+Carottiauthor=P.+Salvatiauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Structures+of+Human+Monoamine+Oxidase+B+Complexes+with+Selective+Noncovalent+Inhibitors%3A+Safinamide+and+Coumarin+Analogs&doi=10.1021%2Fjm070677y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Human Monoamine Oxidase B Complexes with Selective Noncovalent Inhibitors: Safinamide and Coumarin Analogs</span></div><div class="casAuthors">Binda, Claudia; Wang, Jin; Pisani, Leonardo; Caccia, Carla; Carotti, Angelo; Salvati, Patricia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5848-5852</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structures of human monoamine oxidase B (MAO B) in complex with safinamide and two coumarin derivs., all sharing a common benzyloxy substituent, were detd. by x-ray crystallog.  These compds. competitively inhibit MAO B with Ki values in the 0.1-0.5 μM range that are 30-700-fold lower than those obsd. with MAO A.  The inhibitors bind noncovalently to MAO B, occupying both the entrance and the substrate cavities and showing a similarly oriented benzyloxy substituent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBPIubufo89bVg90H21EOLACvtfcHk0ljYsQph2_BzEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFWgurjI&md5=448f65696f4870e2301f46a6f015e35c</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm070677y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070677y%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DStructures%2520of%2520Human%2520Monoamine%2520Oxidase%2520B%2520Complexes%2520with%2520Selective%2520Noncovalent%2520Inhibitors%253A%2520Safinamide%2520and%2520Coumarin%2520Analogs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5848%26epage%3D5852%26doi%3D10.1021%2Fjm070677y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pisani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muncipinto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miscioscia, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolotti, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leonetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caccia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvati, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto-Otero, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendez-Alvarez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Passeleu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carotti, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6685</span>– <span class="NLM_lpage">6706</span>, <span class="refDoi"> DOI: 10.1021/jm9010127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9010127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1artL3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6685-6706&author=L.+Pisaniauthor=G.+Muncipintoauthor=T.+F.+Misciosciaauthor=O.+Nicolottiauthor=F.+Leonettiauthor=M.+Cattoauthor=C.+Cacciaauthor=P.+Salvatiauthor=R.+Soto-Oteroauthor=E.+Mendez-Alvarezauthor=C.+Passeleuauthor=A.+Carotti&title=Discovery+of+a+Novel+Class+of+Potent+Coumarin+Monoamine+Oxidase+B+Inhibitors%3A+Development+and+Biopharmacological+Profiling+of+7-%5B%283-Chlorobenzyl%29oxy%5D-4-%5B%28methylamino%29methyl%5D-2H-chromen-2-one+Methanesulfonate+%28NW-1772%29+as+a+Highly+Potent%2C+Selective%2C+Reversible%2C+and+Orally+Active+Monoamine+Oxidase+B+Inhibitor&doi=10.1021%2Fjm9010127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Class of Potent Coumarin Monoamine Oxidase B Inhibitors: Development and Biopharmacological Profiling of 7-[(3-Chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one Methanesulfonate (NW-1772) as a Highly Potent, Selective, Reversible, and Orally Active Monoamine Oxidase B Inhibitor</span></div><div class="casAuthors">Pisani, Leonardo; Muncipinto, Giovanni; Miscioscia, Teresa Fabiola; Nicolotti, Orazio; Leonetti, Francesco; Catto, Marco; Caccia, Carla; Salvati, Patricia; Soto-Otero, Ramon; Mendez-Alvarez, Estefania; Passeleu, Celine; Carotti, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6685-6706</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In an effort to discover novel selective monoamine oxidase (MAO) B inhibitors with favorable physicochem. and pharmacokinetic profiles, 7-[(m-halogeno)benzyloxy]coumarins bearing properly selected polar substituents at position 4 were designed, synthesized, and evaluated as MAO inhibitors.  Several compds. with MAO-B inhibitory activity in the nanomolar range and excellent MAO-B selectivity (selectivity index SI > 400) were identified.  Structure-affinity relationships and docking simulations provided valuable insights into the enzyme-inhibitor binding interactions at position 4, which has been poorly explored.  Furthermore, computational and exptl. studies led to the identification and biopharmacol. characterization of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (I) (NW-1772) as an in vitro and in vivo potent and selective MAO-B inhibitor, with rapid blood-brain barrier penetration, short-acting and reversible inhibitory activity, slight inhibition of selected cytochrome P450s, and low in vitro toxicity.  On the basis of this preliminary preclin. profile, inhibitor I might be viewed as a promising clin. candidate for the treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX-2hebE1dsbVg90H21EOLACvtfcHk0ljYsQph2_BzEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1artL3N&md5=b5cdda9e190504fced3ed6c5157c3266</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm9010127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9010127%26sid%3Dliteratum%253Aachs%26aulast%3DPisani%26aufirst%3DL.%26aulast%3DMuncipinto%26aufirst%3DG.%26aulast%3DMiscioscia%26aufirst%3DT.%2BF.%26aulast%3DNicolotti%26aufirst%3DO.%26aulast%3DLeonetti%26aufirst%3DF.%26aulast%3DCatto%26aufirst%3DM.%26aulast%3DCaccia%26aufirst%3DC.%26aulast%3DSalvati%26aufirst%3DP.%26aulast%3DSoto-Otero%26aufirst%3DR.%26aulast%3DMendez-Alvarez%26aufirst%3DE.%26aulast%3DPasseleu%26aufirst%3DC.%26aulast%3DCarotti%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Potent%2520Coumarin%2520Monoamine%2520Oxidase%2520B%2520Inhibitors%253A%2520Development%2520and%2520Biopharmacological%2520Profiling%2520of%25207-%255B%25283-Chlorobenzyl%2529oxy%255D-4-%255B%2528methylamino%2529methyl%255D-2H-chromen-2-one%2520Methanesulfonate%2520%2528NW-1772%2529%2520as%2520a%2520Highly%2520Potent%252C%2520Selective%252C%2520Reversible%252C%2520and%2520Orally%2520Active%2520Monoamine%2520Oxidase%2520B%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6685%26epage%3D6706%26doi%3D10.1021%2Fjm9010127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secci, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolasco, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimenti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Ascenzio, M.</span></span> <span> </span><span class="NLM_article-title">Patent-Related Survey on New Monoamine Oxidase Inhibitors and Their Therapeutic Potential</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">759</span>– <span class="NLM_lpage">801</span>, <span class="refDoi"> DOI: 10.1517/13543776.2012.698613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1517%2F13543776.2012.698613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=22702491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC38XptVGrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=759-801&author=S.+Carradoriauthor=D.+Secciauthor=A.+Bolascoauthor=P.+Chimentiauthor=M.+D%E2%80%99Ascenzio&title=Patent-Related+Survey+on+New+Monoamine+Oxidase+Inhibitors+and+Their+Therapeutic+Potential&doi=10.1517%2F13543776.2012.698613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Patent-related survey on new monoamine oxidase inhibitors and their therapeutic potential</span></div><div class="casAuthors">Carradori, Simone; Secci, Daniela; Bolasco, Adriana; Chimenti, Paola; D'Ascenzio, Melissa</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">759-801</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Monoamine oxidase (MAO) plays an important role in the control of intracellular concn. of monoaminergic neurotransmitters or neuromodulators and dietary amines.  The rapid degrdn. of these mols. ensures the proper functioning of synaptic neurotransmission and is crit. for the regulation of several mental and cognitive functions.  The byproducts of MAO-mediated reactions comprehend reactive and toxic chem. species.  As a consequence of this, the development of human MAO inhibitors led to important discoveries in the treatment of several neuropsychiatric and neurodegenerative disorders.Areas covered: This review highlights the recent MAO inhibitors-related patents (2010-2012) and reports on new assocns. of already known MAO inhibitors with other drugs, innovative therapeutic targets, MAO inhibitors obtained by plants extn., alternative administration routes and synthetic processes.Expert opinion: MAO inhibitors appear promising for further clin. development being often endowed with other pharmacol. functions (iron-chelating property, cholinesterase inhibition).  A new golden age' of MAO inhibitors recently started from (i) the discovery of new therapeutic targets (prostate cancer, diabetes, ischemia/reperfusion injury, tobacco dependence, transmissible spongiform encephalopathy); (ii) the recognized role of MAO as biomol. markers (insomnia, chronic alcoholism, obsessive-compulsive behavior); (iii) the activity of these enzymes in other tissues (platelets, prostate cells).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroVBvUJ7wd-7Vg90H21EOLACvtfcHk0lgAUTrQULWHwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptVGrtLo%253D&md5=a7eb2aa2d9a5f4e3f1308b467d78ca7d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1517%2F13543776.2012.698613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2012.698613%26sid%3Dliteratum%253Aachs%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DSecci%26aufirst%3DD.%26aulast%3DBolasco%26aufirst%3DA.%26aulast%3DChimenti%26aufirst%3DP.%26aulast%3DD%25E2%2580%2599Ascenzio%26aufirst%3DM.%26atitle%3DPatent-Related%2520Survey%2520on%2520New%2520Monoamine%2520Oxidase%2520Inhibitors%2520and%2520Their%2520Therapeutic%2520Potential%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2012%26volume%3D22%26spage%3D759%26epage%3D801%26doi%3D10.1517%2F13543776.2012.698613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carradori, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvestri, R.</span></span> <span> </span><span class="NLM_article-title">New Frontiers in Selective Human MAO-B Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6717</span>– <span class="NLM_lpage">6732</span>, <span class="refDoi"> DOI: 10.1021/jm501690r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501690r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntFGiurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6717-6732&author=S.+Carradoriauthor=R.+Silvestri&title=New+Frontiers+in+Selective+Human+MAO-B+Inhibitors&doi=10.1021%2Fjm501690r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">New Frontiers in Selective Human MAO-B Inhibitors</span></div><div class="casAuthors">Carradori, Simone; Silvestri, Romano</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6717-6732</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Accumulating evidence shows a relationship between the human MAO-B (hMAO-B) enzyme and neuropsychiatric/degenerative disorder, personality traits, type II alcoholism, borderline personality disorders, aggressiveness and violence in crime, obsessive-compulsive disorder, depression, suicide, schizophrenia, anorexia nervosa, migraine, dementia, and PD.  Thus, MAO-B represents an attractive target for the treatment of a no. of human diseases.  The discovery, development, and therapeutic use of drugs that inhibit MAO-B are major challenges for future therapy.  Various compds. and drugs that selectively target this isoform have been discovered recently.  These agents are synthetic compds. or natural products and their analogs, including chalcones, pyrazoles, chromones, coumarins, xanthines, isatin derivs., thiazolidindiones, (thiazol-2-yl)hydrazones, and analogs of marketed drugs.  Despite considerable efforts in understanding the binding interaction with specific substrates or inhibitors, structural information available for the rational design of new hMAO-B inhibitors remains unsatisfactory.  Therefore, the quest for novel, potent, and selective hMAO-B inhibitors remains of high interest.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Xz4JhVXeRbVg90H21EOLACvtfcHk0lgAUTrQULWHwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntFGiurk%253D&md5=abe939ceae25d97e83243f9f0af6aef5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjm501690r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501690r%26sid%3Dliteratum%253Aachs%26aulast%3DCarradori%26aufirst%3DS.%26aulast%3DSilvestri%26aufirst%3DR.%26atitle%3DNew%2520Frontiers%2520in%2520Selective%2520Human%2520MAO-B%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6717%26epage%3D6732%26doi%3D10.1021%2Fjm501690r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCrodden, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tipton, K. F.</span></span> <span> </span><span class="NLM_article-title">The Involvement of Intestinal Monoamine Oxidase in the Transport and Metabolism of Tyramine</span>. <i>J. Neural Transm Suppl</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=3162948" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A280%3ADyaL1c7pvFGnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1988&pages=1-9&author=F.+Hasanauthor=J.+M.+McCroddenauthor=N.+P.+Kennedyauthor=K.+F.+Tipton&title=The+Involvement+of+Intestinal+Monoamine+Oxidase+in+the+Transport+and+Metabolism+of+Tyramine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">The involvement of intestinal monoamine oxidase in the transport and metabolism of tyramine</span></div><div class="casAuthors">Hasan F; McCrodden J M; Kennedy N P; Tipton K F</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neural transmission. Supplementum</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-9</span>
        ISSN:<span class="NLM_cas:issn">0303-6995</span>.
    </div><div class="casAbstract">The monoamine oxidase activities were found to be similar in the crypt and villous cells of the different regions of rat small intestine.  In all cases the activity of the A-form of the enzyme constituted more than 70% of the total.  A similar proportion of that form of the enzyme was found in homogenates of biopsy samples of human intestine.  Studies with everted intestines showed that at concentrations above 10 microM over 70% of tyramine was deaminated during transport and the use of selective inhibitors confirmed the A-form of monoamine oxidase to play the dominant role in that process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTo0jAUBc0BxcRAV4D_Ins_fW6udTcc2ebwSSpHR_goB7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c7pvFGnug%253D%253D&md5=4420494d6f41215ba630a87b04c1f321</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHasan%26aufirst%3DF.%26aulast%3DMcCrodden%26aufirst%3DJ.%2BM.%26aulast%3DKennedy%26aufirst%3DN.%2BP.%26aulast%3DTipton%26aufirst%3DK.%2BF.%26atitle%3DThe%2520Involvement%2520of%2520Intestinal%2520Monoamine%2520Oxidase%2520in%2520the%2520Transport%2520and%2520Metabolism%2520of%2520Tyramine%26jtitle%3DJ.%2520Neural%2520Transm%2520Suppl%26date%3D1988%26volume%3D26%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Riederer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muller, T.</span></span> <span> </span><span class="NLM_article-title">Use of Monoamine Oxidase Inhibitors in Chronic Neurodegeneration</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1080/17425255.2017.1273901</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1080%2F17425255.2017.1273901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=27998194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFeqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=233-240&author=P.+Riedererauthor=T.+Muller&title=Use+of+Monoamine+Oxidase+Inhibitors+in+Chronic+Neurodegeneration&doi=10.1080%2F17425255.2017.1273901"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Use of monoamine oxidase inhibitors in chronic neurodegeneration</span></div><div class="casAuthors">Riederer, Peter; Mueller, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">233-240</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Neurotransmission by biogenic monoamines is important for brain function.  Biogenic amine turnover employs the enzymes catechol-O-methyltransferase and monoamine oxidase in neuronal and glial cells.  Inhibition of these enzymes elevates biogenic amine levels in the synaptic cleft.  Subtype selectivity of inhibition is lost during long-term use of 'selective' monoamine oxidase inhibitors.  This narrative review discusses use of monoamine oxidase inhibitors in the context with chronic neurodegeneration.  Antidepressant drugs increase synaptic concns. of biogenic amines.  In the aging brain, then one of the two enzymes involved in degrading synaptic amines, catechol-O-Me transferase, increasingly catalyzes methylation processes.  Therefore, metab. by monoamine oxidase plays an incremental, predominant role in biogenic amine turnover, leading to greater oxidative stress.  In patients with chronic neurodegenerative disorders, symptoms, such as depression and apathy, are often treated with drugs that elevate biogenic amine levels.  This therapeutic strategy increases biogenic amine turnover, thereby generating neurotoxic aldehydes and enhanced oxidative stress, each of which influence and accelerate the course of neurodegeneration.  We propose that antidepressant therapy should be initiated first with monoamine oxidase inhibitors only.  If adequate clin. response is not achieved, only then they should be supplemented with a further antidepressant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVLaXnBjuirrVg90H21EOLACvtfcHk0lgAUTrQULWHwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFeqsQ%253D%253D&md5=0e0c8eb13e16b768b51bd17d494a482d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F17425255.2017.1273901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2017.1273901%26sid%3Dliteratum%253Aachs%26aulast%3DRiederer%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DT.%26atitle%3DUse%2520of%2520Monoamine%2520Oxidase%2520Inhibitors%2520in%2520Chronic%2520Neurodegeneration%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2017%26volume%3D13%26spage%3D233%26epage%3D240%26doi%3D10.1080%2F17425255.2017.1273901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wimbiscus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenko, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malone, D.</span></span> <span> </span><span class="NLM_article-title">MAO Inhibitors: Risks, Benefits, and lore</span>. <i>Cleve Clin J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">859</span>– <span class="NLM_lpage">882</span>, <span class="refDoi"> DOI: 10.3949/ccjm.77a.09103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.3949%2Fccjm.77a.09103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=21147941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A280%3ADC%252BC3M%252FktVehsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2010&pages=859-882&author=M.+Wimbiscusauthor=O.+Kostenkoauthor=D.+Malone&title=MAO+Inhibitors%3A+Risks%2C+Benefits%2C+and+lore&doi=10.3949%2Fccjm.77a.09103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">MAO inhibitors: risks, benefits, and lore</span></div><div class="casAuthors">Wimbiscus Molly; Kostenko Olga; Malone Donald</div><div class="citationInfo"><span class="NLM_cas:title">Cleveland Clinic journal of medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">859-82</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Monoamine oxidase (MAO) inhibitors were the first antidepressants introduced, but their use has dwindled because of their reported side effects, their food and drug interactions, and the introduction of other classes of agents.  However, interest in MAO inhibitors is reviving.  Here, we discuss their use, risks, and benefits in clinical medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5l3ppB6CZKLmQt-ICR3qNfW6udTcc2ebmyHDNcZI7Brntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M%252FktVehsw%253D%253D&md5=557ad1fb6c82cd0fa448fdc72252f690</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3949%2Fccjm.77a.09103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3949%252Fccjm.77a.09103%26sid%3Dliteratum%253Aachs%26aulast%3DWimbiscus%26aufirst%3DM.%26aulast%3DKostenko%26aufirst%3DO.%26aulast%3DMalone%26aufirst%3DD.%26atitle%3DMAO%2520Inhibitors%253A%2520Risks%252C%2520Benefits%252C%2520and%2520lore%26jtitle%3DCleve%2520Clin%2520J.%2520Med.%26date%3D2010%26volume%3D77%26spage%3D859%26epage%3D882%26doi%3D10.3949%2Fccjm.77a.09103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Polli, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baughman, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphreys, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mote, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salisbury, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tippin, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serabjit-Singh, C. J.</span></span> <span> </span><span class="NLM_article-title">P-Glycoprotein Influences the Brain Concentrations of Cetirizine (Zyrtec), a Second-Generation Non-Sedating Antihistamine</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">2082</span>– <span class="NLM_lpage">2089</span>, <span class="refDoi"> DOI: 10.1002/jps.10453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1002%2Fjps.10453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=14502547" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvFOms7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2003&pages=2082-2089&author=J.+W.+Polliauthor=T.+M.+Baughmanauthor=J.+E.+Humphreysauthor=K.+H.+Jordanauthor=A.+L.+Moteauthor=J.+A.+Salisburyauthor=T.+K.+Tippinauthor=C.+J.+Serabjit-Singh&title=P-Glycoprotein+Influences+the+Brain+Concentrations+of+Cetirizine+%28Zyrtec%29%2C+a+Second-Generation+Non-Sedating+Antihistamine&doi=10.1002%2Fjps.10453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">P-glycoprotein influences the brain concentrations of cetirizine (Zyrtec), a second-generation non-sedating antihistamine</span></div><div class="casAuthors">Polli, Joseph W.; Baughman, Todd M.; Humphreys, Joan E.; Jordan, Kelly H.; Mote, Angela L.; Salisbury, Jo A.; Tippin, Timothy K.; Serabjit-Singh, Cosette J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2082-2089</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Recent in vitro studies have suggested that P-glycoprotein (Pgp) and passive membrane permeability may influence the brain concns. of non-sedating (second-generation) antihistamines.  The purpose of this study was to det. the importance of Pgp-mediated efflux on the in vivo brain distribution of the non-sedating antihistamine cetirizine (Zyrtec), and the structurally related sedating (first-generation) antihistamine hydroxyzine (Atarax).  In vitro MDR1-MDCKII monolayer efflux assays demonstrated that cetirizine was a Pgp substrate (B → A/A → B + GF120918 ratio = 5.47) with low/moderate passive permeability (Papp B → A = 56.5 nm/s).  In vivo, the cetirizine brain-to-free plasma concn. ratios (0.367 to 4.30) were 2.3- to 8.7-fold higher in Pgp-deficient mice compared with wild-type mice.  In contrast, hydroxyzine was not a Pgp substrate in vitro (B → A/A → B ratio = 0.86), had high passive permeability (Papp B → A + GF120918=296 nm/s), and had brain-to-free plasma concn. ratios > 73 in both Pgp-deficient and wild-type mice.  These studies demonstrate that Pgp-mediated efflux and passive permeability contribute to the low cetirizine brain concns. in mice and that these properties account for the differences in the sedation side-effect profiles of cetirizine and hydroxyzine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhU1DjQY_bcrVg90H21EOLACvtfcHk0lifRYCP1frKQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvFOms7c%253D&md5=fee50eea6337aa009088c3afb9efcf3b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjps.10453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.10453%26sid%3Dliteratum%253Aachs%26aulast%3DPolli%26aufirst%3DJ.%2BW.%26aulast%3DBaughman%26aufirst%3DT.%2BM.%26aulast%3DHumphreys%26aufirst%3DJ.%2BE.%26aulast%3DJordan%26aufirst%3DK.%2BH.%26aulast%3DMote%26aufirst%3DA.%2BL.%26aulast%3DSalisbury%26aufirst%3DJ.%2BA.%26aulast%3DTippin%26aufirst%3DT.%2BK.%26aulast%3DSerabjit-Singh%26aufirst%3DC.%2BJ.%26atitle%3DP-Glycoprotein%2520Influences%2520the%2520Brain%2520Concentrations%2520of%2520Cetirizine%2520%2528Zyrtec%2529%252C%2520a%2520Second-Generation%2520Non-Sedating%2520Antihistamine%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2003%26volume%3D92%26spage%3D2082%26epage%3D2089%26doi%3D10.1002%2Fjps.10453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span> <i>QUACPAC</i>, version 1.7.0.2; <span class="NLM_publisher-name">OpenEye Scientific
Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+QUACPAC%2C+version+1.7.0.2%3B+OpenEye+Scientific%0ASoftware%3A+Santa+Fe%2C+NM%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DQUACPAC%26pub%3DOpenEye%2520Scientific%250ASoftware%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span> <i>OMEGA</i>, version 2.5.1.4; <span class="NLM_publisher-name">OpenEye Scientific
Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+OMEGA%2C+version+2.5.1.4%3B+OpenEye+Scientific%0ASoftware%3A+Santa+Fe%2C+NM%2C+2013."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DOMEGA%26pub%3DOpenEye%2520Scientific%250ASoftware%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, P.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skillman, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellingson, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, M. T.</span></span> <span> </span><span class="NLM_article-title">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">572</span>– <span class="NLM_lpage">584</span>, <span class="refDoi"> DOI: 10.1021/ci100031x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100031x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=572-584&author=P.%0AC.+Hawkinsauthor=A.+G.+Skillmanauthor=G.+L.+Warrenauthor=B.+A.+Ellingsonauthor=M.+T.+Stahl&title=Conformer+Generation+with+OMEGA%3A+Algorithm+and+Validation+Using+High+Quality+Structures+from+the+Protein+Databank+and+Cambridge+Structural+Database&doi=10.1021%2Fci100031x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Conformer Generation with OMEGA: Algorithm and Validation Using High Quality Structures from the Protein Databank and Cambridge Structural Database</span></div><div class="casAuthors">Hawkins, Paul C. D.; Skillman, A. Geoffrey; Warren, Gregory L.; Ellingson, Benjamin A.; Stahl, Matthew T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">572-584</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we present the algorithm and validation for OMEGA, a systematic, knowledge-based conformer generator.  The algorithm consists of three phases: assembly of an initial 3D structure from a library of fragments; exhaustive enumeration of all rotatable torsions using values drawn from a knowledge-based list of angles, thereby generating a large set of conformations; and sampling of this set by geometric and energy criteria.  Validation of conformer generators like OMEGA has often been undertaken by comparing computed conformer sets to exptl. mol. conformations from crystallog., usually from the Protein Databank (PDB).  Such an approach is fraught with difficulty due to the systematic problems with small mol. structures in the PDB.  Methods are presented to identify a diverse set of small mol. structures from cocomplexes in the PDB that has maximal reliability.  A challenging set of 197 high quality, carefully selected ligand structures from well-solved models was obtained using these methods.  This set will provide a sound basis for comparison and validation of conformer generators in the future.  Validation results from this set are compared to the results using structures of a set of druglike mols. extd. from the Cambridge Structural Database (CSD).  OMEGA is found to perform very well in reproducing the crystallog. conformations from both these data sets using two complementary metrics of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq1SOwPH1NzrVg90H21EOLACvtfcHk0lifRYCP1frKQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtlaisrY%253D&md5=fb87ecc9c51eddef63b41fffcd9babee</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fci100031x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100031x%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DP.%2BC.%26aulast%3DSkillman%26aufirst%3DA.%2BG.%26aulast%3DWarren%26aufirst%3DG.%2BL.%26aulast%3DEllingson%26aufirst%3DB.%2BA.%26aulast%3DStahl%26aufirst%3DM.%2BT.%26atitle%3DConformer%2520Generation%2520with%2520OMEGA%253A%2520Algorithm%2520and%2520Validation%2520Using%2520High%2520Quality%2520Structures%2520from%2520the%2520Protein%2520Databank%2520and%2520Cambridge%2520Structural%2520Database%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D572%26epage%3D584%26doi%3D10.1021%2Fci100031x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span> <i>HYBRID</i>, version 3.2.0.2; <span class="NLM_publisher-name">OpenEye Scientific
Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+HYBRID%2C+version+3.2.0.2%3B+OpenEye+Scientific%0ASoftware%3A+Santa+Fe%2C+NM%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DHYBRID%26pub%3DOpenEye%2520Scientific%250ASoftware%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGann, M.</span></span> <span> </span><span class="NLM_article-title">FRED Pose Prediction and Virtual Screening Accuracy</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">596</span>, <span class="refDoi"> DOI: 10.1021/ci100436p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci100436p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFGqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=578-596&author=M.+McGann&title=FRED+Pose+Prediction+and+Virtual+Screening+Accuracy&doi=10.1021%2Fci100436p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">FRED Pose Prediction and Virtual Screening Accuracy</span></div><div class="casAuthors">McGann, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">578-596</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Results of a previous docking study are reanalyzed and extended to include results from the docking program FRED and a detailed statistical anal. of both structure reprodn. and virtual screening results.  FRED is run both in a traditional docking mode and in a hybrid mode that makes use of 16 the structure of a bound ligand in addn. to the protein structure to screen mols.  This anal. shows that most docking programs are effective overall but highly inconsistent, tending to do well on one system and poorly on the next.  Comparing methods, the difference in mean performance on DUD is found to be statistically significant (95% confidence) 61% of the time when using a global enrichment metric (AUC).  Early enrichment metrics are found to have relatively poor statistical power, with 0.5% early enrichment only able to distinguish methods to 95% confidence 14% of the time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVRPdIDmubh7Vg90H21EOLACvtfcHk0ljEw4RBlYWZjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFGqsbk%253D&md5=8f3ae5972583d0a89d50e35a4b01212e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fci100436p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100436p%26sid%3Dliteratum%253Aachs%26aulast%3DMcGann%26aufirst%3DM.%26atitle%3DFRED%2520Pose%2520Prediction%2520and%2520Virtual%2520Screening%2520Accuracy%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D578%26epage%3D596%26doi%3D10.1021%2Fci100436p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGann, M.</span></span> <span> </span><span class="NLM_article-title">FRED and HYBRID Docking Performance on Standardized Datasets</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1007/s10822-012-9584-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=10.1007%2Fs10822-012-9584-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=22669221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1ens7bO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=897-906&author=M.+McGann&title=FRED+and+HYBRID+Docking+Performance+on+Standardized+Datasets&doi=10.1007%2Fs10822-012-9584-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">FRED and HYBRID docking performance on standardized datasets</span></div><div class="casAuthors">McGann, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">897-906</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The docking performance of the FRED and HYBRID programs are evaluated on two standardized datasets from the Docking and Scoring Symposium of the ACS Spring 2011 national meeting.  The evaluation includes cognate docking and virtual screening performance.  FRED docks 70 % of the structures to within 2 Å in the cognate docking test.  In the virtual screening test, FRED is found to have a mean AUC of 0.75.  The HYBRID program uses a modified version of FRED's algorithm that uses both ligand- and structure-based information to dock mols., which increases its mean AUC to 0.78.  HYBRID can also implicitly account for protein flexibility by making use of multiple crystal structures.  Using multiple crystal structures improves HYBRID's performance (mean AUC 0.80) with a negligible increase in docking time (∼15 %).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDNF1kmgp-WLVg90H21EOLACvtfcHk0ljEw4RBlYWZjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1ens7bO&md5=299f2e795ca922412f57df9434b52661</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs10822-012-9584-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-012-9584-8%26sid%3Dliteratum%253Aachs%26aulast%3DMcGann%26aufirst%3DM.%26atitle%3DFRED%2520and%2520HYBRID%2520Docking%2520Performance%2520on%2520Standardized%2520Datasets%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2012%26volume%3D26%26spage%3D897%26epage%3D906%26doi%3D10.1007%2Fs10822-012-9584-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span> <i>SZYBKI</i>, version 1.9.0.3; <span class="NLM_publisher-name">OpenEye Scientific
Software</span>: <span class="NLM_publisher-loc">Santa Fe, NM</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+SZYBKI%2C+version+1.9.0.3%3B+OpenEye+Scientific%0ASoftware%3A+Santa+Fe%2C+NM%2C+2016."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DSZYBKI%26pub%3DOpenEye%2520Scientific%250ASoftware%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v5z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v5z','PDB','2v5z'); return false;">PDB: 2v5z</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i80"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01588">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_83715"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01588">10.1021/acs.jmedchem.7b01588</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">SMILES string for the 25 final compounds described in <a class="ref showTableEvent internalNav" href="#tbl2">Table <a class="ref showTableEvent internalNav" href="#tbl2">2</a></a> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01588/suppl_file/jm7b01588_si_001.csv">CSV</a>)</p></li><li><p class="inline">Molecular modeling (Docking) studies and <sup>1</sup>H and <sup>13</sup>C NMR spectral data for the 25 final compounds <b>10a</b>–<b>s</b>, <b>21</b>, <b>22</b>, <b>25</b>, <b>26</b>, <b>29</b>, and <b>32</b> and all synthetic intermediates described in the <a class="ref internalNav" href="#sec4">Experimental Section</a>; HPLC data to establish final product purity(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01588/suppl_file/jm7b01588_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01588/suppl_file/jm7b01588_si_001.csv">jm7b01588_si_001.csv (1.39 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01588/suppl_file/jm7b01588_si_002.pdf">jm7b01588_si_002.pdf (9.07 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01588&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-16%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01588%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01588" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991be51c972458","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
